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Abstract 
We are currently in the midst of a revolution in ageing research, with several 
dietary, genetic and pharmacological interventions now known to modulate ageing 
in model organisms. Whilst it has been known for almost 100 years that dietary 
restriction (DR) extends lifespan across wide evolutionary distances, the 
mechanisms through which it acts are still unknown. Using three different 
recombinant inbred ILSXISS mouse strains, which vary in response to DR; from 
lifespan extension to lifespan shortening, my PhD has sought to identify the 
mechanisms involved in DR-induced lifespan extension. Ultimately by exploiting the 
genetic heterogeneity of these mouse strains may help identify the mechanisms 
through which DR acts to slow ageing. During my PhD I (1) examined how these 
animals respond metabolically to DR, (2) determined the impact of DR on 
mitochondrial function, as mitochondrial dysfunction is a well characterised hallmark 
of ageing, and DR is known to attenuate age-related mitochondrial dysfunction, and 
(3) investigated proteostasis in these mice using isotopic labelling. A number of 
metabolic changes were found to be important to lifespan extension with DR, 
namely maintenance of gonadal white adipose tissue (WAT) stores and increases 
in brown adipose tissue (BAT). Conversely, large losses of WAT was associated 
with lifespan truncation following 40% long-term DR. Surprisingly, enhanced 
glucose homeostasis was not found to be a prerequisite to lifespan extension with 
DR. Hepatic mitochondrial dysfunction associated with reduced lifespan of TejJ114 
mice under 40% DR, but similar dysfunction was not apparent in skeletal muscle 
mitochondria, highlighting tissue-specific differences in the mitochondrial response 
in ILSXISS mice to DR. Increased proteostasis as measured by the 
newprotein/newDNA ratio, was increased following short-term DR, highlighting 
increased synthesis of cytoplasmic proteins in the skeletal muscle as important to 
DR-induced lifespan extension, however results were  both tissue and protein 
specific. The evidence produced in this thesis strongly suggests that numerous 
aspects of metabolism and mitochondrial function are associated with lifespan 
shortening, and that the inability for metabolic adaptability may be detrimental to 
lifespan. This thesis helps to elucidate the impact of genotype on key hallmarks of 
DR and highlights the importance of utilising both genders and genetically 
heterogeneous murine strains in order to understand the shared features of slowed 
ageing.    
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Chapter 1: General Introduction 
 
1. Overview 
 
The ageing process is characterised by progressive loss in cellular 
homeostasis and a decline in physiological function, resulting in a decline in 
fecundity and increased risk of mortality over time (Balcombe & Sinclair 2001). While 
ageing was historically believed to be an inevitable and intractable process (for 
discussion see  (Kirkwood & Holliday 1979; Kirkwood 2005; Kirkwood 2008; Munch 
et al. 2008), we now know that ageing can be modulated through various 
environmental, genetic and pharmacological interventions including dietary 
restriction (DR) (Kenyon 2005; Mair & Dillin 2008; Rikke et al. 2010; Swindell 2012; 
Gems & Partridge 2013). DR is defined here in this thesis as a reduction in overall 
energy intake, or in specific components of the diet, relative to that consumed 
normally by individuals with ad libitum (AL) access to food. DR has been repeatedly 
shown to extend lifespan in a wide range of taxonomically diverse organisms (Mair 
& Dillin 2008; Selman 2014a), although the specific mechanism(s) through which 
DR induces its beneficial effects remains unclear. More recently pharmacological 
interventions, many of which appear to act as DR mimetics; including rapamycin 
and metformin, have been shown to extend lifespan in model organisms (Harrison 
et al. 2009; Anisimov et al. 2008; Bjedov & Partridge 2011). This has led to renewed 
hope in identifying realistic, efficacious and safe pharmacological interventions that 
will increase healthspan, which is  the period of our life free from age-related 
diseases (Selman 2014a). Excitingly, evidence exists that some molecular 
processes altered by different lifespan interventions may overlap, thereby 
suggesting some level of commonality (Selman et al. 2009; Yan et al. 2012), 
although such commonality has not been reported in all comparisons (Masternak et 
al. 2004; Bhattacharya et al. 2012; Fok et al. 2014).  
In humans, DR is associated with a number of physiological and metabolic 
improvements to health, although the impact on human longevity remains unclear 
(Fontana & Partridge 2015). Moreover, the level of DR required to induce beneficial 
effects in humans and the chronic nature of typical DR regimes suggest that it is 
unlikely to be a feasible lifestyle choice for most humans. Therefore the 
development of mimetics which capture the beneficial effects of DR, but circumvent 
the unrealistic levels of self-restraint required, will be instrumental in the 
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improvement of human health during ageing (as discussed in Fontana & Partridge 
2015). One other potentially confounding factor in the efficacy of DR in studies, with 
particular relevance to human studies, is the impact of genetic heterogeneity on the 
responsiveness of individuals to DR. Most DR studies are conducted using inbred 
mice (specifically C57BL/6), but evidence is emerging to suggest that the 
effectiveness of DR in slowing ageing is highly sensitive to the effects of genetic 
background (Mitchell et al. 2016; Liao et al. 2010; Rikke et al. 2010; see Swindell 
2012 for review).  
1.1 Background and History of DR 
Humans are now the longest-lived land-based mammal, with an exponential 
increase in life expectancy observed over the past century. In 2010, 524 million 
people globally were estimated to be 65 years of age or older, with this number 
predicted to increase to 1.5 billion by 2050, representing 16% of the world’s 
population (WHO data, see also Suzman et al. 2015 for discussion). This increased 
proportion of elderly in the population has been coined “the silver tsunami” (See Fig 
1.1) (Mitchell 2014; Barusch 2013).  
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Figure 1.1:  Predicted proportion of the population over the age of 60 by (A) 2020 
and (B) 2050. Adapted from World Health Organisation data 
(http://www.who.int/ageing/en/). 
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However, while human life expectancy continues to grow, there is currently 
a growing disconnect between longevity and healthspan; healthspan defined here 
as the period of life free from age-related disease (Figure 1.2). Ageing is the primary 
risk factor for a host of maladies including obesity, sarcopenia, atherosclerosis, 
cancer, type II diabetes mellitus and neurodegenerative disorders (Dietz et al. 
2015). Furthermore, type II diabetes predisposes to vascular and non-vascular 
dementia (Chatterjee et al. 2016), thus highlighting the prevalence of comorbidities 
associated with old age. As the number of elderly individuals in the population 
continues to increase, and thus the proportion of the population suffering from age-
related disease increases, this is undoubtedly going to lead to significant socio-
economic implications in terms of increased costs of health and social care (Bartels 
& Naslund 2013), with fewer people of working age available for care and support. 
In order to enhance the wellbeing of the aged populous, but also to alleviate some 
of the societal strain, it will be imperative to attempt to bridge the gap between 
lifespan and healthspan, in order to compress this period of morbidity and to 
maintain health and vitality in old age.  
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Figure 1.2:  Aim of gerontological research; to compress the period of morbidity and 
to extend the period of life free from age-related disease.  
 
The rate at which organisms age is not universal, with huge variation in life 
expectancy across taxa; from the Greenland shark (Somniosus microcephalus), 
which can live for over 400 years (Nielsen et al. 2016), to the Mayfly 
(Ephemeroptera) which typically lives for 1-2 days (Carey 2002). Furthermore, bats 
and birds live substantially longer on average than non-flying mammals of similar 
body size. Even within mammals, significant variation in ageing rate is observed, 
with rodents of similar sizes having highly variable life expectancies. For example, 
the typical laboratory rat (Rattus norvegicus), lives on average 2 years, the red 
squirrel (Sciurus vulgaris) lives 10 years in captivity, the grey squirrel (Sciurus 
carolinensis) 20 years in captivity and the naked mole rat (Heterocephalus glaber) 
which lives up to 32 years in captivity (Lifespan data from anAge:The animal 
longevity data base; http://genomics.senescence.info/species/). Organisms such as 
hydra, or the immortal jellyfish (Turritopsis dohrnii), appear to forgo the classical 
ageing process and exhibit negligible senescence. Consequently comparative 
biological approaches has been employed relatively successfully to help understand 
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the ageing process, by utilising species with exceptionally slow or rapid ageing 
(Austad 2010).  
1.2 Experimental DR 
DR-induced lifespan extension was first reported approximately one century 
ago, by Osborne et al. in their seminal paper (Osborne et al. 1917), in which they 
reported that restriction of food intake in rats, below that of AL fed counterparts, 
dramatically extended lifespan but decreased reproductive output. Similarly, in 1935 
McCay et al., reported that 40% DR in white rats, from the age of weaning, resulted 
in a significant increase in longevity (McCay et al. 1935). Subsequently, numerous 
studies in a range of species, but most notably in mice, have shown that reductions 
of food intake ranging from 5% to 50% below that eaten by AL controls have a 
significantly greater median and maximal lifespan (Weindruch 1996; Weindruch et 
al. 2001; Ladiges et al. 2009; Kim et al. 2008). In addition to rodents, DR has shown 
beneficial lifespan effects in a wide range of species, spanning several animal taxa 
(as discussed in Mair & Dillin 2008; Masoro 2005) from yeast (Sacchromyces 
cerevisiae) (Fabrizio & Longo 2003), to the nematode worm (Caenorhabditis 
elegans) (Braeckman et al. 2006), to the fruit fly (Drosophila melanogaster) 
(Partridge et al. 2005). This has led to the widely held belief that DR-induced 
longevity is mediated by an evolutionarily conserved mechanism (Le Bourg & Rattan 
2006; Le Bourg 2010; Mair & Dillin 2008). Furthermore, reports in non-model 
organisms such as cattle (Bos Taurus) (Pinney et al. 1972), dogs (Canis 
domesticus) (Lawler et al. 2008) and non-human primates (Macaca mulatta) 
(Mattison et al. 2017) further bolster this premise (Figure 1.3). Therefore, if  the 
beneficial effects of DR are ubiquitous, the argument is that it should confer 
significant longevity benefits to humans (Fontana & Partridge 2015).  
However, despite the well-publicised beneficial effects of DR on lifespan and 
a wealth of candidate mechanisms (see Table 1.1) being proposed as driving DR-
induced longevity, the precise processes through which DR act mechanistically, 
remains elusive. It has been proposed that the lack of consensus regarding 
determining the mechanistic basis of DR relates to the fact that most candidate 
hypothesis focus on a single underlying mechanism, whereas in reality DR is most 
likely underpinned by a number of interconnected mechanistic processes (Masoro 
2009). To further confuse the issue, the beneficial effect of DR on lifespan has not 
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been reported in house-flies,  rotifers or in several mouse strains (Kirk 2001; Cooper 
et al. 2004; Harper et al. 2006; Forster et al. 2003).  
 
 
 
 
Figure 1.3: DR improves longevity in a host of taxonomically diverse organisms. 
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1.3 Variation in DR protocols  
Model systems are invaluable to DR studies, in helping to identify common 
mechanisms which are evolutionary conserved across taxa, and in discerning the 
potential processes underlying DR extension. However, several differences in DR 
protocols arise across species, as a consequence of variation in life history traits, 
making it difficult to directly compare results across model organisms. 
Saccharomyces Cervisae, Caenorhabditis Elegans and Drosophila Melanogaster, 
are typically restricted through dilution of the diet through some indigestible 
component (See Table 1.1 for definitions). However, different DR regimes are likely 
to alter lifespan through different, yet potentially overlapping, mechanisms (Greer & 
Brunet 2009), making it difficult to recapitulate the likely responses to DR in 
mammals. Even within mammals, numerous variations have arisen in restriction 
protocols, and these protocol differences are likely to influence the outcome of DR 
(Anson et al. 2005). For example, age at onset of restriction is likely to impact 
response to DR ( Selman 2014). An additional issue that arises in DR studies is that 
certain strains of over eat and AL controls may experience reduced lifespan as a 
result of obesity (Keenan et al. 1996; Keenan et al. 1997). To overcome this, 
numerous studies restrict the AL controls (by 5-10%) (Mattison et al. 2012; Mattison 
et al. 2017), however it has been found that even mild restriction (8%) has a host of 
beneficial effects in Fischer 344 rats (Kim et al. 2008). Other restriction protocols 
such as alternate day fasting or intermittent fasting (IF) involve periodic cycles of 
DR, also result in lifespan extension in rodents but do not lead to loss of body mass, 
(Mattson et al. 2014; Goodrick et al. 1990; Anson et al. 2003). Furthermore, time 
sensitive feeding; restricting food access to 8 hours during the active phase (during 
dark hours) or for only 4 hours during the light phase, is sufficient to see beneficial 
effects in both health and on lifespan in mice (Chaix et al. 2014; Asher & Sassone-
Corsi 2015). Despite calorie intake being equal to AL counterparts, the mice subject 
to time restricted feeding are afforded protection against hepatic steatosis, 
hyperinsulinemia and obesity. Moreover, mice maintained on high-sugar or high-fat 
diets but subject to daily fasting intervals, are found to do better in endurance testing 
than AL non-fasted mice on regular diet (Chaix et al. 2014).  
Classic DR involves the percentage reduction in the overall nutrient intake of 
the experimental group of animals, calculated from the intake of the AL control 
group, without causing malnutrition. As a result the DR mice experience reduction 
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in their gross calorific intake. Caloric restriction (CR) refers solely to the restriction 
of calories, whereas DR can encapsulate the reduced intake of both calories and 
micro/macro-nutrients, as an overall reduction in dietary nutrients will result in 
reduced calorie intake by proxy. Numerous variations on DR have come into 
existence since classical restriction in 1917, including, but not limited to, protein 
restriction, methionine restriction, macronutrient manipulation (definitions 
summarised in Table 1). Protein restriction (PR) results in decreased IGF-1 levels 
in middle-aged humans, a common outcome seen in animals following DR, and is 
associated with reduced incidence of cancer and all-cause mortality in mice and 
humans (Levine et al. 2014). Wistar rats on 40% PR for 7 weeks had decreased 
hepatic mitochondrial reactive oxygen species (ROS) production and reduced 
oxidative damage to nuclear and mitochondrial DNA (mtDNA), and increased 
lifespan (Sanz et al. 2004; Ayala et al. 2007). In these same studies, similar changes 
were also observed under 40% DR, suggesting that at least some of the beneficial 
effects of DR can be related to nutritional intake over calories, however response 
was smaller than with 40% DR (Sanz et al. 2004; Ayala et al. 2007). Findings that 
alterations in the ratio of macronutrient intake, in terms of carbohydrate and protein 
content, in mice suggest an association between macronutrient intake and lifespan, 
with confirmed health and longevity benefits detected with a low protein, high 
carbohydrate diet (Solon-Biet et al. 2015). Restriction of the single amino acid, 
methionine, extends longevity in numerous model systems from yeast to rodents 
(Madeo et al. 2015; Edwards et al. 2015; Grandison et al. 2009). Restriction of 
dietary methionine by 80%, leads to a reduction of ROS production by mitochondria 
(Sanz et al. 2006; Pamplona & Barja 2006), restores a younger metabolic phenotype 
to adult mice, in terms of body mass, adiposity and insulin resistance, (Lees et al. 
2014) and leads to an increase in lifespan in rats (Orentreich et al. 1993; Richie et 
al. 1994) and mice (Sun et al. 2009; Miller et al. 2005). Thus numerous methods of 
restriction, such as time-restricted restriction, or restriction of dietary components, 
have the potential to induce health benefits without adhering to chronic DR. 
However, as is the case with DR, the question remains as to what mechanistic 
processes are involved in order to identify effective dietary interventions for 
beneficial effects on health and lifespan. 
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 Table1.1: Summary of definitions used in DR literature 
Abbreviation Name Definition 
 
AL 
 
Ad libitum 
 
Food freely available. Animals can potentially over 
consume 
 
WM Weight 
Maintenance 
As AL, however animals are prevented from over 
consuming through slight restriction (5-10%). 
Weight is maintained but development of obesity 
is prevented 
 
DD Dietary 
Dilution 
Diet is diluted to a variable extent with inert 
indigestible component, e.g. cellulose and water 
(Drosophila) 
 
CD Calorie 
Dilution 
 
Diet is diluted to reduce caloric content. Shortfall 
in calories offset by increase in protein 
 
PD Protein 
Dilution 
Diet is diluted to reduce protein content. Protein 
content can vary <20% = PD, >20% = Protein 
Enrichment  
 
DR Dietary 
Restriction 
Reduction in overall intake, without causing 
malnutrition, but insufficient to make daily energy 
demands. Includes alterations of micro and macro-
nutrients. Food is same composition as fed to AL 
controls 
 
CR Caloric 
Restriction 
Deficit in calories alone. Insufficient calories to 
make daily energy demands. Food is same 
composition as fed to AL controls 
 
PR Protein 
Restriction 
 
Restriction of protein intake 
MR Methionine 
Restriction 
 
Restriction of dietary essential amino acid 
methionine 
IF Intermittent 
Fasting 
Fasting period of 24hs where food is not provided. 
The number of 24h fasting periods is equal to or 
less than 50% of the total days 
 
EOD Every Other 
Day Feeding 
Fasting period of 24hs where food is not provided, 
every other day. The number of 24h fasting 
periods is less than 50% of the total days 
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2. Effects of DR 
 
2.1 Lifespan extension and DR 
 
Enhanced mouse longevity in response to DR has been reported extensively 
(Forster et al. 2003; Rikke et al. 2003; Rikke & Johnson 2007; Turturro et al. 1999; 
Weindruch & Walford 1988) (Figure 1.4). However, it is becoming increasingly 
apparent that lifespan extension with DR is modulated by a number of factors. For 
instance, differences in DR protocol, including magnitude and age of onset, appear 
to be important to DR outcome. Reports of DR induced lifespan extension being 
dose-dependent, implicate magnitude of DR as important to the extent of the 
longevity effect, with higher magnitudes of DR appearing to promote greater 
increases in lifespan extension to an upper limit (Figure 1.4) (Weindruch et al. 1986). 
In addition, the age at which DR is initiated appears to impact lifespan, with a greater 
longevity effect apparent when initiated earlier, compared to a diminishing effect 
(Dhahbi et al. 2004; Weindruch & Walford 1982), no effect (Lipman et al. 1995), and 
even a negative effect (Forster et al. 2003), when initiated in middle-age or later in 
life. A meta-analysis, which set out to investigate DR lifespan response across 
gender and taxa found that DR was more effective at extending lifespan in model-
species (fruit fly, nematode worm, yeast, mice and rats) than non-model species 
(Nakagawa et al. 2012). This may suggest a co-adaptive response to DR under 
laboratory conditions, and may explain some of the apparent lack of effects seen in 
some non- model organisms following DR, or alternatively, perhaps a lack of power 
in non-model studies. Moreover, DR was found to generally be more effective at 
extending female lifespan in all species (Nakagawa et al. 2012). 
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Figure 1.4: Dose-dependent response in C3B10RF mice (Females from the 
C3H.SW/Sn inbred strain X males from the C57BL10.RIII/Sn inbred strain) in 
response to varying levels of DR (Data adapted from Weindruch et al. 1986). 
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The C57BL/6 mouse has a robust and reproducible pro-longevity effect with 
DR (Turturro et al. 1999; Weindruch & Walford 1988) and is the most commonly 
used strain in ageing research. However, recently, questions have been raised 
about the translatability of mouse research, the majority of which has been carried 
out on this one strain, to a genetically heterogeneous population, such as humans 
(Miller 2016). A recent study sought to address this problem, and investigate 
reproducibility of results when genetic background is altered slightly. Male C57BL/6J 
mice heterozygous for null alleles of Cacna1c and Tcf7l2 were crossed with wild-
type females from 30 inbred laboratory strains to produce an F1 cross (Sittig et al. 
2016). They found genetic background to be a key determinant of phenotype, more 
so than gender, and found that altering genotype sometimes gave opposite 
conclusions on certain interactions than on the classic C57BL/6 background. Indeed 
the importance of genotype in DR research is becoming increasingly apparent, with 
genetic background appearing to be a crucial factor in both the magnitude and 
direction of the DR response. The DBA/2 mouse for example, has previously been 
reported as unresponsive to DR-induced lifespan extension (Fernandes et al. 1976), 
but has also reported to show a shortening of lifespan under DR (Forster et al. 2003). 
However, in a recent comprehensive assessment of different magnitudes of DR on 
lifespan and healthspan in the DBA/2 and C57BL/6 mouse (Mitchell et al. 2016), it 
was found that the strains had different optimal levels of DR on which lifespan was 
maximised. The DBA/2 mouse was found to have better survival, relative to AL 
controls, when subject to 20% DR rather than 40% DR, unlike the C57BL/6 mouse. 
Moreover, the DR effects in the DBA/2 mouse are less than that of the C57BL/6 
mouse. These results indicate that magnitude of DR is a key mediating variable in 
lifespan extension with DR, and that the degree of restriction can exert strain-
specific lifespan responses. Aside from the monopoly of research being carried out 
on one genotype to date (C57BL/6), the majority of DR studies have been carried 
out on male animals and the role of gender has largely been overlooked. In addition 
to genotype differences, Mitchell et al highlight a number of sex-specific responses 
to DR (Mitchell et al. 2016). For instance, C57BL/6 females did not show DR-
induced lifespan extension under 40% DR, relative to AL controls, unlike male 
animals from this strain, and had higher percentage increase in lifespan under 20% 
DR than males. DBA/2 females had no further benefits from 20% to 40% DR, thus, 
implicating gender as important to DR response (Mitchell et al. 2016). 
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2.2 Healthspan 
 
In addition to enhanced longevity, DR has been shown repeatedly to elicit 
numerous health benefits. Reports of positive effects on age-associated diseases, 
attenuation of functional decline, and inhibition of malignant tumour growth have 
been detected in a number of species (Gross & Dreyfuss 1984; Kritchevsky 2002; 
Tannenbaum 1940; Richard Weindruch & Sohal 1997; Weindruch et al. 1986). DR 
protects animals against a range of age-related and non-age-related pathologies, 
including various cancers, glaucoma, glucose intolerance and sarcopenia 
(Weindruch & Walford 1982; Sheldon, Warbritton, et al. 1995; Sheldon, Bucci, et al. 
1995; McKiernan et al. 2004; Hempenstall et al. 2010). Furthermore, DR decreases 
pathogenesis and increases survival in a range of mouse disease models of disease 
including  a model of neuronal loss used to mimic Parkinson's disease (C57BL/6 
mice administered the toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
(Duan & Mattson 1999), as well as mouse models for Alzheimer's disease (3xTgAD 
mice) (Halagappa et al. 2007), viral myocarditis (obese KKAy mice) (Kanda et al. 
2007) and pancreatic cancer (LSL-KrasG12D/+; Pdx-1/Cre mice) (Lanza-Jacoby et 
al. 2013). The positive effects of DR on healthspan also extend to Rhesus monkeys, 
where the incidence of cancer, cardiovascular disease, type-II diabetes mellitus and 
brain atrophy during are reduced in DR monkeys relative to AL controls (Colman et 
al. 2014; Mattison et al. 2017; Colman et al. 2009; Mattison et al. 2012).  
However, as with the effect of DR on lifespan, DR-induced effects on 
healthspan also show considerable sexual dimorphism. Sex-specific differences in 
glucose homeostasis and in relation to magnitude of DR (20% or 40%) in both 
C57BL/6 mice and DBA/2 mice have been reported (Mitchell et al. 2016). While 
improvements in fasting plasma insulin were observed in male mice of both strains 
following DR, females did not undergo any changes in insulin levels. In rats, 
following 3 months of 30% DR, mitochondrial function in terms of bioenergetics, 
oxidative balance and respirations was found to be sex-specific under both AL and 
DR conditions (Valle et al. 2008), and females were found to have an advantageous 
metabolic efficiency compared to males following DR (Valle et al. 2005). Moreover, 
following DR rhesus macaque monkeys exhibit a sexually dimorphic glucose 
response, in terms of fasting blood glucose levels. Additionally, females displayed 
a different association between food intake and body weight than males, although 
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the effects were found to change with age, highlighting gender-specific differences 
in the allocation of nutritional resources influencing both body composition and 
metabolism (Mattison et al. 2017). It is difficult to directly compare results between 
male and female responses to DR owing to the traditional heavy historical bias 
towards use of male animals in DR studies, and a lack of side-by-side comparisons 
of male and females in response to DR. In May 2014, the NIH issued a policy 
statement promising to redress this imbalance (Clayton & Collins 2014). In terms of 
biomedical research, the inclusion of both sexes is compulsory as results from one 
gender cannot be reliably extended to the other (Austad & Bartke 2015). 
Accumulating evidence reports that DR has numerous protective health 
effects against comorbidities of ageing. DR protects against obesity, type 2 diabetes 
and coronary heart disease in humans (Fontana et al. 2007), and reduces risk 
factors associated with cardio vascular disease (Fontana et al. 2004). Furthermore, 
DR has been shown to have beneficial effects on cardiac function (Stein et al. 2012), 
glucose tolerance and insulin action, in terms of reduced insulin levels, as well as 
improved insulin sensitivity (Weiss et al. 2006), and reportedly ameliorates age-
associated decline in diastolic function (Meyer et al. 2006). DR additionally results 
in a reduction in circulating levels of inflammatory cytokines and adipokines, 
anabolic hormones and growth factors, several of which are associated with 
increased cancer risk, and DR can inhibit the development of tumour growth in 
human models (Fontana et al. 2013). One year of 20% DR in humans decreased 
body mass, as well as visceral and subcutaneous fat (Racette et al. 2006), while 6 
months of 25% DR improves mitochondrial function in young non-obese adults 
(Civitarese et al. 2007). Brown adipose tissue is decreased in elderly humans, 
compared to young individuals (Saito et al. 2009), and while DR induces browning 
of white adipose tissue in mice (Fabbiano, Suá Rez-Zamorano, et al. 2016), the  
impact of DR on BAT in humans remains to be determined.  
2.3 DR- A Universal Modulator of Ageing? 
 
In order for DR research to be translatable to humans, the mechanistic basis 
through which DR acts to slow ageing needs to be conserved across distantly 
related organisms, or taxonomically diverse species (Partridge & Gems 2002). 
These mechanisms are therefore public, that is shared across large evolutionary 
distances. Conversely, private mechanisms of ageing are specific to particular 
species, taxa, or even particular genetic backgrounds. As data emerge from multiple 
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model systems, and murine strains, debate grows over the ubiquitous nature of DR 
on lifespan extension. The use of genetically heterogeneous mouse models will be 
important to DR research in identifying universal mechanisms of slowed ageing.   
    
2.4 ILSXISS Mice  
Recently, lifespan was assayed in heterogeneous ILSXISS recombinant 
inbred (RI) mice derived from eight distinct mouse strains  (Liao et al. 2010; Rikke 
et al. 2010). In two separate studies undertaken by the Universities of Texas and 
Colorado, clear lifespan differences existed between distinct ILSXISS lines under 
40% DR. The Liao et al. study examined 39 female lines and 41 male lines under 
DR and reported that only 21% of female and 5% of male lines showed a significant 
lifespan extension under DR (Liao et al. 2010). In this study, a higher number of 
lines (26% and 27% for males and females, respectively) showed a significant 
shortening of lifespan under DR (Figure 1.5). Similarly, Rikke et al. examined 42 
separate female lines and reported a significant strain-specific difference lifespan 
following DR, with 21% of females showing lifespan extension and 19% showing 
significant truncation of lifespan under DR (Rikke et al. 2010) (Figure 1.6). While 
surprising, these results are not actually unprecedented. Several DR studies have 
reported no lifespan extension following DR; white rats (McCay et al. 1939), certain 
inbred mouse strains (e.g. C57BL/6 and DBA/2) (Cheney et al. 1980; Harrison & 
Archer 1987; Forster et al. 2003), and laboratory-reared descendants of wild-caught 
mice (Harper 2008). These genotype-dependant lifespan responses have been 
proposed as a means of probing candidate mechanisms of DR induced lifespan 
extension, i.e. by comparing responses between “positive” and “negative” DR 
responders (Sohal et al. 2009; discussed in Swindell 2012). Furthermore, 
comparisons across strains with differential lifespan responses to DR would allow 
the uncoupling of lifespan/healthspan benefits. By disentangling  DR responses 
which co-occur with lifespan extension from those that occur following DR in strains 
which experience lifespan truncation following DR, additional insight into how DR 
acts to slow ageing can be gleaned (Selman 2014a). Indeed, the strain-specificity 
of these mice has been utilised previously in order to draw conclusions on how 
genotype may alter well characterised DR responses. For instance,  it is widely 
established that DR leads to a reduction in body temperature (Tb), first described in 
rodents by Weindruch et al (Weindruch et al. 1979), and subsequently by numerous 
41 
 
other rodent studies (Carrillo & Flouris 2011; Turturro & Hart 1991; Ferguson et al. 
2007), humans (Soare et al. 2011) and in non-human primates (Lane et al 1996). 
This reduction of Tb has been suggested to play a direct mechanistic role in the 
beneficial effect of DR on lifespan (Turturro & Hart 1991; Jin & Koizumi 1994). 
Utilising the strain-specific lifespan response of the ILSXISS RI mice, 28 lines of 
female mice were maintained on 40% DR to assess the link between reduced Tb 
with DR and life extension (Rikke et al. 2003). Not only was significant strain 
variation observed, ranging from a 1.5⁰ C to a 5⁰ C reduction in Tb relative to AL 
controls, but reductions correlated well with lifespan response, enabling Rikke et al 
to conclude that that maintenance of Tb above a critical threshold is important to the 
beneficial effects of DR. 
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Figure 1.5: Lifespan response following 40% DR across a panel of 39 female and 
41 male strains of recombinant inbred ILSXISS mice. Variation in lifespan in 
response to DR ranges from lifespan extension, no effect on lifespan, to lifespan 
shortening. *=statistically significant from AL controls. (Data taken from Liao et al. 
2010).  
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Figure 1.6 : Lifespan response following 40% DR across a panel of 42 strains of 
recombinant inbred female ILSXISS mice. Variation in lifespan in response to DR 
ranges from lifespan extension, no effect on lifespan, to lifespan shortening. 
*=statistically significant from AL controls. (Data taken from Rikke et al. 2010).  
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3. Candidate Mechanisms of DR 
 
A number of mechanisms have been proposed as mediating the DR 
response (Fontana & Partridge 2015; Shimokawa & Trindade 2010; Masoro 2005; 
Hine et al. 2015; Anderson & Weindruch 2010). For instance, DR promotes 
proteostasis (Cuervo 2008), reduces insulin/insulin-like growth factor 1 (IGF-1) 
signalling, reduces oxidative stress and /or increases antioxidant protection (Cohen 
et al. 2004), and enhances mitochondrial function (López-Lluch et al. 2008; Nisoli et 
al. 2005). Furthermore, there are nine described hallmarks of ageing; genomic 
instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated 
nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell 
exhaustion, and altered intercellular communication (Lopez-Otin et al. 2013). These 
hallmarks encompass shared characteristics of ageing across the animal kingdom, 
with special emphasis on mammalian aging. Several of these hallmarks are known 
to be positively affected with DR, such as enhanced mitochondrial function (López-
Lluch et al. 2008; Nisoli et al. 2005) and proteostasis (Cuervo 2008), and have 
therefore become extensively studied as candidate mechanisms for lifespan 
extension. 
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Figure 1.7: Plausible candidate pathways through which DR may act to improve 
health and longevity. 
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3.1 Physiology 
 
3.1.1 DR induced changes in body mass and adiposity 
Ageing is characterised by increased body mass, obesity, decline in organ 
function and increased mortality risk (Fontana et al. 2007; Klein et al. 2002; Fontaine 
et al. 2003). DR is associated with a reduction in body mass and body fat, and thus 
decreases in both have been proposed as relating to DR-induced longevity (Berg & 
Simms 1960; Masoro 2005). Excess visceral adiposity is associated with insulin 
resistance, type II diabetes, and metabolic syndrome in mammals (Després & 
Lemieux 2006; Bartke & Brown-Borg 2004). It remains unclear, however, as to how 
alterations in body mass and adiposity relate to the underlying molecular and 
physiological mechanisms through which DR acts to extend lifespan. The reduction 
of fat hypothesis, originally posited by Berg and Simms (Berg & Simms 1960), 
proposed that decreased fat stores underpin DR-induced longevity following reports 
of increased lifespan in rats following either 33% or 46% DR to be associated with 
reduced fat accumulation. Following on from this it was later proposed that 
alterations in adiposity following DR, specifically reductions in visceral fat depots, 
underlie DR-induced longevity (Muzumdar et al. 2008). However, the role of reduced 
fat mass in the life-extending effect is a complex one and there are several 
arguments which contest the relevance to DR (Bertrand et al. 1980; Harrison et al. 
1984; Liao et al. 2011). Moreover, a positive association between body weight and 
survival outcome has been observed in several murine studies, including C57BL/6J 
mice, wild mice, and recombinant inbred ILXISS strains (Goodrick et al. 1990; 
Harper et al. 2006; Rikke et al. 2010; Weindruch et al. 1986). Indeed, survival 
outcomes of C57BL/6 and DBA/2 mice maintained on 20% and 40% were highest 
in individuals which better preserved fat mass in the second year of life (Mitchell et 
al. 2016), suggesting ability to maintain fat as important to lifespan extension. Strain-
specific losses of fat mass in response to DR exist and have been linked to the 
direction of lifespan response. ILSXISS recombinant inbred mouse strains with the 
smallest reductions in fat mass under DR, relative to their appropriate AL controls, 
were more likely to show life extension and those with the greatest reductions were 
more likely to have truncation of lifespan (Liao et al. 2011). This suggests that loss 
of body fat, beyond a critical threshold, as detrimental to lifespan extension with DR. 
One potential pitfall of this association however, discussed in Speakman et al. 
(Speakman & Mitchell 2011), highlights that the association would not uphold if 
47 
 
carried out in the “positive responding” strains alone. Therefore the association 
between the lifespan effect of DR and change in body fatness is only detected in 
the strains where DR impacts negatively on lifespan (Speakman & Mitchell 2011).  
DR invariably leads to a reduction in BM and alterations in body composition. 
However, what is clear is that the weight loss following DR is not uniform between 
different tissue and organs. For example loss of white adipose tissue (WAT) is 
disproportionately large compared to reductions in lean and organ mass (Bertrand 
et al. 1980; Speakman & Mitchell 2011), with WAT preferentially utilised as an 
energy source whilst under DR (Mitchell et al. 2015a). Up until relatively recently 
this was considered the primary function of adipose tissue, however it has become 
clear that adipose tissue performs many vital endocrine roles (Ahima & Flier 2000), 
and therefore it is important that not all stocks become depleted when faced with 
DR. Instead reductions at other sites, such as reductions in lean mass, and organs 
with a high metabolic demand, have been reported under DR (Hempenstall et al. 
2010; Mitchell et al. 2015a), presumably as a way to reduce energy expenditure. 
Furthermore, brown adipose tissue has been implicated as crucial to 
thermoregulation, and the ability to effectively thermoregulate has been shown to 
be  important to DR-induced longevity in ILSXISS mice (Rikke et al. 2003).   BAT is 
specialised for the dissipation of energy through the production of heat. Increased 
levels of WAT are characteristic of ageing (Barzilai & Gupta 1999a; Das et al. 2004; 
Masoro 1999). Smaller BAT depots are associated with old age in mice (Rogers et 
al. 2012), whereas larger phenotypes associated with a healthier metabolic 
phenotype in humans (Saely et al. 2011). Therefore interventions which increase 
BAT have been proposed as a means of affording protecting against diseases of 
ageing and improved insulin sensitivity (Mattson 2010; Dionne et al. 2016; Stanford 
et al. 2013). BAT catabolises lipids to produce heat, a function that is mediated via 
a unique biochemical property of the mitochondria in brown adipocytes; uncoupling 
protein 1 (UCP1), in a process known as non-shivering thermogenesis. DR is found 
to increase BAT mass and DR animals are found to have an increased capacity for 
thermogenic activity in brown adipose tissue (Fabbiano, Suarez-Zamorano, et al. 
2016; Valle et al. 2008; Himms-Hagen 1985). Moreover, DR is associated with 
enhanced fatty acid biosynthesis (Okita et al. 2012; Bruss et al. 2010). Okita et al. 
propose that under DR, WAT and BAT work synergistically together to enable a 
metabolically efficient switch from glucose as an energy source to fatty acid 
oxidation, using WAT as an energy reservoir. 
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Strain-specific responses in fat loss may be relevant to the DR response in 
mice (Liao et al. 2010; Mitchell et al. 2016) however, precisely how genetic 
background mediates adiposity, as well as reductions in BM, with DR remains to be 
elucidated. Sex-specific mechanisms have been reported to regulate energy 
balance and adiposity (Shi et al. 2007), and it is therefore likely that the sexually 
dimorphic strategies involved in regulation of body weight will have an impact on DR 
response. In most instances, females are longer lived than males (Austad & Bartke 
2015) and at reduced risk of mortality from the metabolic complications of obesity, 
despite being more obesity prone (Palmer & Clegg 2015; Vague 1947). In rats, 
changes in UCP1 and BAT levels related to the ability of females to deactivate 
facultative thermogenesis to a greater degree than males following DR (Valle et al. 
2005). This ability may have advantages for female survival whilst on DR or during 
times of nutrient scarcity, but also highlights gender specific responses in fat depots 
under DR.  
3.1.2 Glucose Homeostasis 
 Ageing is accompanied by a marked increase in skeletal muscle and hepatic 
resistance to the action of insulin. In male F344 rats lifespan extension with DR is 
found to be associated with reduced levels of plasma glucose and fasting plasma 
insulin, (Masoro et al. 1992) and reported in, in mice following long-term DR (Masoro 
et al. 1992; Rincon et al. 2005; Berryman et al. 2008; Hempenstall et al. 2012), as 
well as in monkeys (Kemnitz et al. 1994; Lane et al. 1995), and humans (Fontana 
et al. 2010). This has led to the widely accepted theory that reduced levels of plasma 
glucose and insulin underlie the life-extending effect of DR (Masoro 2005).  
Reductions of circulating levels of plasma insulin-like growth factor-1 (IGF-1) 
are widely observed in rats and mice following DR (Argentino et al. 2005; Mitchell 
et al. 2015b; Mitchell et al. 2016). Furthermore, IGF-1 appears to be more sensitive 
to DR than fasting plasma insulin levels, with 3 weeks of 30% DR in both C57BL/6 
and DBA/2 male mice, resulting in markedly lower levels of IGF-1, but having no 
effect on insulin levels (Hempenstall et al. 2010). Long-lived Ames, Snell and 
GHRKO dwarf mice have markedly lower levels of plasma IGF-1 than wildtype litter 
mates, suggesting an association between longevity and reduced plasma IGF-1 
(Brown-Borg et al. 1996; Bartke et al. 2001; Flurkey et al. 2001; Coschigano et al. 
2000). Thus, the reduction of plasma IGF-1 in mice on DR is proposed as having a 
crucial role in the life-extending effect. However, despite the widespread association 
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of reduced glucose, insulin and IGF-1 levels there are a number of observations 
which dispute the universality of this relationship with DR. Firstly, humans, unlike 
rodents do not experience a reduction in serum IGF-1 (Fontana et al. 2008; Fontana 
et al. 2016) following DR. Secondly, strain-specific differences in metabolism exist 
between C57BL/6 and DBA/2 mice (Sohal et al. 2009), and it is well established that 
DBA/2 mice vary in numerous parameters (including insulin sensitivity and glucose 
tolerance) under both AL and DR feeding when compared to C57BL/6 mice (Funkat 
et al. 2004; Berglund et al. 2008; Goren et al. 2004; Hempenstall et al. 2010). 
Consequently, exactly how metabolic profiles of different genetic backgrounds 
relate to lifespan extension with DR remains to be fully examined.  
In addition to strain-specific DR responses sex-specific responses in fasting 
plasma insulin have also been reported. In a study examining the effects of 20% 
and 40% DR on C57BL/6 and DBA/2, females, unlike males were not found to have 
a reduction in fasting plasma insulin following DR, suggesting that lower levels of 
insulin is not critical to enhance longevity (Mitchell et al. 2016). Moreover, a number 
of studies show that male rodents tend to be more insulin resistant than females 
(Goren et al. 2004; Macotela et al. 2009).  
3.2 Mitochondrial Function and DR 
The primary function of the mitochondria is the generation of cellular energy 
through the production of adenosine triphosphate (ATP) (See Figure 1.8), and 
mitochondrial dysfunction appears to play a crucial role in the ageing process (Wang 
& Hekimi 2015). Ageing is associated with altered mitochondrial morphology, 
reduced mitochondrial oxidative capacity and ATP production, increased 
mitochondrial-derived reactive oxygen species (ROS) generation and greater 
oxidative damage (Wang & Hekimi 2015). Mitochondrial dysfunction is a hallmark 
of ageing (Lopez-Otin et al. 2013), and it has been proposed that the gradual 
accumulation of mitochondrial derived ROS-induced damage underlies the ageing 
process (Nicholls 2004; Salvioli et al. 2001; Lenaz et al. 2000; Sohal et al. 1990). 
Dysfunctional mitochondria are associated with the functional decline of organs and 
tissues during ageing (Riera et al. 2016) and with a number of age-related diseases 
such as cardiovascular disease, liver and kidney disease, diabetes and cancer 
(Lane et al. 2015; Payne & Chinnery 2015; Ryan et al. 2015; Wallace 2012). 
Maintenance of mitochondrial function in old age, has therefore been posited as one 
explanation of how DR works to induce health and lifespan benefits (Ruetenik & 
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Barrientos 2015; Lanza et al. 2012).  Consequently, significant research effort has 
investigated whether DR can induce beneficial effects on the mitochondrial function, 
such as maintaining mitochondrial function during ageing, reducing ROS production 
and attenuating oxidative damage. Numerous studies have shown DR to attenuate 
damage from oxidative stress and to effectively decrease electron and proton leak 
in the mitochondria of mammalian cells (Sohal et al. 1990; Weindruch 1996; Masoro 
2000; Masoro 2009; Lopez-Torres et al. 2002; Ramsey J. et al. 2000).  
 
 
 
 
 
 
51 
 
Figure 1.8: Schematic of electron transport chain; 1. Complex I is the site of the 
initial oxidation of NADH, generated by associated Krebs cycle dehydrogenases. 
The energy generated by the transfer of the electrons from NADH to oxidised 
coenzyme Q (the first mobile electron acceptor), is dissipated by the ejection of 
protons. 2. At complex II FADH can donate electrons to Coenzyme Q (thereby 
bypassing CI and one proton ejection site). 3. Complex III receives electrons 
donated by coenzyme Q to cytochrome b, in a process that is in a near potential 
energy neutral process. Electrons are passed to cytochrome C1 with the dissipative 
ejection of protons.4. At Complex IV, following the transfer of electrons from 
Cytochrome C1 to the second mobile element in the cytochrome chain, cytochrome 
c. COX (cytochrome oxidase) is reduced, and ultimately results in the reduction of 
molecular oxygen from water. This final dissipation of the redox energy in 
NADH/FADH at site IV is also associated with a final ejection of protons. 5. In this 
manner, the cytochrome chain transforms the redox energy of the rather stable 
molecules NADH and FADH into a ΔΨ across the inner mitochondrial membrane. 
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Reports of increased mitochondrial respiration with DR in yeast (Lin et al. 
2002) and in male C57BL/6 mice (Hempenstall et al. 2012) suggest a link between 
DR and improved mitochondrial function. Mitochondrial biogenesis has also been 
proposed as being critical to the beneficial effects of DR (López-Lluch et al. 2006; 
López-Lluch et al. 2008; Lanza et al. 2012; Nisoli et al. 2005), with increases in 
mitochondrial DNA content, increased expression of mitochondrial associated 
genes (e.g. peroxisome proliferator-activated receptor gamma co-activator (Pgc-
1α), nuclear respiratory factor-1 (Nrf-1) and mitochondrial transcription factor A 
(Tfam) has been reported in a range of mouse tissues (Nisoli et al. 2005), and in 
human skeletal muscle (Civitarese et al. 2007). PGC-1α regulation is proposed as 
driving an adaptive response to DR in mitochondrial function that protects against 
age-associated DNA damage and loss of mitochondria (Hancock et al. 2011). 
Indeed, increased expression of PGC-1α has been described in the skeletal muscle 
of C57BL/6 mice (Hempenstall et al. 2012) and rats with DR (Hepple et al. 2005).  
Recently a mitohormetic response, called the unfolded protein response (UPRmt) 
has been implicated as an important regulator of longevity (Houtkooper et al. 2013; 
Mouchiroud et al. 2013; Baqri et al. 2014; Hill & Van Remmen 2014a). It is proposed 
that when subject to acute stress, which may lead to an accumulation of damaged 
or misfolded proteins, the UPRmt is triggered and returns the mitochondria to a state 
of homeostasis. The UPRmt is induced by DR mimetics rapamycin and resveratrol 
in mouse hepatocytes in vitro (Houtkooper et al. 2013), and enhanced longevity is 
reportedly linked to the activation of the UPRmt by nicotinamide riboside (Zhang et 
al. 2016; Gariani et al. 2016), suggesting that the UPRmt is associated with ageing 
in mammals. In BXD mice DR protects against the age related reduction in 
mitochondrial ribosomal protein S5 (Mrps5) in skeletal muscle (Houtkooper et al. 
2013), reduced expression of which is associated with ageing. Mrps5 is proposed 
as triggering the UPRmt, and if this is the case implicates the UPRmt as an 
overarching longevity pathway conserved across many species (Houtkooper et al. 
2013). However, the role of UPRmt, as measured by mitonuclear imbalance, and the 
association with lifespan extension, has yet to be determined in mice.   
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Figure 1.9: Proposed mechanisms through which DR acts to improve mitochondrial 
function 
 
Despite reports in support of enhanced mitochondrial function as a mediator 
of longevity with DR, the precise mechanisms are difficult to determine with 
substantial lack of consensus between studies. For instance, the mitochondrial 
theory of ageing proposes that accumulation of damage 
to mitochondria and mitochondrial DNA (mtDNA), induced by reactive oxygen 
species (ROS), is  the cause of ageing (Wei et al. 2001). Indeed, numerous studies 
support a role for decreased mitochondrial ROS as underlying the lifespan benefits 
of DR (Sohal & Weindruch 1996; Masoro 2000). However, a recent meta-analysis 
of rodent response following DR found that the majority of studies reported no 
change in ROS levels relative to AL controls (Walsh et al 2014), with only 4% of 
these studies carried out on female or mixed populations. The impact of DR on 
mitochondrial respiration in rodents is also unclear, with an increase (Hempenstall 
et al. 2012; A. J. Lambert et al. 2004; Nisoli et al. 2005; Lanza et al. 2012) decrease 
(Agarwal & Sohal 1994), or no effect reported relative to AL controls (Gredilla et al. 
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2001). Similarly debate arises over the role of mitochondrial biogenesis as a 
mediator of DR with reports that mRNA levels of several mitochondrial associated 
genes in muscle, heart or liver and PGC-1α protein were unchanged by DR in male 
Wistar rats (Hancock et al. 2011). Both Hempenstall et al and Lanza et al. reported 
no evidence of mitochondrial biogenesis and proposed that DR preserves 
mitochondrial function by protecting the integrity and function of existing cellular 
components (Hempenstall et al. 2012; Lanza et al. 2012). Although mitochondrial 
biogenesis is poorly defined, it can be inferred that protein synthesis is necessary 
for the making of new mitochondria. Humans and animals under DR exhibit 
decreased protein synthesis rates (Henderson et al. 2010; Giroud et al. 2010), and 
these findings challenge the some-what counter intuitive idea of increased 
mitochondrial biogenesis whilst experiencing chronic nutrient deprivation. 
Numerous methods of assessing mitochondrial biogenesis exist, however argument 
has arisen over the best means of quantification suggesting that some means of 
assessment are not reflective of protein synthesis (Miller et al. 2012), and may relate 
to the inconsistent effect of DR on mitochondrial biogenesis. The reason for 
ambiguity between DR studies is unclear, however comparison between various 
tissues (A. J. Lambert et al. 2004; Zangarelli et al. 2006; Miller et al. 2012), different 
sampling techniques (e.g. measurements taken in isolated mitochondria versus 
permeabilised muscle fibres) (Picard et al. 2011; Picard et al. 2010), as well as 
across different genotypes and genders, make direct comparisons across studies 
difficult (Hunt et al. 2006). 
3.3 DR and Protein Synthesis  
Ageing is associated with a progressive loss of protein synthesis (Lopez-
Otin et al. 2013), which is likely the primary cause of the increased number of 
damaged proteins in old age (Wolff et al. 2014). Furthermore, mitochondrial proteins 
are particularly important to ageing, in terms of maintaining a healthy pool of 
mitochondria, and their synthesis has been shown to decrease by middle-age in 
humans (Rooyackers et al. 1996). This encapsulates the protein turnover theory of 
ageing, which postulates that a major mechanism underlying ageing is the increased 
number of aberrant proteins in old age, which consequently reduces the rate of 
protein turnover. The proteome is maintained by the removal of damaged proteins, 
and replacement with new proteins, and therefore both the rate of protein synthesis 
and degradation determines the rate of protein turnover. Indeed an increase in the 
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concentration of damaged proteins (Stadtman 1992), and decline in synthesis rates 
is well documented during ageing in a variety of organisms (Makrides 1983; Rattan 
1996; Ward 2000).  
Loss of proteostasis is a hallmark of ageing (Lopez-Otin et al. 2013)  but is 
reportedly prevented by DR (Kaushik & Cuervo 2015). Therefore DR-induced 
changes in protein synthesis rates have been linked as a mechanism mediating 
lifespan extension with DR (Tavernarakis & Driscoll 2002; Zangarelli et al. 2006; 
Lambert & Merry 2000), although exactly how DR alters protein synthesis rate is 
unclear. While it has been established that aged rats undergo a progressive decline 
in the rate of protein synthesis and degradation (Goldspink et al. 1987) it has been 
reported that under  DR protein turnover is elevated in rodent tissues, including 
skeletal muscle and liver (el Haj et al. 1986; Ward & Richardson 1991). Following 
DR primary rat hepatocyte cultures are protected from decline in protein turnover 
(Lambert & Merry 2000), while conversely in mouse skeletal muscle DR is 
associated with an increased turnover rate (Lee et al. 1999). However other DR 
studies report no changes in (Lanza et al. 2012) or even decreased rates of protein 
synthesis (Henderson et al. 2010; Giroud et al. 2010).  
In an investigation into the effect of different magnitudes on important 
hallmarks  of DR in both male and female C57BL/6 and DBA/2 mice, proteasome 
activity was found to be lower in DR animals, leading the authors to propose that 
autophagy is a more important proteostatic mechanism under DR (Mitchell et al. 
2016). Protein turnover is the sum of both protein synthesis and degradation  and 
consequently measuring protein synthesis in isolation may not provide  an accurate 
measure of protein turnover rate (Miller et al. 2014). For example, during cell division 
sufficient increases in protein synthesis are essential to account for distribution of 
proteins between daughter cells and for dilution of protein damage (Eden et al. 
2011). Furthermore, cell replication is not essential to cellular homeostasis, while 
increases in protein synthesis are, which suggests a dynamic rate of synthesis and 
degradation. In order to combat this issue, Miller et al suggest a method of 
simultaneously assessing both protein and DNA synthesis through deuterium oxide 
incorporation (D2O), and using the ratio between protein and DNA synthesis to 
accurately determine proteostatic mechanisms. D2O is an isotopically labelled 
marker, with free access to all pools of body water, and as hydrogen from water is 
almost universally associated with biosynthetic processes it allows for a reliable 
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measurement of numerous tissues and proteins. Using this means of assessment, 
proteostatic mechanisms were found to be enhanced in a long-lived mouse model 
(Drake et al. 2015), following treatment with rapamycin (Drake et al. 2013) , a 
crowded-litter model (Drake et al. 2014), and following short-term DR in 
B6D2F1male mice (Miller & Hamilton 2012; Miller et al. 2013) relative to controls. 
Such reports implicate increased proteostatic mechanisms as a shared feature of 
slowed ageing and suggest that enhanced protein synthesis is associated with DR-
induced lifespan extension.  
 
4. Aims of Thesis  
 
Evidence suggests that genetic background may impact on the 
responsiveness to DR in both mice (Rikke et al. 2010; Liao et al. 2010; Mitchell et 
al. 2016) and monkeys (Mattison et al. 2017). However, while lifespan responses 
following DR in recombinant inbred ILSXISS mice have been reported (Liao et al. 
2010; Rikke et al. 2010), the impact of genotype on metabolism, mitochondrial 
function and protein synthesis rates following DR are as of yet undetermined in 
these strains. Moreover, although a wealth of research has been carried out to 
determine candidate mechanisms mediating the anti-ageing effects of DR, few of 
these have included female mice, making it difficult to identify universal modulators 
of slowed ageing.   
This thesis set out to investigate this by employing a comparative approach, 
utilising the distinct DR-induced lifespan responses of three genetically 
heterogeneous strains of female ILSIXSS RI mice (Figure 1.9). My PhD sought to 
examine metabolism, mitochondrial function and protein synthesis, three important 
hallmarks of ageing (Lopez-Otin et al. 2013), under the premise that if a candidate 
mechanism was similarly affected in all three strains then it was not an important 
mechanism underlying DR-induced longevity. The objective of this thesis was to 
probe the mechanistic basis of DR, and to gain novel insights into the effect of 
genotype on DR response. This was achieved by addressing the following 
questions: 
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Figure 1.10: Strain-specific lifespan responses following 40% DR in TejJ89 (positive 
responder), TejJ48 (non-responder) and TejJ114 (negative responder) female 
ILSXISS RI mice. (Data from Liao et al. 2010; and Rikke et al. 2010). 
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1. What is the effect of short and long-term DR on metabolic characteristics 
in female recombinant inbred ILSXISS mice?  
 
In Chapter 3 I examined the impact of both short- (2 months) and long-term 
(10 months) 40% DR on body mass, adiposity (white adipose and brown adipose 
tissue mass) and food intake. In addition, glucose homeostasis was determined by 
measuring fed and fasted blood glucose levels, glucose tolerance, fasting plasma 
insulin, insulin resistance (HOMA-IR), and fasting plasma IGF-1.  
 
2. Is enhanced mitochondrial function a candidate mechanism underlying 
lifespan extension with DR? 
 
I investigated the impact of DR on mitochondrial function within liver and 
skeletal muscle of female ILSXISS mice following both short and long-term DR. 
Oxygen consumption rates (OCR) were determined in isolated mitochondria from 
skeletal muscle and liver tissue for each strain using the Seahorse XF24 Flux 
analyser. Hepatic protein levels of PGC-1a (regulator of mitochondrial biogenesis), 
TFAM (key activator of mitochondrial transcription), OXPHOS (oxidative 
phosphorylation in the mitochondrial complexes) and the UPRmt (mitonuclear 
protein imbalance; nDNA:mtDNA ratio) were measured. Mitochondrial ROS 
(Hydrogen peroxide) production was quantified in liver and skeletal muscle tissue, 
and both oxidative damage (protein carbonyl and 4 HNE) and antioxidant defences 
(Superoxide dismutase and total glutathione) were determined.   
 
3. Is enhanced proteostasis associated with DR-induced lifespan? 
 
Following short-term DR protein synthesis rates were assessed in each strain 
using deuterium oxide (D2O) as an isotopically stable marker to label proteins. 
Protein synthesis was assessed in three different subcellular fractions 
(mitochondrial, cytoplasmic and mixed proteins) in the skeletal muscle 
(gastrocnemius), heart and liver. 
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Chapter 2: Materials and Methods 
2.1 Animals 
2.1.1 ILSXISS mice 
ILSXISS recombinant inbred (RI) mouse strains were derived from a cross 
between inbred long sleep (ILS) and inbred short sleep (ISS) mice (Williams et al. 
2004). Originally the founding ILS and ISS strains were generated through an eight-
way cross from heterogeneous stock; A, AKR, BALB/c, C3H/2, C57BL, DBA/2, IsBi, 
RIII (see Figure 2.1) and bred based on their ethanol sensitivity, thus giving rise to 
the long and short sleep models. Following 20 or more successive generations of 
brother/sister matings of the progenitor strains (ILS X ISS), over 75 ILSXISS RI lines 
were generated (See Figure 2.1 for schematic representation) (Williams et al. 2004). 
As each RI strain is inbred, every genetic locus contains either an ISS or ILS allele, 
meaning that each strain has a unique arrangement of ISS and ILS alleles, resulting 
in each line being genetically distinct from one another (Liao et al. 2013). This 
genetic variation creates a unique tool for exploring the differential responses of 
dietary restriction (DR), and can be used to probe the mechanisms which underlie 
DR-induced lifespan extension (Rikke & Johnson 2007; Williams et al. 2004; Liao et 
al. 2013). Mice from three of these strains; TejJ89 (increase in lifespan with DR; 
positive responder), TejJ48 (no effect of DR on lifespan; non-responder) and 
TejJ114 (decrease in lifespan with DR; negative responder) were purchased from a 
commercial breeder (The Jackson Laboratory, Bar Harbour, Maine, URL: 
http://www.informatics.jax.org). 3 males and 3 females from each strain were 
purchased and paired, resulting in 3 breeding pairs per strain. The rationale for 
studying these particular strains was that in addition to the repeatable effect of DR 
on lifespan across two independent studies (Rikke et al. 2010; Liao et al. 2010), no 
strain-specific differences in median lifespan were observed upon ad libitum (AL) 
feeding (See Figure 2.2 Rikke et al. 2010; Liao et al. 2010).   
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Figure 2.1: Generation of ILSXISS RI strains through an 8-way cross from 
heterogeneous stock. Generations of inbreeding resulted in the panel of RI ILSXISS 
mice (Adapted from Williams et al. 2004). 
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Figure 2.2: Median AL and DR lifespan in female ILSXISS mice from strains TejJ89, 
TejJ48 and TejJ114, highlighting the differential impact of 40% DR for each strain 
and the non-strain specific response under AL feeding (Adapted from Rikke et al. 
2010; Liao et al. 2010).  
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2.1.2 Husbandry, Dietary Restriction (DR) and Experimental Design 
Female ILSXISS mice from three genetically distinct strains, shown to have 
repeatable lifespan responses to 40% DR in two independent studies (TejJ89, 
TejJ48 and TejJ114, see Figure 2.3), were used in this study. Mice were kept in 
groups of 4 post-weaning in shoebox cages (48cm×15cm×13cm), with AL access 
to water and standard chow (CRM(P), Research Diets Services, LBS Biotech, UK; 
Atwater Fuel Energy- protein 22%, carbohydrate 69%, fat 9%) and maintained on a 
12L/12D cycle (lights on 0700–1900h) at an ambient temperature of 22±2°C. At 9 
weeks of age, cages were randomly assigned to either an AL or DR group, with no 
difference in body mass observed between treatment groups at this time (TejJ89 AL 
vs. DR t=0.056, p=0.583, TejJ48 AL vs. DR t=0.677, p=0.509, TejJ114 AL vs. DR 
t=0.289, p=0.777). Mice were introduced to DR in a graded fashion (as described in 
Hempenstall et al. 2010); at 10 weeks of age mice were exposed to 10% DR (90% 
of AL feeding), at 11 weeks this was increased to 20% DR, and from 12 weeks of 
age, until the termination of the experiment, mice were exposed to 40% DR, relative 
to their appropriate strain-specific AL controls. Mice were maintained on 40% DR 
for a period of either 2 months (equivalent to 5 months of age), or 10 months 
(equivalent to 13 months of age), (See Figure 2.4 for schematic of experimental 
design). Short-term DR, defined here as a period of 2 months 40% DR, and long 
term DR, a period of 10 months of 40% DR were chosen with previously published 
lifespan data on these strains on DR, in mind (Rikke et al. 2010; Liao et al. 2010). 
10 months of DR was fixed as the upper limit of restriction in this study in order to 
examine the effect of DR on candidate mechanisms, and not late life health. Total 
food intake of AL mice from each strain was measured weekly (±0.01g) and food 
intake of the DR cohort calculated from the average AL intake per mouse over the 
preceding week (Hempenstall et al. 2010). DR mice were fed daily at 1800hrs, with 
the food placed directly onto the cage floor in order to reduce any competition for 
the food. No evidence of fighting or dominance hierarchies was observed in any 
cage.  
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Figure 2.3: ILSXISS mice; positive responder TejJ89 (A), non responder TejJ48 (B) 
and negative responder TejJ114 (C). 
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Figure 2.4: Schematic of experimental design. (A) 2 cohorts of mice were 
maintained on AL or DR treatment for a period of 2 months; Short-Term DR 1 and 
Short-Term DR 2. (B) Over the 2 month period numerous metabolic and 
physiological measurements were taken on Short-Term DR 1 animals, including 
measurements on body mass, food intake, fed and fasted plasma collection, fed 
and fasted glucose measurements and a glucose tolerance test. Short-Term DR 2 
animals were maintained on short-term DR, prior to administration of isotopically 
labelled water, for the assessment of protein turnover. (C)  Samples were collected 
at 5 months of age for both Short-Term DR 1 and Short-Term DR 2 animals, 
following 2 months of DR. Skeletal muscle, WAT, BAT and blood were collected 
from the Short-Term DR 1 cohort for downstream physiological and metabolic 
assays. Liver, heart, skeletal muscle, plasma and bone marrow were dissected and 
snap frozen from the Short-Term DR 2 cohort for protein synthesis assays. (D) Over 
the course of 10 months, measurements were taken on body mass, food intake, fed 
and fasted plasma collection, fed and fasted glucose measurements and a glucose 
tolerance test in the Long-Term DR cohort. (E) After 13 months liver, skeletal 
muscle, WAT, BAT and blood were collected for physiological and mitochondrial 
experiments. 
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At 5 months (2 months of 40% DR) and 13 months (10 months of 40% DR) 
AL and DR mice from Short-term DR 1 and Long-term DR, were fasted overnight 
and weighed prior to being culled by schedule one cervical dislocation. At 5 months 
AL and DR mice from Short-term DR 2 were fasted overnight and culled by cardiac 
puncture and dissection as described in section 2.4. Following cervical dislocation 
Short-term DR 1 and Long-term DR mice were decapitated and trunk blood was 
collected in a petri dish.  Fasting blood glucose was recorded with a glucometer 
(OneTouch Ultra, Lifescan, UK) and the remaining blood pipetted into an EDTA 
coated tube, and spun at 10,000 x g for 10 minutes at 4°C, with the resultant 
supernatant (plasma) collected. All plasma samples were stored at -80°C. The brain, 
hypothalamus, kidneys, heart, WAT, BAT, two lobes of liver and gastrocnemius 
muscle from one hind limb, were rapidly excised, snap frozen in liquid nitrogen and 
stored at -80°C. The remaining gastrocnemius muscle and lobe of liver were 
dissected and subsequently used for the assessment of mitochondrial function (See 
Table 2.1 for tissues and experimental end point). Functional assessment of isolated 
mitochondria was carried out only in the muscle for the short-term DR animals. Liver 
mitochondrial function was also assessed in liver for the long-term DR assay in order 
to compare the effect of DR on a mitotic tissue (liver) with a post mitotic tissue 
(skeletal muscle). A total of 4 mice per day were culled, with the time between 
dissection, mitochondrial isolation and mitochondrial analysis kept as uniform as 
possible. For the long-term DR study the particular tissue (liver or skeletal muscle) 
processed and analysed was alternated each day. All experiments were carried out 
under a licence from the UK Home Office (Project Licence 60/4504) and followed 
the “principles of laboratory animal care” (NIH Publication No. 86-23, revised 1985) 
(See Figure 2.4 for schematic). 
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Table 2.1: All samples and tissues taken for both long and short term studies and 
description of experimental destination 
Experiment Sample Type Action 
Short Term  DR (1)   
Physiology WAT Dissected & weighed -
Adiposity 
 BAT Dissected & weighed -
Adiposity 
 Body Mass Longitudinal measurement 
 Food intake Longitudinal measurement 
 Plasma Fed & fasting glucose, insulin 
sensitivity, IGF-1 –glucose 
homeostasis 
 Blood GTT –glucose homeostasis 
Other Heart Snap Frozen 
 Brain Snap Frozen 
 Hypothalamus Snap Frozen 
 Fur Snap Frozen 
 Kidney Snap Frozen 
Mitochondria Skeletal Muscle (Fresh – 
isolated mitochondria) 
Mitochondrial Respiration & 
ROS 
 Skeletal Muscle (Snap 
Frozen) 
Western Blot 
Short Term DR (2)   
Protein synthesis Liver Snap Frozen 
n=8 Heart Snap Frozen 
  Sk.Muscle Snap Frozen 
 Bone Marrow Femur dissected and marrow 
flushed and frozen 
 Blood/Plasma  Cardiac puncture (See section 
2.4.1) 
Long Term DR    
Physiology WAT Dissected & weighed -
Adiposity 
 BAT Dissected & weighed -
Adiposity 
 Body Mass Longitudinal measurement 
 Food intake Longitudinal measurement 
 Plasma Fed & fasting glucose, insulin 
sensitivity, IGF-1 –glucose 
homeostasis 
 Blood GTT –glucose homeostasis 
Other Heart Snap Frozen 
 Brain Snap Frozen 
 Hypothalamus Snap Frozen 
 Fur Snap Frozen 
 Kidney Snap Frozen 
Mitochondria Liver (Fresh – isolated 
mitochondria) 
Mitochondrial Respiration & 
ROS 
 Liver (Snap Frozen) Oxidative damage & 
antioxidant defence ELISAs, 
PGC-1α, UPRmt & OXPHOS 
western blot, qPCR 
 Skeletal Muscle (Fresh – 
isolated mitochondria)  
Mitochondrial Respiration & 
ROS 
 Skeletal Muscle (Snap 
Frozen) 
PGC-1α western blot, UPRmt & 
OXPHOS western blot 
 Heart (Snap Frozen) UPRmt & OXPHOS western 
blot 
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2.2 Physiology 
 
2.2.1 Body Mass, Food intake and Adiposity 
Body mass (BM) was measured daily for 8 weeks from the introduction of 
10% DR, and weekly thereafter, for both AL and DR mice. Total food intake of AL 
mice from each strain was recorded each week (±0.01g) by weighing the contents 
of food in the hopper of each cage. Intake per AL mouse, per day, for each strain 
was calculated based on the quantity of food consumed the preceding week and the 
daily DR allowance was determined according to this (Hempenstall et al. 2010). BM 
and food intake were measured at the same time, on the same day, every week.  
Adiposity was measured by collecting and weighing gonadal WAT and intrascapular 
BAT depots.  
2.2.2 Glucose tolerance, fasting glucose and fed glucose 
All animals (AL and DR) were fasted overnight in a fresh cage with AL access 
to water (1800 to 0800hrs) at 5 months (2 months 40% DR) and 13 months of age 
(10 months 40% DR). DR mice were fed at ∼1500hrs on the afternoons immediately 
prior to a glucose tolerance test (GTT), to ensure feeding prior to the overnight fast 
(Hempenstall et al. 2010). Glucose tolerance was measured according to standard 
protocols (Selman et al. 2008). On the morning of the glucose tolerance test a 20% 
glucose solution for injection was prepared in a tissue culture hood by adding 5 g of 
pre-weighed glucose powder (Sigma Aldrich, Dorset, UK) incrementally to 20ml of 
sterile water, mixing regularly to ensure complete dissolution of glucose powder, 
and adding water to bring the final volume to 25ml. A heat box, with four chambers, 
was switched on to heat up prior to performing the GTT. Each mouse was weighed, 
marked on the tail for identification purposes, and placed in the heat box at 38°C. 
The animals were heated for approximately 15 minutes in order for vasodilation to 
occur; the dilation of the veins, which makes them more visible. Following this, each 
mouse was taken, held in a restrainer, and fasting blood glucose measurements 
were taken by venosection. With the tail protruding from the restrainer a clean razor 
blade was used to lightly cut across the caudal vein, and then 5µl of blood was 
added to a blood glucose strip of a glucometer (OneTouch Ultra, Lifescan, UK), and 
the resulting blood glucose (mmol/L) level recorded. Following which, mice were 
returned to the hot box. Injectate volume was calculated based on body mass for 
each animal (2g of glucose/kg body mass) and made up in a 1ml syringe and needle 
69 
 
(25cc), prepared with the glucose solution.  Glucose was administered by 
intraperitoneal injection (IP) to each mouse, with a 30 second gap between IPs to 
each animal. Mice were returned to the heat box immediately following IP and 
glucose readings were taken by venosection at 15, 30, 60 and 120 minutes post 
injection. Animals were returned to their cages after the 60 minute reading for water, 
and placed back in the hot box 20 minutes prior to the 120 minute time point. After 
the procedure all animals were placed back in their original cage with access to 
water, and food in the case of the AL mice. DR mice were fed at the usual time 
(1800hr) following the procedure. All mice were checked the evening following a 
GTT. Glucose tolerance was expressed as the area under the curve over a 120 
minute period following the IP injection of glucose. Similarly, fed glucose was 
recorded by venosection with the glucometer, blood was collected per mouse 
directly into an EDTA coated tube and spun at room temperature at 10,000 x g for 
10 minutes, and stored long term at -80°C. Blood from AL mice was collected at 
1100hrs and from DR mice at 1800hrs, following an early feeding at 1500hrs, to 
ensure mice were post-prandial (Hempenstall et al. 2010).  
2.2.3 Fasting plasma insulin levels, insulin sensitivity and IGF-1 levels  
2.2.3 (A) Fasting plasma insulin levels 
Fasting plasma insulin levels were determined using a 96 well plate mouse 
insulin ELISA kit (EMD Millipore Corporation, USA Catalogue #EZRMI-13K) 
precoated in monoclonal insulin antibodies, in order to bind to insulin molecules from 
plasma samples. The plate was washed 3 times with 300 µl of wash buffer (provided 
by the manufacturer made up by a 10X dilution in deionised water) before use. The 
wash buffer was added to each well using a multichannel pipette (Gilson™ 
PIPETMAN™ Multichannel Pipettes) and subsequently decanted in the sink. Any 
residual wash buffer was removed by inverting the plate and tapping on absorbent 
towels, without letting the well dry out completely. 10 µl of assay buffer (provided by 
the manufacturer) was added to each well, followed by the addition of 10 µl of 
standard, control or sample in duplicate to the appropriate well. 80µl of anti-insulin 
“detection” antibody was added to each well to bind the insulin molecules, the plate 
was covered and incubated at room temperature for 2 hours on a plate shaker at 
400 rpm. The plate was washed, as previously described, 3 times with wash buffer 
and thoroughly aspirated. 100µl of enzyme solution, containing horseradish 
peroxidase (HRP) conjugate, was added to each well. The plate was covered once 
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again and incubated at room temperature on a plate shaker 30 minutes on a plate 
shaker at 400 rpm. The plate was washed and aspirated, as described, a total of 6 
times. Following this 100 µl of substrate solution was added to each well, covered 
and sealed on a plate shaker for 10 minutes. A blue colour develops over time, 
following the addition of substrate solution which catalyses the reaction, with insulin 
intensity being directly proportional to increasing insulin concentration. 100 µl of stop 
solution was then added to each well and a colour change from blue to yellow was 
observed, following acidification from the stop solution. The colour change was 
proportional to the amount of insulin protein per sample and was quantified 
spectrophotometrically, using a plate reader at an absorbance of 450nm and 
590nm. The average absorbance was calculated for each sample and standard, 
and the difference in absorbance between 450nm and 590nm was used to calculate 
the standard curve. By comparing the absorbance of the standards of known insulin 
concentration, the standard curve was used to determine the insulin concentration 
of each sample.  
2.2.3 (B) Insulin Sensitivity 
Immediately following 2 and 10 months of DR (5 and 13 months of age 
respectively), all mice were fasted overnight, weighed and culled. Blood was 
collected and the resultant plasma stored at -80°C. Insulin sensitivity was estimated 
using the updated homeostatic model assessment (HOMA2) model (Wallace et al. 
2004), a method used to quantify insulin resistance and beta-cell function from 
fasting glucose and insulin concentrations. This calculator is based on a 
mathematical equation that describes glucose regulation as a feedback loop, and 
the software solves the equation so that insulin resistance can be estimated from 
known fasting glucose and insulin levels (Matthews et al. 1985). Using fasting blood 
glucose (mmol/L) and insulin (pM/L) measurements the HOMA2 calculator (version 
2.2.3) determined HOMA IR, a measure of insulin resistance, in all strains, following 
short and long term treatment.   
2.2.3 (C) Fasting IGF-1 levels 
Fasting plasma IGF-1 levels were determined using a mouse IGF-1 ELISA 
kit (Catalogue #MG100, Quantikine, R and D Systems Inc., USA). Employing the 
quantitative sandwich enzyme immunoassay technique, a 96 well microplate was 
pre-coated with a monoclonal antibody specific for mouse IGF-1. Standards were 
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made up following the manufacturers guidelines, and plasma was diluted 500 fold 
in calibrator diluent RDF5-38 (a buffered protein solution provided with the kit). 
Following this 50 µl of standards, control and samples were pipetted into each well 
in duplicate. At this point any mouse IGF-1 present in the samples were bound and 
immobilised by the antibody. The plate was covered with an adhesive strip and 
incubated at room temperature for 2 hours on a plate shaker set at 500 rpm. The 
plate was washed and aspirated a total of 5 times. This was done by adding 400µl 
of wash buffer (a buffered surfactant, made up by adding 20mls of wash buffer, 
provided with the kit, to 480 ml of deionised water) to each well. Following this all 
liquid was removed by decanting and drying on absorbent surface, the removal of 
all liquid ensured the removal of any unbound substances. Following the wash step, 
100µl of secondary antibody, a polyclonal antibody against mouse IGF-1 conjugated 
to horseradish peroxidase, was added to each well. The plate was covered with a 
fresh adhesive strip, and incubated for 2 hours at room temperature (RT) on a 
shaker. The plate was washed and aspirated 5 times, as previously described, and 
100 µl of substrate solution (equal volumes of stabilised hydrogen peroxide and 
stabilised chromogen, provided by the manufacturer) was added to each well before 
being incubated for 30 minutes at room temperature. The plate was protected from 
light for these 30 minutes by covering in tin foil. 100µl of stop solution was added to 
each well, and a colour change from blue to yellow was observed. The optical 
density of each well was assessed immediately using a microplate reader set to 
450nm. Readings were subtracted from readings made at 540nm in order to correct 
for optical imperfections on the plate. The intensity of the colour measured is in 
proportion to the amount of mouse IGF-I bound in the initial step. The sample values 
were then read off the standard curve. 
2.3 Mitochondria 
2.3.1 (A) Isolation of mouse liver mitochondria 
Liver mitochondria were isolated following previously published protocols 
(Brand & Nicholls 2011; Rogers et al. 2011). The liver was weighed and washed in 
ice-cold MSHE+BSA buffer (210mM mannitol, 70mM sucrose, 5mM HEPES, 1mM 
EGTA and 0.5% (w/v) fatty acid free bovine serum albumin (pH 7.2), all from Sigma 
Aldrich). On ice the liver was rapidly minced with scissors in 10 volumes of chilled 
MSHE+BSA buffer  before homogenisation (2-3 strokes) using a chilled glass-glass 
homogeniser (Fisher Scientific, Loughborough, UK). Liver mitochondria were then 
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isolated using differential centrifugation following a previously described protocol 
(Brand & Nicholls 2011). In brief, the liver homogenate was initially centrifuged at 
8,000 x g for 10 minutes at a temperature of 4°C. The lipid bilayer was then aspirated 
off and the supernatant subsequently passed through two layers of cheesecloth. 
The filtrate was collected in a 50 ml centrifuge tube and spun at 8,000 x g for 10 
minutes at 4°C. Following this spin, the supernatant was discarded and 5mls of 
MSE+BSA buffer was added (without disturbing the pellet) and spun for a second 
time at 8,000 x g. The supernatant was once again discarded, and the resulting 
pellet was gently resuspended in a minimal volume (250 µl) of buffer (MSHE with 
no BSA) buffer prior to protein quantification (see section 2.3.1 (B) below).  
2.3.1 (B) Isolation of mouse skeletal muscle mitochondria 
As with the liver, gastrocnemius muscle was harvested, weighed, washed 
and then minced in ice-cold isolation buffer (100 mM sucrose, 100 mM KCL, 50 mM 
Tris HCl, 1 mM KH2PO4, 0.1 mM EGTA, 0.2% BSA (pH 7.4), all from Sigma 
Aldrich), as previously described (Garcia-Cazarin et al. 2011). The minced muscle 
was rinsed three times in 1 ml of ice cold fresh isolation buffer, before 1 ml of 2% 
(w/v) Proteinase Type XXIV (Sigma Aldrich, Dorset, UK) was added and the sample 
vortexed for 1 minute at RT, followed by a 1 minute incubation on ice. Samples were 
then added to a glass homogeniser containing 4 ml of isolation buffer before 
homogenisation (10 strokes with a glass-glass homogeniser). Through differential 
centrifugation mitochondria were isolated in the form of a pellet from the muscle 
(Garcia-Cazarin et al. 2011). The homogenate was spun at 700 x g for 10 minutes 
at 4°C in the first instance. The supernatant was transferred to a fresh tube and 
spun for a second time at 10,500 x g for 10 minutes, once again at 4°C. Following 
this the supernatant was discarded and the pellet was resuspended in a minimal 
volume of isolation buffer (200 µl). After a final 3 minute spin at 7,000 x g, the 
supernatant was discarded and the pellet was resuspended in 50 µl of suspension 
buffer (225 mM Mannitol, 75 mM sucrose, 10 mM Tris, 0.1 mM EDTA (pH 7.4). 
Total liver and skeletal muscle mitochondrial protein (mg/ml) were 
determined using the Bradford assay (Sigma Aldrich, Dorset, UK). The Bradford 
assay is based on the absorbance shift of the dye, (coomassie brilliant blue G-250), 
to its bluer form, through the binding of the protein being assayed (Bradford 1976). 
The blue colour is given from reflected light and of lower wavelength than the 
absorbance measured in the green/yellow area of the spectrum. Thus the density 
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of the blue colour is effectively directly proportional to the amount of protein in the 
sample and is measured using a plate reader at 595nm. The absorbance of 
standards, of known BSA protein concentration (0 mg/ml-2mg/ml), were compared 
to the samples and the standard curve was used to determine the total mitochondrial 
protein for both liver and muscle.   
2.3.2 XF Assay – Plate preparation 
Isolated mitochondria were diluted 10X in mitochondrial assay solution (MAS; 
70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 
1.0 mM EGTA and 0.2% (w/v) fatty acid-free BSA, pH 7.2, all from Sigma Aldrich) 
containing substrate (10 mM pyruvate, 2 mM malate – Sigma Aldrich), and 
subsequently diluted to produce a  mitochondrial suspension which were then added 
to a Seahorse XF assay plate (Agilent Technologies, CA, USA) at a concentration 
of 10µg per well. The plate was then centrifuged at 2000 x g for 20 minutes at 4°C. 
A XF cartridge (Agilent Technologies) was prepared as described by Brand et al. 
(Brand & Nicholls 2011), (see Figure 2.5). The plate was incubated at 37°C for 6 
minutes before being transferred to a XF24 Analyser (Agilent Technologies) (See 
Figure 2.6) and the experiment initiated as previously described (Rogers et al. 2011) 
(See Figure 2.7 for schematic of workflow and Table 2.2 for XF24 protocol). Basal 
Oxygen consumption rate (OCR) was measured in substrate (10 mM pyruvate, 2 
mM malate). Following this OCR was sequentially recorded for state 3 (addition of 
ADP (4 mM)), state 4 (addition of oligomycin (2.5 µg/ml)), state 3u (FCCP (4 µM 
Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone)), and finally in the 
presence of Antimycin A and rotenone (4 µM) to determine non-mitochondrial 
respiratory capacity (Rogers et al. 2011) (See Figure 2.8 for data output figure, all 
stocks from Sigma Aldrich). Analysis was carried out using Seahorse XF software 
(www.seahorsebio.com). 
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Figure 2.5: (A) The XF24 cartridge was hydrated the night before the respiration 
assay. (B) On the day of the assay compounds were prepared and loaded into Port 
D (4 mM ADP), Port C (2.5 µg/ml Oligomycin), Port B (4 µM FCCP) and Port A (4 
µM Antimycin A and Rotenone) and the cartridge was loaded onto the XF24 flux 
analyser for calibration. (C) Isolated mitochondria are added to each well of the 
XF24 utility plate, each set of ports on the cartridge sits directly on top of a well 
containing isolated mitochondria and sequential injections are made into each well.  
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Figure 2.6: (A) XF24 Flux analyser with cartridge prior to loading of cartridge 
containing compounds and 24 well plate containing isolated mitochondria, (B) XF24 
user console.  
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Figure 2.7: Schematic of experimental procedure used to measure oxygen 
consumption rates of isolated mitochondria using an XF24 analyser. 
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Table 2.2: XF24 mitochondrial respiration protocol including mix, wait and measure 
cycle times and order of compound injection. 
Command Time Port 
   
Calibrate   
Mix 1  
Wait 3  
Mix 1  
Wait 3  
Mix 0.5  
Measure 3  
Mix 0.5  
Inject  D – ADP (4 mM) 
Mix 1  
Measure 3  
Mix 1  
Inject  C – Oligomycin (2.5 
µg/ml) 
Mix 0.5  
Measure 3  
Mix 1  
Inject  B – FCCP (4 µM) 
Mix 0.5  
Measure 3  
Mix 1  
Inject  A – Antimycin A and 
Rotenone (4 µM) 
Mix 0.5  
Measure 3  
 
Firstly the contents of each well were mixed, followed by a wait period. The machine 
then recorded the respiration rate before the injection of any compounds, to get the 
basal respiration rate. Following the injection of each compound a series of mixing 
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and measuring occurs, recording the oxygen consumption rate of the mitochondria 
in response to each compound (Rogers et al. 2011). 
 
 
 
Figure 2.8: Representative trace of data output from XF24 analyser. Mitochondrial 
oxygen consumption rate (OCR (pMoles/min)) was measured over time (minutes). 
Mitochondria respired at a basal rate until injection of ADP (Port D) where an 
increase in respiration was observed (State 3). Following an injection of Oligomycin 
(Port C), respiration rate dropped through inhibition of ATP synthase (State 4o). A 
subsequent injection of FCCP (Port B), a mitochondrial uncoupler, caused 
mitochondria to respire at their maximal rate (State 3u) before non-mitochondrial 
OCR was determined through the addition of Antimycin A and Rotenone (Port A).  
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2.3.3 Protein extraction for western blotting 
Liver, skeletal muscle and heart tissue were suspended in 1ml of ice cold 
RIPA buffer (Radio Immuno Precipitation Assay buffer, 150 mM sodium chloride, 
1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS (sodium 
dodecyl sulphate), 50 mM Tris, pH 8.0) containing protease inhibitors (Halt™ 
Protease and Phosphatase Inhibitor Cocktail, Thermo Fisher Scientific, UK). The 
liver and heart were rapidly minced on ice with scissors prior to homogenisation in 
1 ml of RIPA, using a glass-glass homogeniser (Fisher Scientific, UK). A stainless 
steel bead (Catalogue #69989, QIAGEN, Manchester, UK), was added to the 
eppendorf containing the skeletal muscle tissue and RIPA buffer, and then 
homogenised at maximum speed (30Hz) for 4 minutes on the RETSCH MM 400 
mixer mill (Catalogue #10573034, Fisher Scientific). Following homogenisation all 
lysates were incubated on ice for 40-60 minutes before being centrifuged at 16,000 
x g for 10 minutes at 4°C, and total protein levels subsequently determined using 
the BCA protein assay (G Biosciences, MO, USA). The BCA protein assay is based 
on the reduction of copper (Cu2+) by the protein sample. The amount of CU2+ 
reduced is proportional to the amount of protein in the sample. 25 µl of standards 
and samples were added to the wells of the 96 well plate. 200 µl of working solution 
(50 parts BCA solution to 1 part copper solution) was added to each well. The plate 
was wrapped in tinfoil to protect from light and incubated at 37°C for 30 minutes. 
The plate was read at an absorbance of 562nm and a standard curve was prepared 
to determine the protein concentration of each sample. The amount of protein 
present in a sample was calculated by measuring the absorption spectra of each 
lysate and comparing with protein solutions of known concentrations (0-2mg/ml).  
2.3.4 Extraction of nuclear and cytoplasmic proteins 
Nuclear and cytoplasmic fractionation of liver and skeletal muscle was 
undertaken using the ReadyPrep™ Protein Extraction (Cytoplasmic/Nuclear) Kit 
(Catalogue #163-2089, Bio-Rad, UK). Briefly, ~50mg of tissue was homogenised 
together with 0.75 ml of cold cytoplasmic protein extraction buffer (CPEB) containing 
protease inhibitors using a chilled Wheaton Dounce tissue homogeniser (Catalogue 
#62400-595, VWR, West Sussex, UK). The tissue was broken up with 10 strokes of 
the loose fitting pestle, followed by 10 strokes with the tight pestle, in order to release 
the nuclei from the cells. The homogenate was chilled on ice for 1 minute, to allow 
large fragments to settle, and the supernatant was transferred to a fresh tube. The 
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supernatant was subsequently spun at 1000 x g for 10 minutes at 4°C. The 
supernatant was immediately transferred to a fresh tube. The original tube was spun 
for a further 10 seconds at the same speed, and the supernatant was pooled with 
the supernatant from the first spin. This was the cytoplasmic protein fraction and 
was stored at -80⁰ C until further use. The pellet, containing the nuclei, was washed 
with 250 µl of CPEB, vortexed gently and incubated on ice for 10 minutes. Following 
this the samples were spun at 1000 x g for 10 minutes at 4°C in order to concentrate 
the nuclei. The supernatant was discarded following this spin. Following the protocol 
supplied with the kit complete PSB (Protein Solubilisation Buffer) was prepared by 
adding 2 ml of the provided 2-D rehydration/sample buffer, with 1.1 ml of PSB diluent 
and 1 g of PSB powder. Following this 15.4 mg of DTT (50mM) (BioRad), 20µl of 
100X Bio-Lyte (0.2 %( w/v) (BioRad) and 4µl 1% Bromophenol Blue (0.002 %( w/v)) 
was added to the mixture making up complete PSB. The nuclei were suspended in 
500ul of complete PSB and vortexed 4 times, 60 seconds each. The sample was 
centrifuged at 12,000 x g for 20 minutes at room temperature in order to pellet the 
genomic DNA. The supernatant was transferred into a fresh tube and labelled 
Nuclear Protein Fraction. The pellet was resuspended in 250 µl of PSB and 
centrifuged again at 12,000 x g for 20 minutes at room temperature. The 
supernatant was collected, pooled with the previous supernatant in the tube marked 
nuclear protein fraction and stored at -80°C until future use. The protein 
concentration of each fraction determined using the BCA protein assay (G 
Biosciences).  
2.3.5 Western Blot Analysis 
Equal volumes of tissue protein extract (50  μg) in Laemmli sample buffer 
(Biorad) were loaded onto 4-12% Bis-Tris pre-cast polyacrylamide gels (Life 
Technologies, Paisley, UK). Following this, proteins were transferred to 
polyvinylidene difluoride membranes (BioRad). Ponceau staining (ThermoFisher 
Scientific, UK) was used to ensure equal loading of protein and for normalisation 
purposes. Membranes were incubated in Tris-buffered saline Tween20 (Sigma-
Aldrich, UK) (1X TBST) containing 5% BSA for 1h-1. Blots were then washed in 
TBST (5×5minutes), incubated with primary antibody for 24h-1 (4°C), washed again 
(TBST) and incubated with secondary antibody for 1h-1 at room temperature. Blots 
were visualised using Clarity™ Western ECL Substrate (BioRad) and a 
ChemiDoc™XRS system (BioRad).  
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Antibodies for peroxisome proliferator-activated receptor-gamma co-
activator 1 alpha (PGC-1α) and the oxidative phosphorylation complex antibody 
(OXPHOS cocktail; CI subunit NDUFB8, CII-30kDa (SDH), CIII-Core protein 2 
(UQCRC2), CIV subunit I (MTCO1) and CV alpha subunit (ATP5A) were from 
Abcam, Cambridge, UK. Antibody H2B was purchased from Cell Signalling (New 
England BioLabs, UK) and used as a control when blotting for nuclear PGC-1α to 
ensure that the nucleic protein fraction was not contaminated with cytoplasmic 
proteins. Mitochondrial transcription factor A (TFAM) and secondary (anti-rabbit and 
anti-mouse) antibodies from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA), 
and HSP60 and HSP90 from BD Biosciences (BD Biosciences, Oxford, UK. 
Mitochondrial nuclear imbalance (nDNA: mtDNA ratio) was determined by the ratio 
of nuclear encoded SDHB (Complex II)) to mitochondrial-encoded MTCO1 
(Complex IV) (Houtkooper et al. 2013). Antibodies for uncoupling protein 1 (UCP-1) 
were purchased from Abcam, Cambridge, UK. 
2.3.6 Mitochondrial ROS production  
Mitochondrial ROS production was assayed in mitochondria isolated from 
skeletal muscle and liver (See Figure 2.9 for diagram of ROS production) by Dr 
Karine Salin. Fresh respiratory medium (MAS; 70 mM sucrose, 220 mM mannitol, 
10 mM KH2PO4, 5 mM MgCl2, 2mM HEPES, 1.0 mM EGTA and 0.2% (w/v) fatty 
acid-free BSA, pH 7.2) was supplemented with 1 U/ml horseradish peroxidase and 
10uM Amplex® Red reagent (ThermoFisher Scientific, UK) as previously described 
(Zhou et al 1997). 90µl of this medium was then added to each well of a standard 
96 well plate (Costar®, Sigma Aldrich, UK) and heated for two minutes at 37°C. 
Fluorescence was then measured at 15 second intervals for 2-3 minutes using a 
spectrophotometer (Clariostar microplate reader, BMG Labtech) at excitation and 
emission wavelength of 563 and 587nm respectively. A sequential protocol was then 
run simultaneously for each sample in triplicate and completed within 15 minutes. 
First the baseline fluorescence was measured by adding 10 µl of mitochondrial 
suspension, and then mitochondrial hydrogen peroxide production from all 
complexes was determined by adding a saturating concentration of succinate (10 
mM), and then rotenone added (0.5 uM; an inhibitor of complex I). The fluorescence 
signal was calibrated using 176 nM of hydrogen peroxide, and then hydrogen 
peroxide production was calculated following background correction.  
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Figure 2.9: Complex I-V of the electron transport chain located in the inner 
membrane of the mitochondria. CI and CIII are major sites of oxygen metabolism 
and so the main site of ROS production.  
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2.3.7 Oxidative damage and antioxidant levels 
Protein carbonyl (PC) content and 4-Hydroxynonenal (HNE)-protein adduct 
levels are commonly used biomarkers for oxidative damage (Chevion et al. 2000; 
Castro et al. 2017). NADPH oxidase generates superoxide through electron transfer 
and can also be used as a marker for oxidative damage. Glutathione (GSH) and 
total Superoxide dismutase content are considered important indicators of 
antioxidant defence against ROS and are used as markers of antioxidant levels 
(Singh 2002; Serra et al. 2003).  
2.3.7 (A) Sample Preparation 
A fragment of liver was homogenised at maximum speed (30Hz) for 4 
minutes on the RETSCH MM 400 mixer mill (Fisher Scientific) (as mentioned in 
section 2.3.2) in 1 ml of cold assay buffer (PC and GSH homogenate buffer: 50 mM 
MES, 1 mM EDTA, pH6.7; SOD homogenate buffer: 20 mM HEPES, 1 mM EGTA, 
210 mM mannitol and 70 mM sucrose, pH 7.2; 4-HNE & NADPH oxidase 
homogenate buffer 1 ml RIPA buffer and 10 µl of protein and phosphatase inhibitors 
(as described in section 2.3.2 protein extraction) using one stainless steel bead 
(QIAGEN) per sample. All samples were centrifuged at 10,000 x g for 15 minutes at 
4°C following homogenisation and stored at -80°C until required. Total protein was 
calculated for each sample using the BCA assay (G Biosciences).  
2.3.7 (B) Protein Carbonyl content 
Hepatic protein carbonyl (PC) content was measured using a commercially 
available kit (Carbonyl assay kit, Catalogue #10005020, Cayman, Estonia). The 
assay measured the reaction between 2,4-dinitrophenylhdrazine (DNPH) and 
protein carbonyls, and the reaction was analysed spectrophotometrically to 
determine protein carbonyl content. Prior to the assay the absorbance of each 
sample was checked for nucleic acid content. This was done by measuring the 
absorbance of each sample at 280nm and 260nm, however as the ratio (280/260) 
of all samples was greater than 1, no further action was required with the samples 
(as per specification in the manufacturer protocol). 200µl of sample was added to 
two 2 ml tubes. One tube was labelled C for control and the other S for sample, 
along with the corresponding sample ID number. 800 µl of DNPH was added to the 
tube marked S for sample, and 800 µl of 2.5M HCL was added to the tube labelled 
C for control. Both tubes were incubated in the dark, by covering in tinfoil, at room 
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temperature for 1 hour. Each tube, both sample and control, was vortexed every 15 
minutes during this 1 hour period. Following this 1 ml of 20% (w/v) TCA 
(trichloroacetic acid, provided by the manufacturer) was added to each tube and 
vortexed. All samples were subsequently incubated on ice for 5 minutes. Samples 
were centrifuged at 10000 x g for 10 minutes at 4°C. Following this, the supernatant 
was discarded and the pellet was resuspended in 1 ml of 10% w/v TCA. Samples 
were put on ice for 5 minutes following this. Samples were centrifuged for a second 
time, at 10000 x g for 10 minutes at 4°C. As before, the supernatant was discarded. 
This time the pellet was resupsended in 1 ml of (1:1) ethanol/ethyl acetate mixture. 
The pellet was resuspended, vortexed, and centrifuged for 10 minutes at 10000 x 
g, 4⁰ C. This step was repeated twice more, before resuspending the pellets in 500 
µl of guanidine hydrochloride (supplied with the kit) and vortexing. The samples 
were centrifuged at 10000 x g for 10 minutes at 4°C, in order to remove any 
remaining debris. 220 µl of supernatant from S and C samples were added to the 
plate in duplicate. The absorbance was measured at a wavelength of 360nm using 
a plate reader (Clariostar microplate reader, BMG Labtech). The average of 
absorbance was calculated for each sample and control. The average absorbance 
of the controls was subtracted from the average absorbance of the samples. This 
was called the Corrected Absorbance (CA). The concentration of the carbonyls was 
calculated using the following equation: 
Protein Carbonyl (nmol/ml) = [(CA)/ (*0.011um-1)] (500µl/200µl) 
2.3.7 (C) 4-HNE protein content 
Hepatic 4-Hydroxynonenal (HNE)-protein adduct levels were determined 
using an anti-HNE-His mouse IgG protein binding plate (OxiSelect™ HNE Adduct 
Competitive ELISA Kit, Catalogue #STA-838, Cell Biolabs Inc., CA, USA). This 
assay is an enzyme immunoassay in 96 well format, the primary antibody was 
added to the plate and incubated overnight at 4°C. The quantity of HNE-His adduct 
in protein samples was determined by comparing the absorbance with that of a 
known HNE-BSA standard curve. On the day of the assay 100 µl of standard and 
sample was added to each well in duplicate and incubated at 37°C for 2 hours. The 
well was washed and aspirated twice with 250 µl of phosphate buffered saline (PBS, 
Sigma-Aldrich UK) per well. 200 µl of assay diluent was added and incubated at 
room temperature for 2 hours on an orbital shaker. Following this the plate was 
washed 3 times with 250 µl of wash buffer and aspirated thoroughly. 100µl of anti-
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HNE antibody was added to each well and incubated for 1 hour at room temperature 
on an orbital shaker. The plate was washed and aspirated as previously described 
and 100 µl of secondary antibody-HRP conjugate was added to each well and 
incubated for 1 hour at room temperature on an orbital shaker. The plate was 
washed and aspirated once again before adding 100 µl of substrate solution to each 
well and incubated at room temperature on an orbital shaker for 10 minutes. 100 µl 
of stop solution was added to each well to stop the enzyme reaction and the plate 
was read immediately at 450nm using a plate reader. 4-HNE was calculated using 
the standard curve and expressed relative to protein content as µg/ml, quantified 
using a BCA assay (G Biosciences).  
2.3.7 (D) NADPH Oxidase content 
NADPH oxidase levels were determined using a commercially available kit 
(mouse NADPH oxidase ELISA kit, Catalogue #abx255148, Abbexa ltd, Cambridge, 
UK). Nox1 (NADPH oxidase 1) antibody came pre-coated on a 96 well plate. The 
plate was twice washed with wash buffer before the addition of 100μl of the 
standards and samples to each well. The plate was then covered and incubated at 
37°C for 90 minutes. Following this the contents of the plate were discarded but the 
plate was not washed in this instance and 100 μl of Biotin conjugated antibody, used 
as the detection antibody, or secondary, was added to each well. The plate was 
sealed and incubated at 37°C for 60 minutes. Following this the plate was washed 
three times with wash buffer and thoroughly aspirated, through decanting and drying 
on absorbent towels. Each well was filled with wash buffer and allowed to soak for 
2 minutes before discarding the liquid in the wells. Any unbound conjugates were 
removed through this process and the soaking procedure was carried out a total of 
three times. 100 µl of working solution was added to each well, the plate sealed and 
incubated for 30 minutes at 37°C, and washed 5 more times with wash buffer 
subsequently. 90 µl of TMB (3,3’,5,5’-Tetramethylbenzidine) substrate was used to 
visualise the HRP enzymatic reaction. The plate was incubated at 37°C in the dark 
for 15 minutes and during this time the TMB is catalysed by HRP to produce a blue 
colour product that changes into yellow after adding 50 µl of stop solution. The 
absorbance was measured at 450nm on a microplate reader, and then the 
concentration of Nox1 was calculated from the standard curve.  
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2.3.7 (E) Total GSH content 
Total glutathione (GSH) (Glutathione assay kit, Catalogue #703002 Cayman) 
was measured using an assay that makes use of an enzymatic recycling method, 
using glutathione reductase for the quantification of GSH. The sulfhydryl group of 
GSH reacts with DTNB (5,5'-dithio-bis-2-(nitrobenzoic acid) and produces a yellow 
coloured 5-thio-2nitrobenzoic acid (TNB). The rate of TNB production is directly 
proportional to this recycling reaction which is in turn directly proportional to the 
concentration of GSH in the sample. Samples required deproteination, to avoid 
interference with the assay, before analysis. In order to do this 5mg of 
metaphosphoric acid (Sigma-Aldrich Item no. 239275) was dissolved in dH2O, this 
was called the MPA reagent. An equal volume of MPA reagent was added to the 
sample.  The mixture of sample and MPA was left to stand at room temperature for 
5 minutes and then centrifuged at 2000 x g for 2 minutes. The supernatant was 
carefully collected. 50µl of TEAM reagent, made up of 4M solution of triethanolamine 
(Sigma-Aldrich Item no. T58300) by mixing 531 µl of triethanolamine with 469 µl of 
dH2O, was added per ml of supernatant and vortexed immediately. At this point the 
samples were ready for immediate analysis of total GSH. 50 µl of standards and 
samples were added to the appropriate wells of the 96 well plate. The plate was 
covered with the protective adhesive provided. The assay cocktail was prepared as 
per assay protocol, by mixing 11.25 ml of MES buffer (consisting of 0.4M 2-(N-
morpholino) ethanesulphonic acid,), 0.1 M phosphate and 2 mM EDTA, pH6.0. 
Entire mixture diluted 1:2 with dH2O for MES buffer), 0.45 ml of reconstituted 
Cofactor mixture, 2.1ml of reconstituted enzyme mixture, 2.3 ml of dH2O, and 0.45 
ml of DTNB. The plate cover was removed and 150 µl of the assay cocktail was 
added to all wells using a multichannel pipette (Gilson™ PIPETMAN™ Multichannel 
Pipettes). The plate was covered with a new protective cover, covered in tinfoil to 
protect from light, and left on an orbital shaker for 25 minutes. At this point the plate 
was read at 405nm using a plate reader. The average absorbance was calculated 
for all standards and samples. The absorbance value of standard A (0 µM) was 
subtracted from itself and from all other values. This was the corrected absorbance 
(CA). The corrected absorbance was plotted as a function of the concentration of 
total GSH. The total GSH was calculated from the standard curve, and all values 
were expressed relative to total protein concentration. 
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Total GSH = [
(Absorbance at 405 − 414nm) − (y − intercept)
Slope
]  x 2 x Sample Dilution 
 
2.3.7(F) Total superoxide dismutase activity 
Total superoxide dismutase (SOD) activity was measured using a 
commercially available kit (Total SOD activity assay kit, Catalogue #706002, 
Cayman). This assay utilises a tetrazolium salt for detection of superoxide radicals 
generated by xanthine oxidase and hyposanthine. One unit of SOD is defined as 
the amount of enzyme needed to exhibit 50% dismutation of the superoxide radical. 
200 µl of the diluted radical detector (diluted tetrazolium salt solution, prepared as 
per manufacturer guidelines) was added to each of the 96 wells on the plate. 
Standards of known concentration were provided and labelled A- G, A being the 
lowest known concentration and G being the highest (0-0.05 U/ml total SOD). 10 µl 
of standard and sample was added to the appropriate well. The reaction was 
initiated by adding 20 µl of diluted Xanthine oxidase to all the wells, as quickly as 
possible, to avoid time differences between addition to first well and last well. The 
plate was covered with an adhesive cover, and shaken for a few seconds to mix. 
The plate was incubated on a shaker for 30 minutes at room temperature. The 
absorbance was read at 440nm using a plate reader. The average absorbance was 
calculated for each standard and sample. The linearised rate (LR) was determined 
by dividing standard A’s absorbance by all the other standards, and by all the sample 
absorbance’s. The linearised rate was plotted as a function of final SOD activity 
(U/ml). The SOD activity of the samples was calculated using the equation (See 
below) obtained from the linear regression of the standard curve and substituting in 
the LR value for each sample.  
 
SOD(U/ml) = ((
Sample LR − y intercept
Slope
  )  x 
0.23ml
0.01ml
 x sample dilution 
 
All assays were read on a plate reader (BMG Labtech, UK) and expressed relative 
to protein content (mg/ml).  
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2.4 Protein Synthesis  
We employed a method using a stable isotope, deuterium oxide (2H2O Catalogue 
#756822, Sigma), to assess the rate of protein turnover and DNA synthesis. Skeletal 
muscle, heart and liver were examined, to allow a comparison of tissues 
representative of post mitotic, semi-mitotic and mitotic tissues, in order to give a 
more complete assessment of the impact of short term DR on protein and DNA 
synthesis in three genetically heterogeneous mouse strains. The in vivo labelling 
with 2H2O  gave a measure of proteostatic mechanisms through the concurrent 
measurement of both protein (Busch et al. 2006; Drake et al. 2013; Miller et al. 2012; 
Miller et al. 2013; Robinson et al. 2011) and DNA synthesis (Drake et al. 2013; Miller 
et al. 2012; Miller et al. 2013; Robinson et al. 2011; Neese et al. 2002). The ratio of 
protein:DNA synthesis is indicative of the proteostatic process, and gives insight to 
cellular processes that may be concealed by measurements of DNA or protein 
concentration alone (Hamilton & Miller 2017; Miller et al. 2014). Following an 
injection, enrichment of the body water pool with 2H2O is rapidly established, and 
the 2H label is incorporated at multiple sites. Newly synthesised metabolites 
incorporate deuterium into stable Carbon-Hydrogen (C-H) bonds, and 2H 
incorporation can be measured by gas chromatography mass spectrometry 
(GC/MS). The label is incorporated into deoxyribose (dR), which has 7 C-H bonds 
available for the incorporation of 2H2O  and a given amino acid (AA), in this case 
alanine, with 4 C-H bonds available (compared with 2 available C-H bonds in AA 
glycine and 1 C-H bond in AA leucine, see Busch et al 2006 for in depth description), 
and allows for the determination of rates of newly synthesised DNA and protein. 
One advantage to this method is that it can be dispensed over prolonged periods of 
time. This allows measurement of proliferation of cells with a slow rate of turnover, 
and provides information on processes over the course of the labelling period rather 
than one metabolic moment in time, without interfering with daily movements of the 
experimental animals (Miller & Hamilton 2012; Miller et al. 2014; Hamilton & Miller 
2017). 
2.4.1 Experimental Design and Labelled Water 
At 5 months of age (2 months of 40% DR), AL and DR animals were fasted 
overnight, in a fresh cage, with AL access to normal drinking water. DR mice were 
given an initial intraperitoneal injection (IP) of 99% 2H2O to rapidly enrich the pool of 
body water with deuterium.  Enrichment was then maintained by ad libitum access 
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to drinking water enriched with 8% 2H2O for a 2-week period (Miller et al. 2012; 
Neese et al. 2002). Following this 2-week enrichment period, the mice were fasted 
overnight, and sacrificed under HO licence following CO2 inhalation. Blood was 
collected by cardiac puncture (0.1 ml – 1 ml) followed by dissection and snap 
freezing of the heart, liver and the gastrocnemius of both hind limbs. All tissues were 
stored at −80°C. Bone marrow was collected to represent a fully turned over 
population of cells. The marrow was extracted by taking the femur and cutting both 
ends. 1ml of PBS was drawn into a 3cc syringe with a 25 gauge needle. The femur, 
with both ends removed, was held over a fresh tube, the syringe stuck in the hole 
on one end of the bone and the marrow flushed out and collected in the tube. All 
bone marrow samples were stored at -20°C. Samples were shipped on dry ice to 
the Translational Research on Aging and Chronic Disease Laboratory at Colorado 
State University for analysis (See Figure 2.10 for experimental design). 
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Figure 2.10: Schematic of experimental design used to determine the synthesis of 
DNA and protein at 5 months of age (Short Term DR 2). (A) (2H2O) was administered 
through AL access to drinking water for 2 weeks following IP injection. (B) Liver, 
heart, gastrocnemius and bone marrow were collected and (C) through a series of 
differential centrifugation steps and DNA extraction procedure, DNA was extracted 
and tissue separated into the mixed (consisting of primarily of contractile proteins), 
cytoplasmic and mitochondrial protein fractions. (D) It was possible to measure the 
rates of newly synthesised proteins and DNA, assessed through the incorporation 
of deuterium from body water (Adapted from Miller et al. 2014). 
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2.4.2 Tissue Isolation and DNA Extraction 
Fractionation of heart, liver and skeletal muscle tissue was carried out 
according to a series of differential centrifugation steps, as described in previously 
published protocols (Robinson et al. 2010; Miller et al. 2012), under the supervision 
of, and with the assistance of collaborators at Colorado State University (CSU), CO, 
USA. Tissues were powdered using a pestle and mortar, under liquid nitrogen. 
Tissue was weighed out (50-70mg) and homogenised, using a bead homogenizer 
(Next Advance Inc., Averill Park NY), 1:10 in isolation buffer (100 mM KCl, 40 mM 
Tris HCl, 10 mM Tris Base, 5 mM MgCl2, 1 mMEDTA, 1 mM ATP, pH=7.5) with 
phosphatase and protease inhibitors (HALT, Thermo Scientific). Subcellular 
fractions of myofibrillar/mixed (Mixed; consisting of nuclei and of essential 
contractile components in muscle tissues), cytosolic (Cyto) and mitochondrial (Mito) 
proteins were isolated following homogenisation as previously described (Miller et 
al 2012, Miller et al 2015).  
2.4.2 (A) Mixed (Myofibrillar) Fraction:  
The homogenate was centrifuged at 4°C, 800 x g, for 10 minutes. The 
supernatant was removed for the isolation of the Mito fraction and the resulting pellet 
was washed with 500 µl 100% EtOH and spun at 100 x g for 1 minute. The 
supernatant was removed, discarded and subsequently washed with 5 00µl of 
dH2O, before being spun again at 100 x g for 1 minute.  This series of wash steps 
was repeated once more.   
2.4.2 (B) Mito Fraction: 
The supernatant from the 800 x g spin was transferred to a fresh tube labelled 
Mito, and subsequently centrifuged at 9000 x g for 30 minutes. The supernatant was 
removed and set aside for the isolation of the Cyto fraction. The pellet from this spin 
contained the mitochondrial fraction to which 200 µl of mitochondrial buffer (100 mM 
KCl, 10 mM Tris HCl, 10 mM Tris Base, 1 mM MgCl2, 0.1 mM EDTA, 0.02 mM ATP, 
1.5% (w/v) BSA, pH 7.5) was added followed by centrifugation at 8000 x g for 10 
minutes at 4°C. The supernatant from this spin was discarded and 100 µl of 
mitochondrial buffer was added to the pellet, without resuspending, followed by 
centrifugation at 6000 x g for 10 minutes at 4°C. The supernatant from this spin was 
discarded and the remaining pellet was washed in 1 ml of water. 
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2.4.2 (C) Cyto Fraction:  
Following the spin at 9000 x g for 30 minutes, 400 µl of supernatant was 
removed and transferred to a new tube labelled Cyto. An equal volume (400 µl) of 
14% SSA was added to each Cyto tube for deproteinisation, followed by 1 hour 
incubation on ice. After the incubation the Cyto sample was centrifuged at 16000 x 
g for 10 minutes at 4°C. The supernatant was removed and discarded. Each pellet 
was washed with 500 µl 100% EtOH and centrifuged at 100 x g for 1 minute. The 
supernatant was removed, discarded and subsequently washed with 500 µl of 
dH2O, before being spun again at 100 x g for 1 minute.  This series of wash steps 
was repeated once more.   
The Mixed, Cyto and Mito samples were solubilized with the addition of 250 
µl of 1M NaOH followed by incubation for 15 minutes on a shaker at 50°C at 
900rpms to obtain a homogeneous solution.  
2.4.2 (D) DNA Isolation 
For DNA, ~8 µg of total DNA was extracted following the manufacturer’s 
protocol (MiniDNA kit, Qiagen) from approximately 30 mg tissue. This process 
involved leaving the tissue overnight in lysis buffer at 37°C to access DNA in the 
nucleus. The sample was prepared, loaded to a spin column, and centrifuged, 
through a series of purification steps. The DNA was eluted, to ensure the removal 
of nuclei from the spin column, into 200µl TE buffer (10 mM Tris, 1 mM EDTA, pH 
8.0) and stored at -20°C until preparation for analysis via GC/MS. Bone marrow 
suspension was centrifuged for 10 minutes at 2,000 x g. The pellet was treated the 
same as the tissue DNA isolation. 
2.4.3 Sample Preparation and Analysis of derivatised amino acids via Gas 
chromatography–mass spectrometry (GC/MS).  
To hydrolyse the protein samples, 3 ml (Cyto and Mix) or 750 µl (Mito) of 6N 
HCL was added to 13X100 glass tubes, labelled to correspond with the appropriate 
samples followed by incubation for 24 h at 120°C.  
All subsequent steps described for this protocol were carried out by 
collaborators at CSU. The hydrolysates were ion exchanged, dried under vacuum, 
and resuspended in 1 ml molecular biology grade H2O. Derivation of 500µl of 
suspended samples (500 µl acetonitrile, 50 µl 1M K2HPO4 (pH 11), and 20 µl of 
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pentafluorobenzyl bromide (Pierce Scientific, Rockford, IL)) was carried out, 
samples were sealed and left to incubate for 1h at 100°C. Ethyl acetate was used 
to extract derivatives. Through drying by N2 and subsequent vacuum centrifugation, 
the organic layer was removed, and samples were reconstituted in 1 ml of ethyl 
acetate prior to GC/MS analysis. Negative chemical ionisation (NCI) was used to 
analyse derivatised amino acids (AA) on a DB225 gas chromatograph column, with 
a starting temperature of 100°C, and increased to 220°C by increasing 10°C per 
minute. An Agilent 7890A GC coupled to an Agilent 5975C MS (Drake et al. 2014; 
Miller et al. 2012; Miller et al. 2013) was employed and mass spectrometry using 
NCI with helium as the carrier gas and methane as the reagent gas. The mass-to-
charge ratios of 448,449 and 450 were recorded for the pentafluorobenzyl-N,N-
di(pentafluorobenzyl) derivative of alanine. Primary daughter ions that included all 
of the original hydrocarbon bonds from the given amino acid, were represented by 
these mass-to-charge ratios. 2H enrichment was calculated as set out in previously 
described protocols (Fanara et al. 2004). Briefly, a reaction with calcium carbide 
was used to transfer protons from plasma water to acetylene. Using a Series 3000 
cycloidal mass spectrometer (Monitor Instruments, Cheswick, PA), modified to 
record ions at m/z 26 and 27 (M0 and M1) and calibrated against a standard curve 
prepared by mixing 99.9% 2H2O with unlabelled water. acetylene samples were 
analysed (Fanara et al. 2004).  The newly synthesised fraction (f) of proteins was 
calculated from the true precursor enrichment (p) with plasma analysed for 2H2O 
enrichment and adjusted by mass isotopomer distribution analysis (MIDA: see 
Hellerstein & Neese 1999; Busch et al. 2006). Protein synthesis was calculated the 
change in enrichment of deuterium-labelled alanine (Busch et al. 2006) bound in 
muscle proteins over the entire labelling period and expressed as the common unit 
for protein synthesis rates (%*h-1) (Drake et al. 2015; Miller et al. 2013).  
To determine body water enrichment, 125 μl of plasma was placed into the 
inner well of o-ring screw on cap and placed inverted on heating block overnight. 
Next, 2 μl of 10 M NaOH and 20 μl of acetone were added to all samples and 20 μl 
0%–20% D2O standards and capped immediately. Samples were vortexed at low 
speed and kept overnight at room temperature. Samples were extracted with 
addition of 200 μl hexane, and the organic layer was transferred through anhydrous 
Na2SO4 into gas chromatography vials and analysed via EI mode using a DB-17MS 
column. 
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2.4.4 DNA synthesis measurement 
Determination of 2H incorporation into purine deoxyribose (dR) of DNA was 
performed, as previously described (Drake et al. 2014; Neese et al. 2002; Miller et 
al. 2013), by collaborators at CSU.  Nuclease S1 and potato acid phosphatase was 
used to hydrolyse DNA isolated from whole tissue at 37°C overnight. 
Pentafluorobenzyl hydroxylamine and acetic acid were reacted with hydrolysates 
and then acetylated with acetic anhydride and 1-methylimidazole. Dichloromethane 
extracts were dried, resuspended in ethyl acetate, and analysed by GC/MS as 
previously described (Drake et al. 2014; Neese et al. 2002; Miller et al. 2013), on a 
DB-17MS column with NCI, using helium as a carrier and methane as the reagent 
gas. Using ChemStation software, the fractional molar isotope abundances at m/z 
435 (M0, mass isotopomer) and 436 (M1) of the pentafluorobenzyl triacetyl 
derivative of purine dR. The analysed sample and an unenriched pentafluorobenzyl 
triacetyl purine dR derivative standard, were referred to as sample and standard 
respectively. The fractional synthesis rate (f) was calculated by a comparison with 
bone marrow cells in the same animal, which represents an essentially fully turned 
over population of cells (Miller et al. 2012; Drake et al. 2013). The calculation for 
excess fractional M+1 enrichment (EM1) was: 
𝐸𝑀1 =
(abundance𝑚/z436)sample
(abundance𝑚/z435 + z436)sample
−
(abundance𝑚/z436)std
(abundance𝑚/z435 + z436)std
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2.5 Statistical Analysis  
All statistical analyses were performed using R and figures were produced using 
GraphPad Prism (GraphPad Inc., La Jolla, CA, USA, version 5) software. Data were 
checked for normality using the Shapiro–Wilks test and a logarithmic transformation 
was undertaken if data not normally distributed. Following transformation, if the data 
was not normally distributed an appropriate non-parametric test was applied. 
Results are reported as mean±standard error of the mean (SEM), with p<0.05 
regarded as statistically significant. 
A linear model (lm) was used for the analysis of the effect of either short-term 
or long-term DR. Strain and treatment were considered explanatory variables in the 
lm, with all experimental parameters input as single response variables and 
assessed within each strain; AL vs. DR.  All non-significant interaction effects (p > 
0.05) were removed to obtain the best-fit model in each case, with only significant 
interactions reported. Post-hoc Tukey tests were performed to examine directional 
differences, although it should be noted that these analyses do not take into account 
the treatment or treatment*strain effects. A one way ANOVA was used to assess 
strain effects within treatment AL and DR groups. For example AL treatment group 
as TejJ89 vs. TejJ48 vs. TejJ114 after 2 and 10 months of treatment. Results are 
reported as mean ± standard error of the mean (SEM), with n = 8 per group and with 
p < 0.05 regarded as statistically significant. * denotes p < 0.05, **p<0.01, 
***p<0.001. t= treatment effect; t=p<0.05, tt=p<0.01, ttt denotes p<0.001, S= strain 
effect; S=p<0.05, SS=p<0.01, SSS denotes p<0.001. 
2.5.1 Metabolic Characteristics: 
WAT and BAT were corrected for body mass prior to analysis. The impact of 
short and long-term DR on starting body mass (g), end body mass (g), WAT/body 
mass (g), BAT/body mass, glucose tolerance, fed and fasting glucose levels, fasting 
plasma insulin, HOMA IR and fasting plasma IGF-1 levels was determined using an 
lm as described in section 2.5. 
2.5.2 Mitochondrial Function: 
Mitochondrial function was analysed the same way, by employing a linear 
model (lm) to determine oxygen consumption rate (OCR), ROS production, PGC-1-
α, oxidative damage, antioxidant defence and the UPRmt response following long-
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term DR in liver, skeletal muscle or heart tissue. Nuclear and cytosolic PGC1-α 
protein levels, Tfam, OXPHOS and Heat shock proteins assessed by western blot 
were all normalised to total protein by Ponceau staining, prior to analysis.  
2.5.3 Protein Synthesis: 
% Fractional synthesis rates of proteins and % DNA synthesis rates for 
skeletal muscle, heart and liver were determined by collaborators at CSU. From the 
synthesis rates of protein and DNA, the newprotein/newDNA ratio was calculated. A 
two way ANOVA was employed by collaborators in order to determine treatment 
and strain effects in each tissue. I repeated the analysis here using a linear model 
to ensure consistency between previous analyses, although lm and 2 way ANOVA 
are essentially the same test.  
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Chapter 3: The impact of short and long-term dietary restriction on metabolic 
characteristics in female recombinant inbred ILSXISS mice 
3.1 Abstract 
To investigate potential differences underlying the DR response in female 
ILSXISS RI mice, I examined several metabolic parameters in strain TejJ89 
(lifespan increased under DR), TejJ48 (lifespan unaffected by DR) and TejJ114 
(lifespan decreased under DR) following short- (2 months) and long-term (10 
months) 40% DR. Short-term DR decreased body mass (BM) in all strains, with 
largest losses observed in strain TejJ114. White adipose tissue (WAT) and brown 
adipose tissue (BAT) were not reduced by DR, although surprisingly WAT was 
higher in strain TejJ114 relative to AL controls. Following long-term DR BM was 
reduced in all strains, again with largest losses reported in strain TejJ114. WAT 
levels were unaffected by DR in TejJ89 and TejJ48 relative to strain-specific AL 
controls, but decreased by DR in TejJ114. BAT was increased in strain TejJ89 with 
long-term DR but unchanged in TejJ48 or TejJ114. Short-term DR decreased fed 
and fasting blood glucose levels in TejJ48, and increased fasting blood glucose in 
strain TejJ114. No alterations in any parameters of glucose homeostasis were 
changed with short-term DR in strain TejJ89. Following long-term DR fasting blood 
glucose was increased in all three strains, and fed blood glucose was reduced in 
TejJ48 and TejJ114 but unchanged in TejJ89. Surprisingly strain TejJ89 had 
increased insulin resistance, as measured by HOMA IR, and were 
hyperinsulinaemic compared to TejJ48 and TejJ114 following DR,  with no changes 
in insulin resistance or insulin levels apparent in the other strains. Moreover, short 
or long-term DR had no effect on insulin-like growth factor-1 (IGF-1) levels in any 
strain. My findings indicate that reductions in WAT were associated with reduced 
lifespan of TejJ114 mice under 40% DR, while ability for strain TejJ89 to maintain 
WAT teamed with an increase in BAT mass, may be important to lifespan extension. 
These strain-specific differences in body composition may underlie the reported 
lifespan truncation of TejJ114 mice to DR. Surprisingly I report a delineation in the 
response of glucose, insulin and IGF-1 mice and find no evidence to suggest that 
improved glucose homeostasis is necessary for lifespan extension with DR.  
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3.2 Introduction 
The impact of dietary restriction (DR) on organisms is multifarious, from 
effects on whole-animal physiology to changes at the tissue, organelle and 
molecular level. Not only is DR well established as a means of lifespan extension 
(Fontana & Partridge 2015; Masoro 2005; Speakman & Mitchell 2011) but it also 
induces positive effects on healthspan, such as affording protection against disease 
(Omodei & Fontana 2011), including in human subjects (Fontana et al. 2004; Cava 
& Fontana 2013). Ageing in mammals is characterised by an overall increase in 
adiposity (Huffman & Barzilai 2009) and an impairment in glucose tolerance and 
insulin resistance (DeFronzo 1981; Stout 1994), with both short and long-term DR 
found to ameliorate these  age-related features (Mitchell et al. 2015a; Mitchell et al. 
2016; Hempenstall et al. 2010). Consequently, reductions in adiposity and 
improvements in glucose homeostasis following  DR have been proposed as being 
critical to DR’s beneficial effects on lifespan and healthspan (Berg & Simms 1960; 
Barzilai & Gupta 1999b; Masoro et al. 1992). However, despite DR being the most 
widely used intervention used to slow ageing the precise mechanism(s) underlying 
the beneficial effects of DR on lifespan and healthspan have yet to be defined. To 
further complicate the picture, the status of DR as a ubiquitous means of lifespan 
extension is in some dispute, with evidence suggesting that DR does not increase 
lifespan in all species,  such as flies or rotifers, (Carey et al. 2002; Cooper et al. 
2004; Kirk 2001), or all murine strains (Harper et al. 2006; Sohal et al. 2009; Rikke 
et al. 2010; Liao et al. 2010). Genetic background, gender and magnitude of DR are 
emerging as key determinants in lifespan extension, suggesting that the 
mechanisms involved in DR-induced longevity, and the overlapping processes 
involved in ageing, may be more complex than first thought (Mitchell et al. 2016; 
Hayflick 2010; Selman 2014a). 
3.2.1 DR and Genetic Background 
 C57BL/6 mice are the most widely used murine model in ageing research, 
showing repeatable pro-longevity effects under DR (Turturro et al. 1999; Weindruch 
& Walford 1988). Accumulating evidence has implicated genetic background as a 
potentially important factor that mediates DR response (Selman 2014b; Mulvey et 
al. 2014; Partridge 2012; Swindell 2012), with several studies reporting little or no 
effect of DR on lifespan (Fernandes et al. 1976; Forster et al. 2003; Goodrick et al. 
1990; Harper et al. 2006; Harrison & Archer 1987; Liao et al. 2010; Rikke et al. 
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2010), which in turn raises the question as to whether the relationship between DR 
and lifespan can be accurately inferred from studies of a single genotype. For 
example, the DBA/2 mouse was once considered to have an ambiguous longevity 
response with DR, with reports of no effect (Fernandes et al. 1976) and negative 
impact on lifespan (Forster et al. 2003). However, recently it has been proposed that 
responses to DR are context dependent, and that the ideal context for DR is 
mediated by factors such as genotype and/or gender (Mitchell et al. 2016). Indeed, 
DBA/2 mice subject to 20% DR had an improved survival outcome over 40% DR, 
relative to AL controls. The DBA/2 mouse was not only responsive to DR but also 
had a strain-specific optimal magnitude of DR, which may explain some previously 
reported unresponsiveness in this strain (Mitchell et al. 2016). In addition this study 
highlighted the importance of gender in DR response, reporting a number of sexually 
dimorphic outcomes. For example, C57BL/6 females did not show DR induced 
lifespan extension with 40% DR, relative to AL controls, unlike male DR 
counterparts. DR studies have traditionally been biased towards the use of male 
mice, making it difficult to accurately predict female response, and identify public 
modulators of ageing. Genetic background was unequivocally linked to survival 
outcome following 40% DR based on reports from two independent studies studying 
ILSXISS recombinant inbred (RI) mice. These genetically heterogeneous strains 
exhibit extensive genetic variation in the lifespan response to DR (Liao et al. 2010; 
Rikke et al. 2010), from lifespan lengthening to lifespan shortening.  Furthermore, 
the genotype-dependent response of the ILSXISS mice provide a comparative 
model to examine the role of candidate mechanisms in life extension with DR, and 
provide insight into how these mechanisms may be regulated during slowed ageing. 
3.2.2 DR, Body Mass and Ageing 
DR leads to a reduction in body mass as well as alterations in body 
composition and adiposity. Reports of reduced BM are widespread across taxa and 
extend to both non-human primates and humans (Mattison et al. 2017; Fontana et 
al. 2004). Similarly reductions in adiposity are widely reported with DR, specifically 
reductions in visceral fat such as the white adipose tissue (WAT) (Mitchell et al. 
2015a). As a result reductions in BM and adiposity have been proposed to underlie 
DR-induced longevity (Berg & Simms 1960; Muzumdar et al. 2008). Reductions in 
WAT appear to be a key component of longevity induced by DR, as mice 
manipulated to have reduced levels of WAT are long-lived and protected from age-
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related obesity (Blüher et al. 2003). Surgical excision of visceral fat both ameliorates 
insulin resistance (Barzilai et al. 1998; Das et al. 2004) and increases longevity in 
one strain of rat (Muzumdar et al. 2008) and high levels of visceral fat are associated 
with an increased risk of type 2 diabetes and mortality (Carey et al. 1997; Wang et 
al. 2005; Nicklas et al. 2006; Ross et al. 2008). However, not all fat depots are 
reduced with DR. Brown adipose tissue (BAT), for instance, is subject to an age-
related reduction in mass, yet DR has been found to slow this decline (Valle et al. 
2008). In addition to this, higher levels of BAT mass are associated with a leaner 
phenotype, and reduced insulin resistance (Lowell et al. 1993; Mattson 2010; 
Rogers et al. 2012) and DR has been proposed as driving a shift from WAT to BAT 
stores as a source of energy (Dionne et al. 2016; Okita et al. 2012; Fabbiano, 
Suarez-Zamorano, et al. 2016). A recent study found 40% DR in male C57BL/6 and 
BALB/C mice promoted the development of beige fat (Fabbiano, Suarez-Zamorano, 
et al. 2016) suggesting that promotion of brown fat development as a potentially 
common feature of DR, and involved in the prolongevity effect. 
However, the impact of DR on BM and adiposity is not a straightforward one, 
and genotype appears important.  Strain-specific differences in BM and body 
composition exist under both AL and DR conditions. For instance, under AL 
conditions DBA/2 mice with unrestricted access to normal chow have higher weight 
gain and larger fat depots compared to age-matched C57BL/6 and 129T2 mice 
(Funkat et al. 2004). In addition to this strain-specific losses of fat in the ILSXISS RI 
following 40% DR have been reported previously (Liao et al. 2011). These losses 
have been found to correlate to lifespan data for these strains, such that increased 
lifespan was associated with increased fat mass, while conversely lifespan 
shortening was linked to reduced fat mass following DR. This resulted in the 
proposal that maintenance of adiposity with DR, instead of reduction of fat (as 
proposed by Berg & Simms 1960), is key to DR induced lifespan extension. 
Moreover, this positive correlation between fat mass and lifespan has been reported 
in a number of rodent studies, including wild mice, C57BL/6 mice, DBA/2 mice and 
F344 rats (Harper et al. 2006; Mitchell et al. 2016; Bertrand et al. 1980). While 
changes in adiposity with DR have been previously examined in ILSXISS mice (Liao 
et al. 2011), changes in WAT and BAT mass have yet to be determined. Therefore 
the question as to how alterations in body mass and adiposity relate to lifespan 
extension with DR, and the role genotype plays, remains to be elucidated. 
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3.2.3 Glucose Homeostasis 
Glucose intolerance and insulin resistance are well characterised hallmarks 
of mammalian ageing (Masoro 2005; Barzilai et al. 2012), and enhanced glucose 
tolerance, reduced fasting levels of insulin and insulin-like growth factor (IGF-1) and 
insulin sensitivity, have all been observed under DR (Anson et al. 2003; Argentino 
et al. 2005; Colman et al. 2014; Mattison et al. 2017).  Enhanced glucose 
homeostasis, in particular increased insulin sensitivity, has been considered a 
conserved characteristic of DR in mammals and has led to the proposal that 
maintenance of glucose homeostasis as a key underlying mechanism of DR-
mediated lifespan extension (Barzilai et al. 1998; Barzilai et al. 2012).   
Improvements to glucose tolerance and insulin sensitivity are almost 
universally associated with DR response (Anson et al. 2003; Masoro 2009; 
Speakman & Mitchell 2011). However, a number of strain-specific differences have 
been reported in murine strains following DR and may relate to lifespan response. 
The DBA/2 mouse for example has a number of metabolic differences when 
compared to the C57BL/6 strain both under AL and DR conditions (Kooptiwut et al. 
2002; Andrikopoulos et al. 2005; Goren et al. 2004). Under short-term 30% DR male 
DBA/2 mice are hyperinsulinaemic and relatively insulin resistant, but with improved 
glucose tolerance, and reduced fed blood glucose levels relative to the C57BL/6 
strain (Hempenstall et al. 2010). Moreover, the impact of gender is emerging as key 
in DR response. Female DBA/2 mice, unlike male counterparts, reportedly have no 
changes in circulating insulin levels following 20% or 40% DR (Mitchell et al. 2016). 
This may indicate that improvements in insulin sensitivity are not important to 
survival outcome in female mice following DR. In contrast to fasting plasma insulin, 
IGF-1 appears much more responsive to DR, with reductions observed in both 
strains, under short and long-term DR (Hempenstall et al. 2010; Mitchell et al. 2016). 
Thus IGF-1 may be a more relevant candidate for driving DR-induced longevity. To 
the best of our knowledge the metabolic phenotype of ILSXISS recombinant inbred 
(RI) mouse strains has not been examined. Previously strain-specific differences in 
body temperature and fat maintenance in the ILSXISS mice have been described in 
response to 40% DR and have been found to correspond to lifespan data of these 
strains (Liao et al. 2011; Rikke et al. 2003). Investigations into the strain-specific 
responses with short and long-term DR in ILSXISS mice will offer insight as to 
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whether improvements to glucose homeostasis underlies enhanced longevity with 
DR. 
3.2.4 Predictions and Aims 
In order to investigate the physiological correlates of DR, a comparative 
approach was employed utilising the strain-specific longevity observed in ILSXISS 
RI mouse strains under 40% DR (Liao et al. 2010; Rikke et al. 2010). We examined 
the response of three strains of age-matched female ILSXISS mice following short 
(animals were 5 months of age, maintained on DR for a period of 2 months) or long-
term (animals were 13 months of age, maintained on DR for a period of 10 months) 
40% DR initiated at 3 months of age. Body weight, fat mass (weight of gonadal WAT 
and interscapular BAT depots) and glucose homeostasis (glucose tolerance, fed 
and fasting blood glucose, fasting plasma insulin levels, insulin sensitivity, insulin 
resistance and fasting plasma IGF-1 levels), were determined. We compared 
females from strain TejJ89 (increased lifespan with DR relative to AL fed controls), 
TejJ48 (lifespan unaffected by DR) and TejJ114 (lifespan reduced with DR), which 
have shown repeatable responses to DR across two independent studies (Rikke et 
al. 2010; Liao et al. 2010). We predicted that DR would positively influence body 
composition and enhance glucose homeostasis in strain TejJ89 that DR would have 
no effect on these parameters in strain TejJ48, and that DR would be detrimental to 
these parameters, and negatively impact glucose homeostasis, in the negative 
responder TejJ114. 
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3.3 Materials and Methods 
3.3.1 Animal Husbandry, Dietary Restriction (DR) and Experimental Design 
This study used 3 ILSXISS recombinant inbred (RI) mouse strains originally 
developed to analyse genetic variation in alcohol sensitivity  (Williams et al. 2004). 
The animal husbandry was described in Chapter 2 (Figure 2.1). Briefly, these strains 
have well documented lifespan responses under both ad libitum (AL) feeding 
conditions and 40% DR (Liao et al. 2010; Rikke et al. 2010). Mice from three of 
these strains; TejJ89 (increase in lifespan with DR; positive responder), TejJ48 (no 
effect of DR on lifespan; non-responder) and TejJ114 (decrease in lifespan with DR; 
negative responder) were purchased from a commercial breeder (The Jackson 
Laboratory, Bar Harbour, Maine, URL: http://www.informatics.jax.org).  
Mice were kept in groups of 4 post-weaning in shoebox cages 
(48cm×15cm×13cm), with AL access to water and standard chow (CRM(P), 
Research Diets Services, LBS Biotech, UK; Atwater Fuel Energy- protein 22%, 
carbohydrate 69%, fat 9%) and maintained on a 12L/12D cycle (lights on 0700–
1900h) at an ambient temperature of 22±2°C. At 9 weeks of age, cages were 
randomly assigned to either an AL or DR group, with no difference in body mass 
observed between treatment groups at this time (TejJ89 AL vs. DR t=0.056, 
p=0.583, TejJ48 AL vs. DR t=0.677, p=0.509, TejJ114 AL vs. DR t=0.289, p=0.777). 
Mice were introduced to DR in a graded fashion (as described in Hempenstall et al. 
2010); at 10 weeks of age mice were exposed to 10% DR (90% of AL feeding), at 
11 weeks this was increased to 20% DR, and from 12 weeks of age, until the 
termination of the experiment, mice were exposed to 40% DR, relative to their 
appropriate strain-specific AL controls. Mice were maintained on 40% DR for a 
period of either 2 months (equivalent to 5 months of age), or 10 months (equivalent 
to 13 months of age), (See Figure 2.4 for schematic of experimental design in 
Chapter 2). We defined 2 months of 40% DR as short-term DR and 10 months of 
40% DR as long-term DR and n was 8 mice per group.  
There were two distinct cohorts termed Short-term 1 and Long-term. Short-
term 1 animals were culled following 2 months of AL or DR feeding (short-term) in 
November 2014. Long-term animals were maintained on an AL or DR regime for a 
period of 10 months (long-term) and culled in April 2015, thus both cohorts were 
analysed on different occasions. The extent of the long-term DR protocol was based 
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on previously published lifespan data on these strains following DR (Rikke et al. 
2010; Liao et al. 2010) (see Figure 3.2). Hence 10 months of DR was fixed as the 
upper limit of restriction in this study in order to examine the effect of DR on 
candidate mechanisms of enhanced ageing and not late life pathology, given the 
reported truncation of lifespan in strain TejJ114 with 40% DR, approximately 400 
days median lifespan with DR. Total food intake of AL mice from each strain was 
measured weekly (±0.01g) and food intake of the DR cohort calculated from the 
average AL intake per mouse over the preceding week (Hempenstall et al. 2010). 
DR mice were fed daily at 1800hrs, with the food placed directly onto the cage floor 
in order to reduce any competition for the food. No evidence of fighting or dominance 
hierarchies was observed in any cage.  
Following short and long-term DR, both, AL and DR mice were fasted 
overnight and then culled by schedule one cervical dislocation. Mice were 
decapitated and trunk blood was collected. Fasting blood glucose was recorded with 
a glucometer (OneTouch Ultra, Lifescan, UK). The remaining blood pipetted into an 
EDTA coated tube, and spun at 10,000 x g for 10 minutes at 4°C, with the resultant 
supernatant (plasma) collected. All plasma samples were stored at -80°C. A total of 
4 mice per day were culled a day and samples for mitochondrial studies (as 
described in Chapter 4) were collected. All experiments were carried out under a 
licence from the UK Home Office (Project Licence 60/4504) and followed the 
“principles of laboratory animal care” (NIH Publication No. 86-23, revised 1985) 
 
3.3.2 Body Mass, Food intake and Adiposity 
 
Body mass (BM) was measured daily for 8 weeks from the introduction of 
10% DR, and weekly thereafter, for both AL and DR mice. BM and food intake were 
measured at the same time, on the same day, every week. Adiposity was measured 
by collecting and weighing (±0.001g) gonadal WAT and BAT, which were 
subsequently snap frozen liquid nitrogen and stored at -80°C. 
 
3.3.3 Fed glucose, fasting glucose and glucose tolerance 
 
Glucose tolerance was determined after an overnight fast, described in full in 
Chapter 2, section 2.2.2.  All animals (AL and DR) were fasted overnight in a fresh 
cage with AL access to water (1800 to 0800hrs) following short and long-term DR. 
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DR mice were fed at ∼1500hrs on the afternoons immediately prior to a glucose 
tolerance test (GTT), to ensure feeding prior to the overnight fast (Hempenstall et 
al. 2010). Glucose tolerance was measured according to standard protocols (as 
described in Chapter 2)  (Selman et al. 2008; Lees et al. 2015). Mice were weighed 
and a fasting blood glucose measurement was taken with a blood glucose strip 
using a glucometer (OneTouch Ultra, Lifescan, UK). Mice were injected 
intraperitoneally (IP) with 20% D-glucose (2g kg-1) and blood glucose levels 
collected from tail vein samples as previously described (Cantley et al. 2009). 
Glucose tolerance was expressed as the area under the curve over a 120 minute 
period following the IP injection of glucose. Fed blood glucose was recorded with a 
blood glucose strip using a glucometer. Blood from AL mice was collected at 
1100hrs and from DR mice at 1800hrs, following an early feeding at 1500hrs, to 
ensure mice were post-prandial (Hempenstall et al. 2010).  
 
3.3.4 Fasting plasma insulin levels, insulin sensitivity and IGF-1 levels  
 
Fasting plasma insulin levels were determined using a mouse insulin ELISA 
kit (EMD Millipore Corporation, USA Catalogue #EZRMI-13K). Insulin sensitivity 
was estimated using the updated homeostatic model assessment (HOMA2) model 
(Wallace et al. 2004), a method used to quantify insulin resistance  from fasting 
glucose and insulin concentrations. Fasting plasma IGF-1 levels were determined 
using a mouse IGF-1 ELISA kit (Catalogue# MG100, Quantikine, R and D Systems 
Inc., USA).  
 
3.3.5 UCP-1 protein levels 
 
Protein was extracted from liver tissue as described in Chapter 2 (section 
2.3.3). Equal volumes of tissue protein extract (50 μg) in Laemmli sample buffer 
were loaded onto 4–12% Bis-Tris pre-cast polyacrylamide gels (Life Technologies, 
Paisley, UK). Following this, proteins were transferred to polyvinylidene difluoride 
membranes (BioRad). Ponceau staining (Thermo Fisher Scientific, UK) was used 
to ensure equal loading of protein and for normalisation purposes. Membranes were 
incubated in Tris-buffered saline Tween (1X TBST) containing 5% BSA for 1 h−1. 
Blots were then washed in TBST (5 × 5min), incubated with primary antibody for 24 
h−1 (4 °C), washed again (TBST) and incubated with secondary antibody for 1 h−1 at 
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room temperature. Blots were visualised using Clarity™ Western ECL Substrate 
(BioRad) and a ChemiDoc™XRS system (BioRad). Antibodies for uncoupling 
protein -1 and secondary (anti-rabbit) antibodies were purchased from Abcam 
(Cambridge, UK) and Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA) 
respectively.  
  
3.3.6 Statistical Analysis  
 
All statistical analyses were performed using R and Graphpad Prism 
(GraphPad Inc., La Jolla, CA, USA, version 5). Figures were produced using 
GraphPad Prism software. One-way analysis of variance and linear modelling (lm) 
were used as appropriate. Lm was employed with strain (TejJ89, TejJ48, TejJ114) 
and treatment (AL or DR) as fixed factors. All non-significant variables (p>0.05) were 
removed from the lm analyses in order to obtain the minimum adequate model. 
Multiple comparisons were obtained through Tukey’s post-hoc test.  Data were 
checked for normality using the Shapiro–Wilks test and a logarithmic transformation 
was undertaken if data not normally distributed. Results are reported as 
mean±standard error of the mean (SEM), with p<0.05 regarded as statistically 
significant.  
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3.4 Results 
Table 3.1 denotes treatment effects on a range of metabolic parameters following short- and long-term 40% DR.  
Table 3.1 Summary of treatment effects within each strain (AL vs DR) 
Strain  Duration BM WAT BAT Fasting 
B.G. 
Fed 
B.G. 
AUC Fasting 
 Insulin 
HOMA IR IGF-1 
           
TejJ 89 ST ↓ ns ns ns ns ns ns ns ns 
TejJ 48 ST ↓ ns ns ↓ ↓ ns ns ns ns 
TejJ 114 ST ↓ ↑ ns ↑ ns ns ns ns ns 
TejJ 89  LT ↓ ns ↑ ↑ ns ns ns ↑ ns 
TejJ 48  LT ↓ ns ns ↑ ↓ ns ns ns ns 
TejJ 114 LT ↓ ↓ ns ns ↓ ns ns ns ns 
           
ST = Short-term DR                                                                                                             Fed B.G = Fed blood glucose 
Long-term DR                                                                                 AUC = Area under the Curve 
 ns=non-significant                                                              F. Insulin = Fasting insulin 
↓= decreased with DR                                                                                                                                                                                                                              
↑= increased with DR 
Fasted B.G = Fasting blood glucose
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3.4.1 Effects of Short-term DR on the metabolic phenotype of female ILSXISS 
mice 
3.4.1 (A) Body Mass  
Initial body mass (BM) (Figure 3.1), prior to introduction of DR protocol, was 
dependent on strain, with strain TejJ114 being significantly lighter at 9 weeks of age 
than either strain TejJ89 (t=4.569, p<0.001) or strain TejJ48 (t=-6.539, p<0.001). No 
difference was observed between strains TejJ89 and TejJ48 (t=-0.374, p=0.7108). 
BM across all 3 strains was significantly reduced, relative to their appropriate ad 
libitum (AL) controls, following 1 week of 20% DR (12 weeks of age), and remained 
significantly reduced in the DR mice for the remainder of the study (Figure 3.2A-C; 
TejJ89 t=4.404, p<0.001 (Fig. 3.2A), TejJ48 t=3.182, p=0.007 (Fig. 3.2B), TejJ114 
t=2.606, p=0.021 (Fig. 3.2C)). A significant treatment (F= 77.66, p < 0.001), strain 
(F = 20.41, p < 0.001) and an interaction effect, between treatment and strain, (F= 
3.323, p = 0.0456) on BM was observed following 2 months of DR (Figure 3.3 A).  
At the termination of the experiment (5 months of age), no strain-specific 
differences in BM was observed in the AL mice (Figure 3.3 B), but a significant 
strain-specific effect was detected in the DR mice (Figure 3.3C; F=4.562, =0.031); 
strain TejJ114 lost significantly more BM under 40% DR when compared with strains 
TejJ89 and TejJ48, with strain TejJ89 having the highest BM following short-term 
DR. When expressed as percentage loss in BM relative to the relevant AL mice, 
strain TejJ114 lost a greater percentage (~22%) of BM compared to either strain 
TejJ89 (~12%) or strain TejJ48 (~18%). No differences in average weekly food 
intake were detected over the duration of the study in the AL mice (Figure 3.4). 
 
.  
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Figure 3.1: Initial body mass (BM) of strains TejJ89, TejJ48 and TejJ114 
immediately before the start of the DR experiment (9 weeks of age) TejJ114 was 
significantly lighter than the other 2 strains at this time. Values are expressed as 
mean ± SEM, with n = 8 per group, *** denotes p<0.001. 
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Figure 3.2: Body mass (BM) of female TejJ89 (A), TejJ48 (B) and TejJ114 (C) 
ILSXISS mice fed an ad libitum (AL) or 40% dietary restricted (DR) diet for 2 months. 
Values are expressed as mean ± SEM, with n = 8 per group. * denotes **p<0.01, 
***p<0.001. 
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Figure 3.3: Body mass (BM) of female  TejJ89, TejJ48 and TejJ114 ILSXISS mice 
fed an ad libitum (AL) or 40% dietary restricted (DR) diet for 2 months. (A) BM was 
significantly reduced in all strains of mice following DR. (B) No strain-specific 
differences in BM were observed within AL mice, but within the DR group (C) a 
significant strain-effect was detected in BM. Values are expressed as mean ± SEM, 
with n = 8 per group. * denotes p < 0.05, **p<0.01, ***p<0.001. t= treatment effect; 
ttt denotes p<0.001, S= strain effect; SSS denotes p<0.001. 
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Figure 3.4: Food intake per mouse (g) of AL female ILSXISS mice from 12 weeks 
of age until 20 weeks of age. No differences in food intake were observed at any 
point between any strains. Values are expressed as mean ± SEM, with n = 8 per 
group. 
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3.4.1 (B) White Adipose Tissue 
Gonadal white adipose tissue (WAT) data was corrected for BM and all 
analysis performed on corrected data. WAT mass (expressed as a percentage of 
BM) was affected by treatment (F=16.24, p<0.001), strain (F=9.563, p<0.001) and 
a significant treatment*strain interaction was also observed (F = 8.603, p= 0.001) 
following short-term DR (Figure 3.5 A). Strain TejJ114 was found to have increased 
gonadal fat mass under DR relative to its AL control (p<0.001). While no strain 
specific-differences were apparent between the AL group (Figure 3.5 B), a 
significant strain effect was detected between the DR mice (F=13.18, p<0.001), with 
strain TejJ48 having a reduced WAT mass relative to both TejJ89 (p<0.05) and 
TejJ114 (p<0.001), (Figure 3.5 C). 
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Figure 3.5: Gonadal white adipose tissue (WAT) mass of female TejJ89, TejJ48 and 
TejJ114 ILSXISS mice fed an ad libitum (AL) or 40% dietary restricted (DR) diet for 
2 months (A). WAT was increased with DR in strain TejJ114. (B) WAT levels in the 
AL and (C) DR mice. Values are expressed as mean ± SEM, with n = 8 per group. 
* denotes p < 0.05, ***p<0.001, t= treatment effect; ttt denotes p<0.001, S= strain 
effect; SSS denotes p<0.001. 
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3.4.1 (C) Brown Adipose Tissue 
Brown adipose tissue (BAT) data was corrected for BM and all analysis 
performed on corrected data. No treatment effect was observed following short-term 
DR on interscapular BAT mass (expressed as a % of body mass), (Figure 3.6 A). A 
significant strain effect was detected overall (F = 4.312, p = 0.022), however when 
analysed independently of treatment no strain effects were apparent within the AL 
mice (Figure 3.6 B) or DR animals (Figure 3.6 C). 
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Figure 3.6: Brown adipose tissue (BAT) mass in female ILSXISS mice following 2 
months of 40% DR or AL feeding (A). No changes in BAT were observed in the AL 
(B) or DR (C) mice. Values are expressed as mean ± SEM, with n = 8 per group. S= 
strain effect; SSS denotes p<0.05. 
117 
 
3.4.1 (D) Fasting blood glucose 
Significant treatment (F=8.65, p=0.005), strain (F=3.547, p=0.037) and an 
interaction between treatment and strain (F= 24.9, p<0.001) on fasting blood 
glucose (FBG) levels was observed following short-term DR (Figure 3.7 A). FBG 
levels were significantly decreased under DR in strain TejJ48 (p<0.05) but increased 
significantly by DR in strain TejJ114 (p<0.001) relative to AL controls. Within AL 
mice strain had a significant effect on FBG (F=38.55, p<0.001) with an elevated 
FBG observed in strain TejJ48 compared to the other two strains (Figure 3.7 B). 
Within DR mice, strain-specific differences were similarly apparent (F=3.889, 
p=0.036), but strain TejJ114 having a higher FBG level compared to strain TejJ48 
(Figure 3.7 C). 
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Figure 3.7: Fasting blood glucose levels in female ILSXISS mice following 2 months 
of 40% DR or AL feeding (A). A significant treatment and strain effect was detected 
on fasting blood glucose levels. Fasted blood glucose in the AL (B) and DR (C) mice. 
Values are expressed as mean ± SEM, with n = 8 per group. * denotes p < 0.05, 
**p<0.01, ***p<0.001, t= treatment effect; tt denotes p<0.01, S= strain effect; S 
denotes p<0.05. 
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3.4.1 (E) Fed Blood Glucose 
Fed blood glucose levels were significantly affected by both treatment (F = 
8.575, p= 0.005) and strain (F = 8.679, p < 0.001). DR significantly reduced fed 
blood glucose levels in strainTejJ48 (p<0.05) only (Figure 3.8A). Within the AL mice 
a significant strain-effect was detected (F=6.495, p<0.001), with strain TejJ89 
having significantly increased fed blood glucose levels compared to TejJ114 mice 
(Figure 3.8 B). In the DR mice (F=4.836, p=0.019), strain TejJ48 had reduced fed 
blood glucose levels relative to both TejJ89 and TejJ114 (Figure 3.8 C).  
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Figure 3.8: Fed blood glucose levels in female ILSXISS mice following 2 months of 
40% DR or AL feeding (A). Treatment and strain were found to have a significant 
effect on fed blood glucose levels. Strain differences were observed within both AL 
(B) and DR mice (C). Values are expressed as mean ± SEM, with n = 8 per group. 
* denotes p < 0.05, **p<0.01, t= treatment effect; tt denotes p<0.01, S= strain effect; 
SSS denotes p<0.001. 
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3.4.1 (F) Glucose Tolerance 
Following an intraperitoneal injection of glucose, glucose tolerance (as 
determined by area under curve (AUC)) showed a significant treatment effect 
(F=14.28, p<0.001), with DR mice of all strains following short-term DR appearing 
to have impaired glucose tolerance. However, when analysed with Post-hoc tests, 
DR mice were not more glucose intolerant compared to AL controls within each 
strain (Figure 3.9A). No strain-specific effects on glucose tolerance were observed 
within either the AL (Figure 3.9B) or DR (Figure 3.9 C) mice. (See Figure 3.10 for 
glucose tolerance response curves). 
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Figure 3.9: Glucose tolerance (denoted by area under the curve (AUC) following a 
glucose injection) in female ILSXISS mice after 2 months of 40% DR or AL feeding. 
Glucose tolerance was increased with treatment (A). No effect of strain was 
observed in the AL (B) or DR (C) mice. Values are expressed as mean ± SEM, with 
n = 8 per group. t= treatment effect; ttt denotes p<0.001. 
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Figure 3.10: Glucose tolerance curves for strain TejJ89 (A), TejJ48 (B) and TejJ114 
(C) following an IP injection of 20% glucose (2g kg-1). Values are expressed as mean 
± SEM, with n = 8 per group.  
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3.4.1 (G) Fasting Plasma Insulin 
No treatment effect on fasting plasma insulin levels was detected, but a 
significant strain effect was observed (F = 3.854, p = 0.031), being higher, albeit 
non-significantly, in strain TejJ114. However, no strain-specific effects were 
detected within the AL (Figure 3.11 B) or DR (Figure 3.11 C) mice. 
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Figure 3.11: Fasting plasma insulin levels in female ILSXISS mice following 2 
months of 40% DR or AL feeding. Fasting plasma insulin levels (A) were unaffected 
by treatment, however a significant strain effect was apparent. No strain effects were 
observed at 5 months of age within the AL (B) or DR (C) mice. Values are expressed 
as mean ± SEM, with n = 8 per group. S= strain effect; S denotes p<0.05. 
 
 
 
 
 
 
 
 
126 
 
3.4.1 (H) Insulin resistance - HOMA IR 
No treatment effect was apparent following short-term DR on insulin 
resistance, as assessed using the homeostasis model assessment of insulin 
(HOMA2) (Figure 3.12 A). However, a significant strain-effect existed (F = 3.336, p 
= 0.048), with strain TejJ114 appearing more insulin resistant relative to the other 
strains, however with post-hoc testing this was not statistically significant. When 
analysed independently of treatment, no strain-specific effects were observed in 
either the AL (Figure 3.12 B) or DR (Figure 3.12 C) mice.  
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Figure 3.12: Homeostatic Model of Assessment (HOMA) of insulin resistance (IR) 
in female ILSXISS mice following 2 months of 40% DR or AL feeding. Treatment 
had no effect on HOMA IR, however strain was found to have an effect on HOMA 
IR (A). No strain effect was found within the AL (B) or DR (C) mice. Values are 
expressed as mean ± SEM, with n = 8 per group. S= strain effect; S denotes p<0.05. 
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3.4.1 (I) Fasting plasma IGF-1 
No treatment or strain effect on fasting plasma IGF-1 levels were detected 
(Figure 3.13 A). Similarly no strain effect was found, with plasma IGF-1 levels in the 
AL (Figure 3.13B) or DR (Figure 3.13C) mice.  
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Figure 3.13: Fasting plasma IGF-1 levels in female ILSXISS mice following 2 months 
of 40% DR or AL feeding (A). No strain effect was found in AL (B) or DR (C) mice 
at 5 months of age. Values are expressed as mean ± SEM, with n = 8 per group.  
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3.4.2 Effects of Long-term DR on the metabolic phenotype of female ILSXISS 
mice 
3.4.2 (A) Body Mass  
As with the mice in the short-term DR study (Short-term 1), BM was reduced 
significantly from 12 weeks of age onwards in the Long-term study. Following 10 
months of DR (13 months of age; Figure 3.14 A- C) all mice subject to DR were 
significantly lighter than their respective AL controls (AL vs. DR TejJ89; 25.3g vs. 
17.8g t=11.66, p< 0.001, TejJ48; 24.7g vs. 19.3g t=11.98, p< 0.001, TejJ114; 25.6g 
vs. 14.9g t=12.40, p< 0.001; mean+/- SEM). A significant treatment (F=410.0, 
p<0.001), strain (F=7.277, p=0.002) and strain*treatment interaction (F=15.22, 
p<0.001) were observed (Figure 3.15 A). While no strain-specific differences in BM 
were observed between the AL mice (Figure 3.15B), a significant strain-effect 
existed in the DR mice (Figure 3.15C); strain TejJ114 was significantly lighter than 
both TejJ89 (p<0.01) and TejJ48 (p<0.001). The loss in BM following DR over the 
course of the experiment (relative to their AL controls) was greatest in strain TejJ114 
(~52.3%) compared to the respective losses in BM in strain TejJ89 (~34.5%) and 
TejJ48 (~24.6 %). Average weekly food intake in the AL mice over the duration of 
the experiment, did not differ between the strains (Figure 3.16). 
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Figure 3.14: Body mass (BM) of female TejJ89 (A), TejJ48 (B) and TejJ114 (C) 
ILSXISS mice fed an ad libitum (AL) or 40% dietary restricted (DR) over a 10 month 
period (equivalent to 13 months of age). BM differed significantly with treatment from 
20% onwards.  Values are expressed as mean ± SEM, with n = 8 per group. * 
denotes p < 0.05, **p<0.005, ***p<0.0001. 
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Figure 3.15: Body mass (BM) of female TejJ89 (A), TejJ48 (B) and TejJ114 (C) 
ILSXISS mice fed an AL diet or 40% DR over a 10 month period (equivalent to 13 
months of age). Treatment had a significant effect on BM in all strains, with DR mice 
having reduced BM compared to AL controls (A). No strain effect was detected on 
BM in the AL mice (B). Within the DR mice (C) strain was found to have a significant 
effect on BM. Values are expressed as mean ± SEM, with n = 8 per group. ** 
denotes p<0.01, ***p<0.0001. t= treatment effect; ttt denotes p<0.001. S= strain 
effect; SS denotes p<0.001. 
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Figure 3.16: Food intake per mouse (g) of AL female ILSXISS mice from 12 weeks 
of age until 52 weeks of age. No strain-specific differences in food intake were 
observed. Values are expressed as mean ± SEM, with n = 8 per group. 
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3.4.2 (B) White Adipose Tissue 
WAT data was corrected for BM and all analysis performed on corrected 
data. A significant treatment (F=21.25, p<0.001) and strain (F=6.078, p=0.004) 
effect on gonadal WAT was detected, with a highly significant reduction in WAT 
mass (expressed as a percentage of BM) following long-term DR (Figure 3.17 A). 
However, strain TejJ114 was the only strain to show a significant reduction in WAT 
when compared to its AL control (p<0.01). When considered as percentage loss, 
strain TejJ114 had the greatest reduction of WAT (60.3%) relative to AL WAT levels, 
withTejJ89 and TejJ48 mice having a lesser reduction compared to AL counterparts 
(48.6% and 43.9% respectively). Strain-specific differences were detected within the 
AL mice (F= 4.301, p=0.022), (Figure 3.17B), with strain TejJ114 having greater 
gonadal WAT mass relative to strain TejJ48 (p<0.05). No strain-specific differences 
were seen in the DR mice (Figure 3.17 C). 
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Figure 3.17: Gonadal white adipose tissue (WAT) ILSXISS mice fed an AL diet or 
40% DR over a 10 month period (equivalent to 13 months of age.) A treatment effect 
was observed with long-term DR in all strains (A). Strain specific differences were 
observed within AL mice (B) unlike the DR mice (C). Values are expressed as mean 
± SEM, with n = 8 per group. * denotes p < 0.05, **p<0.005. t= treatment effect; ttt 
denotes p<0.001. S= strain effect; SS denotes p<0.01. 
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3.4.2 (C) Brown Adipose Tissue 
BAT mass (expressed as percentage of BM) was significantly increased in 
DR mice (F = 14.47, p< 0.001). Following post hoc analysis, this DR effect was 
found to be significant only in strain TejJ89 mice (Figure 3.18 A). Within both the AL 
(Figure 3.18B) and the DR mice (Figure 3.18 C), no strain-specific effects on BAT 
mass were detected.  
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Figure 3.18: Brown adipose tissue (BAT) mass in female ILSXISS mice fed an AL 
diet or 40% DR over a 10 month period (equivalent to 13 months of age). BAT was 
increased with DR in strain TejJ89 relative to AL controls (A). No detectable strain-
effect was reported in the AL (B) or DR mice (C). Values are expressed as mean ± 
SEM, with n = 8 per group. ** denotes p p<0.005, t= treatment effect; ttt denotes 
p<0.001. 
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3.4.2 (D) UCP-1 
UCP-1 protein levels in BAT were unaffected by treatment and strain (Figure 
3.19 A, B and C).  
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Figure 3.19 : UCP-1 protein levels in brown adipose tissue in female ILSXISS mice 
fed an AL diet or 40% DR over a 10 month period (equivalent to 13 months of age 
)(A). No detectable treatment or strain effect was reported (DR mice (C). Values are 
expressed as arbitrary units (AU) relative to total protein (determined by Ponceau 
staining) and as mean ± SEM, with n = 8 per group. 
 
 
 
 
 
 
 
 
140 
 
3.4.2 (D) Fasting blood glucose 
Fasting blood glucose levels were significantly affected by both treatment (F 
= 38.03, p < 0.001) and strain (F = 14.67, p< 0.001; Figure 3.20A). Long-term DR 
increased fasting blood glucose levels relative to AL controls in strain TejJ89 
(p<0.001) and TejJ48 (p<0.05). Within the AL mice, a significant strain-specific 
effect existed (F=7.635, p=0.002) with elevated fasting blood glucose in strain 
TejJ48 relative to both TejJ89 (p<0.01) and TejJ114 (p<0.01) (Figure 3.20 B). 
Similarly within the DR mice a significant strain effect was reported (F=9.397, 
p=0.004), but with reduced levels of fasting blood glucose in strain TejJ114 
compared to both TejJ89 (p<0.01) and TejJ48 (p<0.001) (Figure 3.20C).  
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Figure 3.20: Fasted blood glucose levels in female ILSXISS mice fed an AL diet or 
40% DR over a 10 month period (equivalent to 13 months of age). Fasting blood 
glucose levels were increased overall by treatment (A). Strain effect apparent in 
both AL (B) and DR (C) mice. Values are expressed as mean ± SEM, with n = 8 per 
group. * denotes p < 0.05, **p<0.005, ***p<0.0001. , t= treatment effect; ttt  denotes 
p<0.001, S= strain effect; SS denotes p<0.01. 
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3.4.2 (F) Fed blood glucose 
Fed blood glucose levels were significantly affected by treatment (F=49.86, 
p<0.001), strain (F=9.364, p<0.001), with a significant treatment*strain interaction 
observed (F=4.887, p=0.011) (Figure 3.21 A). DR decreased fed blood glucose 
levels relative to AL controls in strains TejJ48 (p<0.001) and TejJ114 (p<0.001). 
Within the AL mice, a significant strain-specific effect existed (F=4.226, p=0.023) 
with strain TejJ114 having higher fed blood glucose levels relative to strain TejJ89 
(p<0.05) (Figure 3.21 B). Similarly within the DR mice a significant strain effect was 
identified (F=10.28, p=0.004) with lower fasting blood glucose observed in strain 
TejJ48 compared to both TejJ89 (p<0.01) and TejJ114 (p<0.01) (Figure 3.21C).  
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Figure 3.21: Fed blood glucose levels in female ILSXISS mice fed an AL diet or 40% 
DR over a 10 month period (equivalent to 13 months of age). Fed blood glucose 
was reduced by treatment (A). Strain differences were detected in both the AL (B), 
DR mice (C). Values are expressed as mean ± SEM, with n = 8 per group. * denotes 
p < 0.05, **p<0.005, ***p<0.0001. t= treatment effect; ttt denotes p<0.001, S= strain 
effect; SSS denotes p<0.001. 
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3.4.2 (G) Glucose Tolerance 
Glucose tolerance was significantly affected by treatment, being reduced 
overall in DR mice (F=49.86, p<0.001; Figure 3.22A), however glucose tolerance 
was not improved in DR mice of any strain relative to AL controls. While no strain-
specific effect was identified in AL mice (Figure 3.252B), a significant strain-specific 
effect was seen under DR (F-3.561, p =0.038); strain TejJ89 had poorer glucose 
tolerance relative to strain TejJ114 (p<0.05) (Figure 3.22 C). Glucose tolerance 
responses are plotted in Figure 3.23. 
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Figure 3.22: Glucose tolerance (denoted by area under the curve (AUC)) following 
an IP injection of 20% glucose (2g kg-1) in female ILSXISS mice fed an AL diet or 
40% DR diet over a 10 month period (equivalent to 13 months of age).  Treatment 
was found to have a significant effect on glucose tolerance (A). No strain specific 
differences were observed within the AL (B) or DR (C) mice. Values are expressed 
as mean ± SEM, with n = 8 per group. * denotes p < 0.05. t= treatment effect; t 
denotes p<0.05. 
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 Figure 3.23: Glucose tolerance curves for strain TejJ89 (A), TejJ48 (B) and TejJ114 
(C) in female  ILSXISS mice fed an AL diet or 40% DR over a 10 month period 
(equivalent to 13 months of age, following an IP injection of 20% glucose (2g kg-1). 
Values are expressed as mean ± SEM, with n = 8 per group. 
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3.4.2 (H) Fasting plasma insulin 
Fasting plasma insulin levels were unaffected by treatment (Figure 3.24 A). 
However, a significant strain-effect was detected (F = 4.349, P = 0.021). While no 
strain-specific differences were observed within AL mice (Figure 3.24 B), a 
significant strain-specific effect was observed within the DR group (F=4.526, 
p=0.028), with strain TejJ89 (p<0.05) hyperinsulinaemic relative to strain TejJ48 
(Figure 3.24 C). 
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Figure 3.24: Fasted plasma insulin levels in female ILSXISS mice fed an AL or 40% 
DR over a 10 month period (equivalent to 13 months of age). No treatment effect 
was apparent following long-term DR on fasting plasma insulin levels (A). 
Representative of fasting plasma insulin in AL (B) and DR (C) mice. Values are 
expressed as mean ± SEM, with n = 8 per group. * denotes p < 0.05. S= strain 
effect; S denotes p<0.05. 
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3.4.2 (I) Insulin resistance - HOMA IR 
Insulin resistance, as assessed using the homeostatic model assessment of 
insulin (HOMA2), was affected by both treatment (F = 6.898, P = 0.013) and strain 
(F= 3.480, p = 0.044) (Figure 3.25 A). Long-term DR surprisingly increased insulin 
resistance relative to AL controls in strain TejJ89 (p<0.01). Within the AL mice 
(Figure 3.25B) a significant strain-specific effect existed (F=5.200, p=0.018), with 
strain TejJ114 being more insulin resistant than either TejJ89 (p<0.05) or TejJ48 
(p<0.05). Within DR mice a significant strain-specific effect was seen (F=4.152, 
p=0.037), with strain TejJ89 (p<0.05) having increased insulin resistance when 
compared to TejJ48 (Figure 3.25 C). 
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Figure 3.25: Homeostatic Model of Assessment (HOMA) of insulin resistance (IR) 
in female ILSXISS mice fed an AL diet or 40% DR over a 10 month period 
(equivalent to 13 months of age)(A). HOMA IR was found to be strain-specific in the 
AL (B) and DR mice (C). Values are expressed as mean ± SEM, with n = 8 per 
group. * denotes p < 0.05, **p<0.005. 
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3.4.2 (J) Fasting plasma IGF-1  
Fasting plasma IGF-1 levels were found to be unaltered by treatment or strain 
following long-term DR (Figure 3.26 A). However, when assessed independent of 
treatment, i.e. to assess strain effects within AL or DR groups no strain-specific 
differences were found within the AL treatment group (Figure 3.26 B).A significant 
strain effect was observed however in DR mice (Figure 3.26 C), with strain TejJ89 
appearing to have the lowest levels of fasting plasma IGF-1, although the results 
were not significantly different following post-hoc analysis.  
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Figure 3.26: Fasting plasma IGF-1 levels in female ILSXISS mice fed an AL diet or 
40% DR over a 10 month period (equivalent to 13 months of age). Plasma IGF-1 
was unaltered by treatment (A). IGF-1 levels in AL (B) and DR (C) mice. Values are 
expressed as mean ± SEM, with n = 8 per group. * denotes p < 0.05, **p<0.005. 
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3.5 Discussion 
The pursuit of effective strategies and therapeutics for improved health and 
survival has long relied on DR for determining the mechanistic processes of ageing. 
However, emerging evidence calls into question the universality of the effects of DR 
in extending lifespan, with genotype appearing to dictate both the magnitude and 
direction of lifespan response. In this study we employed a comparative approach 
to address the effects of 40% DR on numerous key physiological and metabolic 
hallmarks of DR response (BM, adiposity, glucose homeostasis), in three 
heterogeneous strains of ILSXISS RI mice, and to investigate these hallmarks as 
proposed candidate mechanisms underlying lifespan extension and slowed ageing. 
Our results indicate that genetic background appears relevant to the physiological 
response of mice to DR, with changes in body composition, specifically in body and 
fat mass following long-term DR found to correspond with the reported lifespan 
response to DR in these strains.  
3.5.1 DR and Body Mass  
Reductions in BM are characteristic of DR in mammals (Mattison et al. 2017; 
Mitchell et al. 2016), and female ILXISS mice of each strain weighed less than AL 
controls following both short and long-term 40% DR. However, interestingly strain 
TejJ114, which exhibits lifespan shortening under 40% DR (Rikke et al. 2010; Liao 
et al. 2010), lost significantly more BM under both short-term (2 months) and long-
term (10 months) DR relative to their appropriate AL controls. Whilst  BM loss is a 
universal feature of DR in rodents (Weindruch & Walford 1988), my data shows that 
strain TejJ114 lost over 50% of BM  under DR which may help explain the negative 
effect or DR on lifespan in this strain. Indeed it has been shown that adenylyl cyclase 
type 5 knockout mice (AC5 KO) that are long lived under AL conditions, show 
lifespan shortening under DR that is associated with a significant reduction in BM 
(Yan et al. 2012). Potentially 40% DR is too severe a protocol in TejJ114, as 
evidenced by the >50% loss in total BM in this strain. Organisms typically display a 
tent-shaped lifespan response to DR (Clancy et al. 2002; Fontana & Partridge 
2015), in that there is a dietary regime that maximises lifespan. In mice, different 
genotypes have different optimal DR conditions for longevity. For example, lifespan 
in DBA/2 mouse is maximal under 20% DR but maximal in C57BL/6 mice under 
40% DR (Mitchell et al. 2016). Similarly in flies, the long-lived chico genotype are 
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found to have similar lifespan peaks to control flies following DR, but at different 
levels of nutrient restriction (Clancy et al. 2002).  
Mice preferentially utilise WAT as an energy source under DR, in order to 
meet essential energy requirements in a time of reduced food intake (Mitchell et al. 
2015a). In addition, losses in visceral adipose tissue have been associated with the 
beneficial metabolic effects of DR (Berg & Simms 1960; Barzilai et al. 1998; Gabriely 
et al. 2002). Despite TejJ114 showing a clear reduction in BM during short-term DR, 
surprisingly I observed an increase in gonadal WAT suggesting that other WAT pads 
and/or lean mass were preferentially lost in this strain. Reductions in specific organs 
have reported in rodents under DR, including hearts, livers, kidney (Bevilacqua et 
al. 2005), prostate, spleen, and skeletal muscle mass (Mitchell et al. 2015b; R 
Weindruch & Sohal 1997; Selman et al. 2005). It has been suggested that a 
selective reduction of different fat depots and the redistribution of fat mass to other 
sites may play a role in lifespan extension (Muzumdar et al. 2008), and in support 
of this C57BL/6 female mice under DR reportedly undergo redistribution of fat stores 
from visceral to subcutaneous depots (Varady et al. 2010). Increases of WAT mass 
at several fat depots including inguinal, gonadal, subcutaneous retroperitoneal, and 
mesenteric white adipose tissue, has also been reported following short-term mild 
(5%) DR in female C57BL/6 mice (Li, Cope, Johnson, D. L. J. Smith, et al. 2010). 
One limitation of my study was that no other fat depots, such as the mesenteric or 
omental, were measured.   
In contrast, under long-term DR strain TejJ114 lost >50% of BM relative to 
AL controls and also lost the greatest percentage gonadal WAT. Previous work has 
shown that ILSXISS strains with greater capacity for fat preservation under 40% DR 
showed the greatest increase in lifespan under DR, whereas conversely larger 
losses of fat mass were associated with lifespan shortening under DR (Liao et al. 
2011), with my data showing this relationship for TejJ114. While this association has 
come under some criticism, with Speakman et al (2011) highlighting that if positive 
responders are analysed irrespective of non- and negative-responders, no 
association between fat maintenance and longevity with DR exists.  Contrary to this 
argument, a study of DBA/2 and C57BL/6 mice under different levels of DR,  
reported preservation of fat mass to be associated with increased lifespan, 
suggesting that a limit to adipose loss is in fact crucial to show lifespan benefits 
under DR (Mitchell et al. 2016).  
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BAT mass tends to increase under DR in rodents (Valle et al. 2008; 
Fabbiano, Suá Rez-Zamorano, et al. 2016; Ghosh et al. 2014), and higher levels of 
BAT has been shown to afford protection against metabolic dysfunction (Lowell et 
al. 1993) and obesity (Yoneshiro et al. 2013). Short-term DR had no impact on BAT 
mass in any ILSXISS strain, with the reasons for this unclear. However, it has 
recently been proposed that increased BAT mass following DR is directly linked to 
alterations in WAT (Fabbiano, Suá Rez-Zamorano, et al. 2016). We observe no 
changes in WAT in any strain under short-term DR, which may help explain the lack 
of effect in BAT. In most rodent DR studies, including my own, DR animals are 
maintained at 22⁰ C, i.e. below the lower limit of the thermoneutral temperature zone 
(Speakman & Keijer 2012), thus DR mice are subject to thermoregulatory stress. 
Following implementation of DR animals must employ a number of compensatory 
strategies in order to conserve energy and preserve fat mass (Waterlow 1986). 
Following long-term DR, we observed BAT hypertrophy in strain TejJ89 only, the 
strains that shown lifespan extension under 40% DR. This may suggest that the 
metabolic efficiency and/ or plasticity of this strain is important to lifespan extension, 
with enhanced thermoregulation through non-shivering thermogenesis perhaps 
involved in the beneficial effect of DR on lifespan. Indeed transgenic over-
expression of UCP1 extends lifespan in mice (Gates et al. 2007), and BAT, which 
is responsible for non-shivering thermogenesis, is increased with DR in rodents 
(Valle et al. 2008; Fabbiano, Suá Rez-Zamorano, et al. 2016) . Conversely, we 
propose that the inability of strain TejJ114 to defend against loss of WAT, combined 
with the inability to increase BAT mass during a time of thermoregulatory stress, 
may indicate that this strain are metabolically constrained under 40% DR. In 
agreement, ILSXISS strains with the greatest reductions in body temperature 
following DR were those same strains which were less responsive to the lifespan 
effects of DR (Rikke & Johnson 2007).  
3.5.2 Glucose Homeostasis 
The responses identified in relation to aspects of metabolism between the 
ILSXISS mice collectively suggest that no link exists between improved glucose 
homeostasis and longevity under 40% DR. This is perhaps surprising, given that 
improvements in glucose homeostasis are thought to be key components of 
extended lifespan (Bartke, 2008; Bartke & Brown-Borg, 2004). Glucose tolerance 
was not improved in DR mice under either long or short term DR, unlike findings 
previously reported in C57BL/6 or DBA/2 mice (Hempenstall et al. 2010; Mitchell et 
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al. 2016; Mitchell et al. 2015b). This suggests that certain strains are more 
responsive to DR than others, and may perhaps explain the observed lack of effect 
in glucose tolerance in the ILSXISS mice. Indeed C57BL/6 mice under DR have 
been shown to be more glucose intolerant than DBA/2 mice (Hempenstall et al. 
2010). We similarly saw no clear association between fasting plasma insulin or IGF-
1 levels or insulin sensitivity under DR and reported lifespan response between 
strains, despite the widespread support for such a link to longevity following DR in 
other strains (Hempenstall et al. 2010; Mitchell et al. 2015b). However, clear strain-
specific differences were observed in line with comparative studies of DBA/2 mice 
and C57BL/6 mice (Hempenstall et al. 2010; Berglund et al. 2008; Goren et al. 
2004).  
The reasons for differences between this study and  those which report 
reduced insulin/IGF-1 levels and insulin sensitivity following DR is unclear but may 
be due to differences in magnitude or duration of DR,  whether animals were fed or 
fasted at time of sampling, and/or the lack of a graded reduction in food intake 
between studies. Indeed the protocol in this study is similar to that of Hempenstall 
et al, who also report no improvements in insulin with DR (Hempenstall et al. 2010). 
They too employ a stepwise reduction in food intake to introduce DR, and restrict 
DR mice on a daily basis, unlike some studies which feed animals double or triple 
rations on certain days. Moreover, such a discrepancy in protocol exists between 
the Liao et al and Rikke et al study which independently describe the lifespan effects 
of the ILSXISS mice (Liao et al. 2010; Rikke et al. 2010) and the current one. In 
these studies (Liao et al. 2010; Rikke et al. 2010) mice were essentially under 
intermittent fasting (IF), and it would be interesting to assess if the lifespan response 
in the strains would be upheld if carried out with 40% DR as employed in this study. 
Moreover, it would be useful to determine measures of glucose homeostasis under 
the IF protocol used in Liao et al and Rikke et al, to investigate if they correlated well 
with direction of reported lifespan response. 
Previous reports of gender-speciﬁc effects on murine lifespan have been 
reported (Holzenberger et al. 2003; Selman et al. 2008), and the importance of 
gender in DR response is becoming more apparent (Mitchell et al. 2016). Male mice 
are known to be more susceptible to conditions which are associated with insulin 
resistance and impaired glucose homeostasis (Merry et al. 2017). Furthermore, 
lifelong 20% and 40% DR in female C57BL/6 and DBA/2 mice had no effect on 
fasting plasma insulin levels (Mitchell et al. 2016), unlike male counterparts. If 
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fasting plasma insulin response is dictated by gender, it would indicate that 
improved insulin sensitivity is not a universal driver of DR. It would be interesting to 
investigate the metabolic phenotype in the corresponding male ILSXISS strains 
under DR and AL conditions, to determine if improved insulin sensitivity with DR is 
in fact a health benefit only associated with males. Recently questions have been 
raised about the translatability of mouse research, the majority of which has been 
carried out on the C57BL/6 strain, to a genetically heterogeneous population, such 
as humans (Miller 2016). Moreover, the majority of DR studies have been largely 
investigating responses in male animals, with the NIH seeking to address this 
problem and include females in research (Clayton & Collins 2014). The lack of 
research on female animals makes comparing results across studies difficult. 
Moreover, studying the glucose homeostatic response to DR in male animals of a 
single genetic background may not produce definitive results from which deductions 
can be made for female ILSXISS strains. It is becoming more apparent that both 
gender and genotype interact to dictate the DR response (Mitchell et al. 2016; Valle 
et al. 2005), therefore exactly how DR would impact IGF-1 is not known in female 
ILSXISS mice, and may explain the apparent lack of beneficial effects with DR.  
3.6 General conclusion 
In summary, loss of WAT with long-term DR was associated with reduced 
lifespan, indicating that fat maintenance is important to the beneficial effects of DR. 
Moreover, BAT hypertrophy was associated with longevity, suggesting that 
cooperation between these two fat types following DR may be a key component of 
slowed ageing. These data suggests that that DR-induced lifespan extension in 
ILSXISS mice is not linked with improved glucose tolerance, enhanced insulin 
sensitivity or decreased IGF-1. My findings do however highlight the complex 
relationship between DR, genotype and lifespan extension. Most likely improved 
glucose homeostasis is one branch of an overarching mechanistic process 
underlying DR (see Anderson & Weindruch 2010) and it will be important to assess 
glucose homeostasis under less restrictive feeding conditions, in order to determine 
if a strain-specific optimal level of restriction will elicit improvements associated with 
DR in these strains. Furthermore it is not known how genotype impacts metabolic 
signatures commonly associated with DR. Disentangling the effects of genotype on 
classic hallmarks of DR will be crucial in understanding the mechanisms involved in 
lifespan extension and the shared processes of mammalian ageing.  
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Chapter 4: Disentangling the effect of dietary restriction on mitochondrial 
function using recombinant inbred mice 
4.1 Abstract  
Dietary restriction (DR) extends lifespan and healthspan in many species, but 
precisely how it elicits its beneficial effects is unclear. We investigated the impact of 
DR on mitochondrial function within liver and skeletal muscle of female ILSXISS 
mice that exhibit strain-specific variation in lifespan under 40% DR. Strains TejJ89 
(lifespan increased under DR), TejJ48 (lifespan unaffected by DR) and TejJ114 
(lifespan decreased under DR) were studied following 10 months of 40% DR (13 
months of age). Oxygen consumption rates (OCR) within isolated liver mitochondria 
were unaffected by DR in TejJ89 and TejJ48, but decreased by DR in TejJ114. DR 
had no effect on hepatic protein levels of PGC-1a, TFAM, and OXPHOS complexes 
I-V. Mitonuclear protein imbalance (nDNA:mtDNA ratio) was unaffected by DR, but 
HSP90 protein levels were reduced in TejJ114 under DR. Surprisingly hepatic 
mitochondrial hydrogen peroxide (H2O2) production was elevated by DR in TejJ89, 
with total superoxide dismutase activity and protein carbonyls increased by DR in 
both TejJ89 and TejJ114. In skeletal muscle, DR had no effect on mitochondrial 
OCR, OXPHOS complexes or mitonuclear protein imbalance, but H2O2 production 
was decreased in TejJ114 and nuclear PGC-1a increased in TejJ89 under DR. Our 
findings indicate that hepatic mitochondrial dysfunction associated with reduced 
lifespan of TejJ114 mice under 40% DR, but similar dysfunction was not apparent 
in skeletal muscle mitochondria. We highlight tissue-specific differences in the 
mitochondrial response in ILSXISS mice to DR, and underline the importance and 
challenges of exploiting genetic heterogeneity to help understand mechanisms of 
ageing. 
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4.2 Introduction  
Dietary restriction (DR), in its most general sense; defined here as reductions 
in energy intake, reductions in specific macro or micronutrients or as intermittent 
fasting, is the most extensively applied experimental intervention employed to 
manipulate ageing and longevity (Selman 2014b; Mair & Dillin 2008). Since the first 
study demonstrating that DR extended the reproductive period and lifespan of 
female rats almost one century ago (Osborne et al. 1917), an extensive body of 
research has studied the effects of DR in a wide number of organisms (Selman 
2014b; Mair & Dillin 2008; Fontana & Partridge 2015; Shimokawa & Trindade 2010; 
Weindruch & Walford 1988). In addition to its effects on lifespan, DR also attenuates 
and/or postpones a broad-spectrum of age-associated pathologies, including 
obesity, insulin resistance, cognitive decline, immune dysfunction, stem cell ageing, 
sarcopaenia and cataracts (Selman 2014b; Mair & Dillin 2008; Fontana & Partridge 
2015; Shimokawa & Trindade 2010). DR in rodents confers protection against a 
number of spontaneous and experimentally-induced cancers (Weindruch & Walford 
1988),  and delays several age-associated pathologies, including metabolic and 
cardiovascular disease, cancer and brain atrophy in non-human primates (Colman 
et al. 2009; Colman et al. 2014; Mattison et al. 2012) . Similarly, DR elicits numerous 
beneficial metabolic effects in humans including weight loss, lower visceral and 
intramuscular adiposity, insulin sensitivity and lowers several risk factors linked to 
cancer and cardiovascular disease (Fontana et al. 2010; Murphy et al. 2011).  
However, contrary to the belief that the effect of DR on longevity is universal, 
several studies have reported a lack of, or even a detrimental effect of, DR on 
lifespan (Mattison et al. 2012; Harrison & Archer 1987; Carey et al. 2002; Forster et 
al. 2003; Rikke et al. 2010; Schleit et al. 2013; reviewed in Mulvey et al. 2014). In 
Rhesus macaques (Macaca mulatta), DR extended lifespan in a study conducted 
by the National Primate Research Centre at the University of Wisconsin (Colman et 
al. 2014), but did not extend lifespan in a study undertaken by the National Institute 
of Health (Mattison et al. 2012). The precise reasons for the differing outcomes 
between these studies appears complex but may reflect inter-study differences in 
diet, animal husbandry and geographical origin (Selman 2014b; Colman et al. 2014; 
Partridge 2012). In addition, a potentially critical factor that may help explain the 
unresponsiveness of particular organisms to DR-induced longevity is genetic 
background (Selman 2014b; Colman et al. 2014; Partridge 2012; Swindell 2012). 
For example, the effect of DR on survival in DBA/2 mice has been a source of debate 
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for many years, with DR reported to extend (Turturro et al. 1999; Lipman 2002), 
have no effect (Fernandes et al. 1976), or shorten lifespan (Forster et al. 2003). 
However, a recent study examining lifespan in male and female DBA/2 and C57BL/6 
mice under 20% and 40% DR revealed that DBA/2 mice are indeed responsive to 
DR, although the impact of sex, strain and the magnitude of DR on survival outcome 
appears important (Mitchell et al. 2016). In two independent studies undertaken by 
the Universities of Texas (Liao et al. 2010) and Colorado (Rikke et al. 2010), survival 
was determined in multiple strains of heterogeneous ILSXISS recombinant inbred 
mice maintained on 40% DR, with distinct strain-specific effects on survival 
observed following 40% DR. The first study (Liao et al. 2010) reported that across 
39 female and 41 male strains studied, only 21% of female strains and 5% of male 
strains showed life extension under DR. Surprisingly, a greater number of strains 
(27% and 26% for females and males respectively) showed reduced lifespan under 
DR. The latter study (Rikke et al. 2010), which assayed 42 female ILSXISS strains, 
similarly reported a significant strain-specific response to DR, with only 21% of 
strains showing life extension and 19% showing life shortening effects of DR. 
Despite DR being the primary experimental intervention used to study 
ageing, it is still unclear as to precisely how DR acts mechanistically to induce its 
effects, although a multitude of mechanisms have been proposed (Fontana & 
Partridge 2015; Shimokawa & Trindade 2010; Masoro 2005; Hine et al. 2015; 
Anderson & Weindruch 2010). Mitochondrial dysfunction is a key hallmark of ageing 
and disease (Lopez-Otin et al. 2013), with ageing associated with altered 
mitochondrial morphology, reduced mitochondrial oxidative capacity and ATP 
production, increased mitochondrial derived reactive oxygen species (ROS) 
generation and greater oxidative damage (Wang & Hekimi 2015). Consequently, 
significant research effort has investigated whether DR can induce beneficial effects 
on the mitochondrial phenotype, such as maintaining mitochondrial function during 
ageing, reducing ROS production and attenuating oxidative damage. While it is 
generally assumed that DR reduces ROS production, a recent meta-analysis 
involving 157 rodent DR studies in which ROS levels (primarily hydrogen peroxide) 
were assayed, highlighted that 62% of studies actually reported no change in ROS 
levels relative to ad libitum (AL) fed controls (Walsh et al. 2014). Ambiguity also 
exists regarding the effect of DR on mitochondrial respiration in rodents, with DR 
reported to increase (Hempenstall et al. 2012; A. J. Lambert et al. 2004; Nisoli et al. 
2005; Lanza et al. 2012), decrease (Sohal et al. 1994), or have no effect relative to 
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AL controls (Gredilla et al. 2001). Similarly, the impact of DR on various antioxidants 
and markers of oxidative damage appears fairly inconclusive, although as with all 
these parameters tissue-specific effects, the duration and intensity of DR, the sex 
and the age of the animals at the point of study may affect experimental outcomes 
(Walsh et al. 2014). The concept that DR induces mitochondrial biogenesis, that is 
the production of new mitochondrial proteins, has been proposed as a critical 
mechanism underlying the beneficial effects of DR (Civitarese et al. 2007), with DR 
reported to induce mitochondrial biogenesis in a number of tissues including liver 
(Nisoli et al. 2005). Peroxisome proliferator activated receptor gamma coactivator 
1-alpha (PGC-1α is described as the master regulator of mitochondrial biogenesis 
(Puigserver et al. 1998). DR slows age-related declines in Pgc-1a expression in rat 
skeletal muscle and heart, and it is proposed that mitochondrial function adapts to 
DR through PGC-1α  regulation (Nisoli et al. 2005; Anderson et al. 2008; López-
Lluch et al. 2006). However, there is considerable debate in the literature as to how 
best to quantify biogenesis. Indeed, several studies suggest that DR may increase 
mitochondrial efficiency in order to maintain an ‘optimally efficient’ electron transport 
system, potentially driven by the nuclear localisation of PGC-1α (Anderson et al. 
2008; Finley et al. 2012) without any increase in mitochondrial number per se 
(Hempenstall et al. 2012; Lanza et al. 2012; Hancock et al. 2011). Hancock et al. 
(2011) examined a range of tissues, including liver and skeletal muscle, in rats and 
suggested that rather than altering rate of protein synthesis in the mitochondria that 
DR affords protection to mitochondria through defending against DNA damage. 
Similarly, Lanza et al. (2012) reported that DR did not stimulate the synthesis of new 
mitochondrial proteins in mouse skeletal muscle, but rather minimised damage to 
existing cellular components, through decreased mitochondrial oxidant emission 
and upregulated antioxidant defences. Indeed, mitochondrial protein synthesis 
within liver, muscle and heart of mice was unaffected by DR, although cellular 
proliferation was decreased (Miller et al. 2012), with a recent proteomic approach 
reporting that mitochondrial biogenesis may actually be reduced within liver of DR 
mice (John C Price et al. 2012). Consequently, such findings question the concept 
that DR increases mitochondrial biogenesis, and further challenge the somewhat 
counterintuitive idea of expending energy on protein synthesis at a time of energy 
and/or nutrient restriction (Lanza et al. 2012). 
Recently, the role of mitonuclear protein imbalance, that is a stoichiometric 
imbalance between OXPHOS subunits encoded by nuclear DNA (nDNA) and 
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mitochondrial DNA (mtDNA) which activates the cytoprotective mitochondrial 
unfolded protein response (UPRmt), in longevity control has gained significant 
coverage (Houtkooper et al. 2013; Mouchiroud et al. 2013; Baqri et al. 2014; Hill & 
Van Remmen 2014b).  Both rapamycin and resveratrol induced mitonuclear protein 
imbalance and UPRmt in mouse hepatocytes in vitro (Houtkooper et al. 2013). UPRmt 
induction in C. elegans also appeared necessary for longevity in developing worms 
exposed to high glucose, but shortened lifespan when induced in adulthood 
(Tauffenberger et al. 2016). Longevity in BXD mice is associated with reduced 
mitochondrial translation as determined by reduced expression of mitochondrial 
protein 5 (Mrps-5); Mrps-5 expression in skeletal muscle decreases with age and 
this is attenuated by DR (Houtkooper et al. 2013). Similarly, skeletal muscle from 
long-lived Surf1/ mice display evidence of UPRmt (Pulliam et al. 2014). However, 
whether mitonuclear imbalance and UPRmt are important in DR-induced longevity in 
mice remains to be elucidated. 
Given the ongoing quest to identify the mechanistic drivers of DR, it has been 
suggested that employing a comparative-type approach which takes advantage of 
the variability in the DR response reported in certain rodent strains may help 
delineate the mechanisms underpinning DR (Mulvey et al. 2014; Swindell 2012). 
Indeed, several groups have already undertaken such approaches using DBA/2 
mice (Rebrin et al. 2011; Ferguson et al. 2007; Sohal et al. 2009), showing for 
example that this strain are hyperinsulinaemic and insulin resistant compared to 
C57BL/6 mice (Hempenstall et al. 2010). In the present study we investigated the 
potential linkage between DR-induced longevity and mitochondrial function within 
both liver and skeletal muscle by exploiting the highly variable effect of DR on 
lifespan in ILSXISS mice. To this end we compared females mice from three 
ILSXISS strains showing repeatable responses to 40% DR across two independent 
studies (Rikke et al. 2010; Liao et al. 2010); TejJ89 (lifespan extended under DR 
relative to AL controls), TejJ48 (lifespan unaffected by DR), and TejJ114 (lifespan 
shortened under DR). We predicted that DR would positively impact on a number of 
parameters associated with mitochondrial function in strain TejJ89, that DR would 
have no impact on these parameters in strain TejJ48, and that DR would induce 
mitochondrial dysfunction in the negative responding TejJ114 (see Fig 4.1 for 
schematic outlining of our original predictions). 
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Fig. 4.1: Schematic showing the predicted mitochondrial functional response to 10 
months of 40% dietary restriction (DR) in three strains of female ILSXISS mice that 
show a differential response of DR on longevity (TejJ89 lifespan extension; TejJ48 
no change in lifespan; TejJ114 lifespan shortening). 
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4.2. Materials and methods  
4.2.1. Animals  
ILSXISS recombinant inbred (RI) mouse strains are derived from a cross 
between inbred long sleep (ILS) and inbred short sleep (ISS) mice (Williams et al. 
2004). Mice from three strains; TejJ89, TejJ48 and TejJ114 were purchased from a 
commercial breeder (The Jackson Laboratory, Bar Harbour, Maine, URL: 
http://www.informatics.jax.org). The rationale for studying these particular strains 
was that in addition to repeatable effect of DR on lifespan across two independent 
studies (Rikke et al. 2010; Liao et al. 2010), no strain-specific differences in median 
lifespan were observed upon ad libitum (AL) feeding. Mice were maintained in 
groups of 4 post-weaning in shoebox cages (48 cm × 15 cm × 13 cm), with AL 
access to water and standard chow (CRM(P), Research Diets Services, LBS 
Biotech, UK; Atwater Fuel Energy-protein 22%, carbohydrate 69%, fat 9%) and 
maintained on a 12L/12D cycle (lights on 0700–1900h) at 22 ± 2 °C. At 9 weeks of 
age, cages were assigned to either an AL or DR group, with no difference in body 
mass observed between treatment groups at this time (TejJ89 AL vs. DR t = 0.056, 
p = 0.583, TejJ48 AL vs. DR t = 0.677, p = 0.509, TejJ114 AL vs. DR t = 0.289, p = 
0.777). Mice were introduced to DR in a graded fashion; at 10 weeks of age mice 
were exposed to 10% DR (90% of AL feeding), at 11 weeks this was increased to 
20% DR, and from 12 weeks of age until the termination of the experiment mice 
were exposed to 40% DR, relative to their appropriate strain-specific AL controls. 
Total food intake of AL mice from each strain was measured weekly (±0.01 g) and 
food intake of the DR cohort calculated from the average AL intake per mouse over 
the preceding week (Hempenstall et al. 2010). DR mice were fed daily at 1800 hrs 
and fed directly into the cage. Following 10 months of 40% DR (equivalent to 13 
months of age), mice were fasted overnight and then culled the following morning 
by cervical dislocation. One lobe of liver, one gastrocnemius muscle and the heart 
were dissected and immediately snap-frozen in liquid nitrogen and stored at −80 °C 
until use. The remaining liver tissue and gastrocnemius muscle were subsequently 
used for the mitochondrial functional studies. A total of 4 mice per day were culled, 
with the time between dissection, mitochondrial isolation and mitochondrial analysis 
kept as uniformed as possible, with the particular tissue (liver or skeletal muscle) 
processed and analysed alternated each day. All experiments were carried out 
under a licence from the UK Home Office (Project Licence 60/4504) and followed 
the “principles of laboratory animal care” (NIH Publication No. 86-23, revised 1985). 
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4.2.2. Mitochondrial respiration 
4.2.2.1. Isolation of mouse liver and skeletal muscle mitochondria 
Liver mitochondria were isolated using previously published protocols (Brand 
& Nicholls 2011; Rogers et al. 2011). Briefly the liver was weighed and washed in 
MSHE + BSA buffer (210 mM mannitol, 70 mM sucrose, 5 mM HEPES, 1 mM 
EGTA and 0.5% (w/v) fatty acid free bovine serum albumin (pH 7.2)). The liver was 
then rapidly minced with scissors in 10 vol of MSHE + BSA buffer before 
homogenisation (2–3 strokes) using a glass-glass homogeniser (Fisher Scientific, 
Loughborough, UK). As with the liver, gastrocnemius muscle was harvested, 
weighed, washed and then minced in ice-cold isolation buffer (100 mM sucrose, 
100 mM KCL, 50 mM Tris HCl, 1 mM KH2PO4,0.1 mM EGTA, 0.2% BSA (pH 7.4)), 
as previously described (Garcia-Cazarin et al. 2011). The muscle was subsequently 
rinsed three times in 1 ml of fresh isolation buffer, and then 1 ml of 2% Proteinase 
Type XXIV (Sigma Aldrich, Dorset, UK) was added and the sample vortexed for 
1 min−1 at room temperature, followed by 1 min−1 incubation on ice. Samples were 
subsequently added to a glass homogeniser and 4 ml of isolation buffer added 
before homogenisation (10 strokes). Using differential centrifugation for both liver 
(Brand & Nicholls 2011; Rogers et al. 2011) and muscle (Garcia-Cazarin et al. 2011) 
a mitochondrial pellet was isolated and subsequently re-suspended (liver; MSHE 
buffer with no BSA, skeletal muscle; suspension buffer (225 mM Mannitol, 75 mM 
sucrose, 10 mM Tris, 0.1 mM EDTA (pH 7.4)). Total liver and skeletal muscle 
mitochondrial protein (mg/ml) were determined using the Bradford assay (Sigma 
Aldrich, Dorset, UK). 
4.2.2.2. XF assay – plate preparation 
Isolated mitochondria were diluted 10X in mitochondrial assay solution (MAS; 
70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 
1.0 mM EGTA and 0.2% (w/v) fatty acid-free BSA, pH 7.2) containing substrate 
(10 mM pyruvate, 2 mM malate), and subsequently diluted to produce a 10 μg 
mitochondrial suspension. Mitochondria were added to a Seahorse XF assay plate 
(Agilent Technologies, CA, USA) at a concentration of 10 μg per well. The plate was 
centrifuged at 2000g for 20 min at 4 °C. A XF cartridge (Agilent Technologies) was 
then prepared as described by Brand et al. (Brand & Nicholls 2011). The plate was 
then transferred to a XF24 Analyser (Agilent Technologies) and the experiment 
initiated as previously described (Rogers et al. 2011). Basal Oxygen consumption 
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rate (OCR) was measured in substrate (10 mM pyruvate, 2 mM malate). Following 
this OCR was sequentially recorded for state 3 (addition of ADP (4 mM)), state 4 
(addition of oligomycin (2.5 μg/ml)), state 3u (FCCP (4 μM Carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone)), and finally in the presence of Antimycin A and 
rotenone (4 μM), inhibitors of Complex III and I respectively, to determine non-
mitochondrial respiratory capacity (Rogers et al. 2011). Analysis was carried out 
using Seahorse XF software (www.seahorsebio.com). Respiratory control ratio, 
expressed as the ratio between state 3u (FCCP-induced maximal uncoupled-
stimulated respiration) and state 4° (respiration in the absence of ADP) did not differ 
by treatment within a strain or between strains for either liver or muscle mitochondria 
(Figure S1A&B). 
4.2.3. Protein extraction 
Liver, skeletal muscle and heart tissue were suspended in 1 ml of ice cold 
RIPA buffer (Radio Immuno Precipitation Assay buffer, 150 mM sodium chloride, 
1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS (sodium 
dodecyl sulphate), 50 mM Tris, pH 8.0) containing protease inhibitors (Halt™ 
Protease and Phosphatase Inhibitor Cocktail, Thermo Fisher Scientific, UK). The 
liver and heart were rapidly minced on ice with scissors and homogenised. A 
stainless steel bead (Catalogue # 69989, QIAGEN, Manchester, UK) was added to 
the eppendorf containing the skeletal muscle tissue and RIPA buffer, and then the 
muscle was homogenised at maximum speed (30 Hz) for 4 min−1 on the RETSCH 
MM 400 mixer mill (Catalogue# 10573034, Fisher Scientific). Following 
homogenisation all lysates were incubated on ice for 40-60 min−1 before being 
centrifuged at 16,000 g for 10 min−1 at 4 °C, and total protein levels subsequently 
determined using the BCA protein assay (G Biosciences, MO, USA). Nuclear and 
cytoplasmic fractionation of liver and skeletal muscle was undertaken using the 
ReadyPrep™ Protein Extraction (Cytoplasmic/Nuclear) Kit (Catalogue #163-2089, 
Bio-Rad, UK). Briefly, ∼50 mg of tissue was homogenised together with 0.75 ml of 
cold cytoplasmic protein extraction buffer containing protease inhibitors (Halt™ 
Protease and Phosphatase Inhibitor Cocktail) using a chilled Wheaton Dounce 
tissue homogeniser (Catalogue #62400-595, VWR, West Sussex, UK), with protein 
concentration of each fraction determined using the BCA protein assay. 
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4.2.4. Western blot analysis 
Equal volumes of tissue protein extract (50 μg) in Laemmli sample buffer 
were loaded onto 4–12% Bis-Tris pre-cast polyacrylamide gels (Life Technologies, 
Paisley, UK). Following this, proteins were transferred to polyvinylidene difluoride 
membranes (BioRad). Ponceau staining was used to ensure equal loading of protein 
and for normalisation purposes. Membranes were incubated in Tris-buffered saline 
Tween (1X TBST) containing 5% BSA for 1 h−1. Blots were then washed in TBST 
(5 × 5min), incubated with primary antibody for 24 h−1 (4 °C), washed again (TBST) 
and incubated with secondary antibody for 1 h−1 at room temperature. Blots were 
visualised using Clarity™ Western ECL Substrate (BioRad) and a ChemiDoc™XRS 
system (BioRad). Antibodies for peroxisome proliferator-activated receptor-gamma 
co-activator 1 alpha (PGC-1α) and the oxidative phosphorylation complex antibody 
(OXPHOS cocktail; CI subunit NDUFB8, CII-30kDa (SDH), CIII-Core protein 2 
(UQCRC2), CIV subunit I (MTCO1) and CV alpha subunit (ATP5A) were from 
Abcam, Cambridge, UK, mitochondrial transcription factor A (TFAM) and secondary 
(anti-rabbit) antibodies from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA), 
and HSP60 and HSP90 from BD Biosciences (BD Biosciences, Oxford, UK. 
Mitonuclear protein imbalance (nDNA:mtDNA ratio) was determined by the ratio of 
nuclear encoded SDHB (Complex II) to mitochondrial-encoded MTCO1 (Complex 
IV) as described previously (Houtkooper et al. 2013). 
4.2.5. Mitochondrial ROS production 
Fresh respiratory medium (MAS; 70 mM sucrose, 220 mM mannitol, 10 mM 
KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1.0 mM EGTA and 0.2% (w/v) fatty acid-free 
BSA, pH 7.2) was supplemented with 1U/ml horseradish peroxidase and 10 μM 
Amplex® Red reagent (ThermoFisher Scientific, UK) as previously described (Zhou 
et al. 1997). 90 μl of this medium was then added to each well of a standard 96 well 
plate (Costar®, Sigma Aldrich, UK) and heated for 2 min-1 at 37 °C. Fluorescence 
was then measured at 15 s intervals for 2–3 min using a spectrophotometer 
(Clariostar microplate reader, BMG Labtech) at excitation and emission wavelength 
of 563 and 587 nm respectively. A sequential protocol was then run simultaneously 
for each sample in triplicate and completed within 15 min−1. First the baseline 
fluorescence was measured by adding 10 μl of mitochondrial suspension, and then 
mitochondrial hydrogen peroxide production from all complexes was determined by 
adding a saturating concentration of succinate (10 mM), and then rotenone added 
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(0.5 μM; an inhibitor of complex I). The fluorescence signal was calibrated using 
176 nM of hydrogen peroxide, and then hydrogen peroxide production was 
calculated following background correction. 
4.2.6. Oxidative damage and antioxidant levels 
Protein carbonyl (PC), total glutathione (GSH) and total superoxide 
dismutase (SOD) activity were measured in liver samples using commercially 
available kits and following the manufacturer's protocols (Catalogue#10005020 
Carbonyl assay kit, #706002 Total SOD activity assay kit, #703002 Glutathione 
assay kit, Cayman Chemical Company, Estonia). Hepatic 4-Hydroxynonenal (HNE)-
protein adduct levels were determined using an anti-HNE-His mouse IgG protein 
binding plate (Catalogue#STA-838, Cell Biolabs Inc., CA, USA). All assays were 
read on a plate reader (BMG Labtech, UK). 
4.2.7. Statistical analysis 
All statistical analyses were performed using R and figures were produced 
using GraphPad Prism (GraphPad Inc., La Jolla, CA, USA, version 5) software. Data 
were checked for normality using the Shapiro–Wilks test and a logarithmic 
transformation was undertaken if data not normally distributed. Data was analysed 
using linear modelling (LM) with treatment (AL or DR) and strain (TejJ89, TejJ48 
and TejJ114) introduced as fixed factors. Following transformation, if the data was 
not normally distributed an appropriate non-parametric test was applied. Results are 
reported as mean ± standard error of the mean (SEM), with p < 0.05 regarded as 
statistically significant. 
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4.3. Results 
Mitochondrial oxygen consumption rates (OCR) within isolated liver 
mitochondria under all conditions studied (Figure 4. 2 A) were unaffected by 10 
months of 40% DR in strain TejJ89 relative to AL controls. A similar lack of a DR 
effect on hepatic respiratory capacities was observed in strain TejJ48 (Figure 4.2 
B). In contrast, DR in strain TejJ114 (Figure 4. 2 C) significantly reduced State 3 
(t = 2.860, p = 0.006) and State 3u (t = 2.950, p = 0.006) mitochondrial OCR relative 
to AL controls. While no differences in mitochondrial OCR were observed across 
ILSXISS strains under AL feeding (Figure 4.2 D), State 3 OCR in TejJ89 was 
significantly increased (t = 2.24, p = 0.039) relative to the other two strains under 
DR (Figure 4.2 E). 
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Figure 4.2: Mitochondrial respiration (Oxygen consumption rate, OCR) was unaltered by 10 months of 40% DR in isolated liver mitochondria 
from strains TejJ89 (A) and TejJ48 (B). In strain TejJ114 (C), a treatment effect was observed, with State 3 and State 3u OCR significantly 
reduced under DR relative to AL mice. No strain differences on mitochondrial functional was observed in AL mice (D). (E) State 3 respiratory 
capacity was significantly increased in strain TejJ89 under DR when compared with the other strains under DR. Values are expressed as 
mean ± SEM, with n = 8 per group. * denotes p < 0.05. 
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Mitochondrial hydrogen peroxide (H2O2) production within liver was 
increased significantly (t = 3.555, p = 0.002) by DR in strain TejJ89 relative to its 
appropriate control, but DR had no effect on H2O2 production in strains TejJ48 and 
TejJ114 (Figure 4.3 A). While no difference between strains in H2O2 production was 
observed under AL feeding (Figure 4.3 B), strain TejJ89 had significantly higher 
ROS levels compared to TejJ48 and TejJ114 under DR, and TejJ48 had significantly 
higher ROS levels (t = 2.339, p = 0.039) compared to TejJ114 (Figure 4.3 C). Total 
hepatic SOD activity was increased by DR treatment in strains TejJ89 (t = 3.776, 
p = 0.004) and TejJ114 (t = 2.845, p = 0.010) relative to their respective AL controls 
(Figure 4.3 A), but no strain-specific effect on SOD activity was observed under 
either AL or DR feeding (Figure S2A & B). Liver total glutathione (Figure 4.4 
B; Figure S2C and D) and 4-HNE (Figure 4.4 C; Figure S2E & F) were unaffected 
by either treatment or strain. However, hepatic protein carbonyl (PC) levels (Figure 
4 4 D) were significantly increased in strains TejJ89 (t = 2.420, p = 0.037) and 
TejJ114 (t = 2.440, p = 0.040) under DR when compared to their respective AL 
controls. In addition, while PC levels were not different between strains under AL 
feeding (Figure S2G), hepatic PC levels were significantly lower in TejJ48 compared 
to both TejJ89 (t = 6.860, p < 0.001) and TejJ114 (t = 3.220, p = 0.010) under DR 
(Figure S2H). Total hepatic protein levels of PGC-1α (Figure 4.5 A), a key 
transcriptional co-activator linked to mitochondrial metabolism and biogenesis, was 
unaltered by treatment or strain, with both nuclear (Figure 4.5 B) and cytoplasmic 
(Figure 4.5 C) PGC-1α levels likewise unaffected. Similarly, mitochondrial 
transcription factor A (TFAM), a key activator of mitochondrial transcription, was 
unaffected by DR or strain (Figure 4.5 D). We then examined various OXPHOS 
complexes within liver, but again observed no treatment effect or observed any 
differences between strains under AL or DR feeding (Figure S3A-C). Given the 
evidence of mitochondrial dysfunction in TejJ114, we then went on to investigate 
whether DR induced mitonuclear protein imbalance and UPRmt by firstly calculating 
the ratio of nuclear encoded SDHB to mitochondrially encoded MTCO1 as 
previously described (Houtkooper et al. 2013). We observed no effect of either 
treatment or strain on mitochondrial nuclear imbalance (Figure 4.6 A–C). No 
differences were observed between either treatment groups or strains in the 
mitochondrial chaperone HSP60 (Figure 4.6 D), but a significant reduction in hepatic 
HSP90 (Figure 4.6 E) was observed in strain TejJ114 under DR (t = 2.267, 
p = 0.045) relative to AL controls. 
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Figure 4.3: Hydrogen peroxide (H2O2) production within isolated liver mitochondria, 
expressed as fold change relative to respective AL controls. (A) H2O2 production 
was increased by DR in strain TejJ89. H2O2 production was unaltered between 
strains under AL feeding (B), but under DR (C) H2O2 production was elevated in 
strain TejJ89 relative to both TejJ48 and TejJ114, and strain TejJ48 produced more 
H2O2 than TejJ114. Values are expressed as mean ± SEM, with n = 6 per group. 
**p < 0.001, *p < 0.05. 
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Figure 4.4: Hepatic antioxidant defence and oxidative damage markers. (A) Total 
SOD activity was significantly increased by DR in strains TejJ89 and TejJ114 
relative to their respective AL controls. (B) Total glutathione (GSH) and (C) 4-
Hydroxynonenal (HNE) levels were unaffected by treatment or strain. (D) Protein 
carbonyl (PC) levels were significantly increased by DR in strains TejJ89 and 
TejJ114 relative to AL controls. Values are expressed as mean ± SEM, where n = 6 
per group. **p < 0.001, *p < 0.05. 
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Figure 4.5: Total (A), nuclear (B), and cytosolic (C) hepatic PGC-1α protein levels. 
No treatment or strain differences in hepatic PGC-1α protein levels were observed 
(D). DR and strain similarly had no effect on hepatic TFAM levels. Values are 
expressed as arbitrary units (AU) relative to total protein (determined by Ponceau 
staining). All values are expressed as means ± SEM, where n = 6 per group. 
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Figure 4.6: Hepatic mitonuclear protein imbalance, expressed as the ratio between 
the nuclear DNA (SDHB) relative to mitochondrial DNA (MTCO1). (A–C) 
Mitochondrial protein imbalance was unaffected by treatment or strain. No treatment 
or strain effects were detected in HSP60 levels (D), however hepatic HSP90 was 
significantly reduced by DR in strain TejJ114 compared to its AL counterpart (E). No 
differences in HSP90 levels were observed between strains within the AL or DR 
treatment groups. Values are expressed as arbitrary units (AU) relative to total 
protein (determined by Ponceau staining). All values are expressed as means ± 
SEM, where n = 6 per group. *p < 0.05. 
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In order to determine whether mitochondrial dysfunction in strain TejJ114 
was specific to liver, we also examined a number of mitochondrial parameters in 
isolated skeletal muscle from these same mice. No treatment or strain-specific 
differences in mitochondrial OCR were observed (Figure 4.7A–E). Similar to liver, 
total and cytosolic PGC-1α levels in muscle (Figure 4.8 A and C) were unaffected 
by DR in all strains, although nuclear PGC-1α levels (Figure 4.8 B) were increased 
by DR in TejJ89 (t = 3.174, p = 0.034). Skeletal muscle mitochondrial 
H2O2 production was significantly reduced under DR in strain TejJ114 (Mann 
Whitney p = 0.009) (Figure 4.9 A) compared to AL controls, but unaffected by DR in 
the other two strains. No differences in mitochondrial H2O2 production was observed 
between strains under AL feeding (Figure 4.9 B), but was significantly reduced in 
TejJ114 under DR relative to TejJ89 (t = 2.903, p = 0.044) and TejJ48 (Mann 
Whitney p = 0.009; Figure 4.9 C). Protein levels of various OXPHOS complexes and 
mitonuclear protein imbalance within skeletal muscle were unaffected by treatment 
and strain (Fig. S3D-F; Figure 4.10A), with similar findings observed in heart 
(Figure S3G-I; Figure 4.10 B). 
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Figure 4.7: Mitochondrial respiration (Oxygen consumption rate, OCR) in isolated 
skeletal muscle mitochondria was unaltered by 10 months of 40% DR in all strains 
(A–C). Similarly no differences were observed between strains within the AL (D) or 
DR groups (E). Values are expressed as mean ± SEM, with n = 8 per group. 
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Figure 4.8: Total (A), nuclear (B), and cytosolic (C) PGC-1α protein levels in skeletal 
muscle. No differences in PGC-1α protein levels were observed by treatment in total 
(A) or cytosolic (C) skeletal muscle fractions. An increase in PGC-1α was observed 
in nuclear PGC-1α protein fraction with DR (B). Strain was not found to alter PGC-
1α levels in total, nuclear or cytosolic proteins within either the AL or DR treatment 
group. Values are expressed as arbitrary units (AU) relative to total protein 
(determined by Ponceau staining). All values are expressed as means ± SEM, 
where n = 6 per group. 
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Figure 4.9: Skeletal muscle mitochondrial hydrogen peroxide (H2O2 production, 
expressed as fold change relative to respective AL controls. (A) H2O2 production 
was significantly decreased by DR in strain TejJ114. H2O2 production was unaltered 
between strains under AL feeding (B), but under DR feeding H2O2 production was 
reduced in strain TejJ114 relative to the other two strains (C). Values are expressed 
as mean ± SEM, with n = 6 per group. **p < 0.001, *p < 0.05. 
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Figure 4.10: Mitonuclear protein imbalance in gastrocnemius (A) and heart (B), 
expressed as the ratio between the nuclear DNA (SDHB) relative to mitochondrial 
DNA (MTCO1). No treatment or strains effects were detected. Values are expressed 
as arbitrary units (AU) relative to total protein (determined by Ponceau staining). All 
values are expressed as means ± SEM, where n = 6 per group. 
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4.4 Discussion 
The phenotypic plasticity of the mitochondria is crucial to allow energetic 
demands to be met and in order to sustain bioenergetic efficiency (Hancock et al. 
2011; Brand 2005). Consequently impairments in this dynamic system can lead to 
profound health consequences, with mitochondrial dysfunction widely proposed as 
a hallmark of ageing (Finley & Haigis 2009; Hunt et al. 2006). As discussed earlier, 
enhanced mitochondrial function has been put forward as a candidate mechanism 
underlying the beneficial effects of DR on lifespan and healthspan (Ruetenik & 
Barrientos 2015; Gouspillou & Hepple 2013). Here we sought to investigate 
mitochondrial function in using a comparative approach in ILSXISS mice which are 
known to show significant strain-specific variation in lifespan under 40% DR (Rikke 
et al. 2010; Liao et al. 2010). 
Contrary to our initial predictions, 40% DR did not alter hepatic mitochondrial 
respiratory capacity in strain TejJ89, which is reported to show lifespan extension 
under DR. While several studies have reported that DR increases mitochondrial 
respiratory capacity in rodents (Hempenstall et al. 2012; A. J. Lambert et al. 2004; 
Nisoli et al. 2005; Lanza et al. 2012), other studies have reported a DR-induced 
decrease (Bevilacqua et al. 2004; Sohal et al. 1994; Weindruch et al. 1980), or no 
effect of DR on mitochondrial respiratory capacity (Gredilla et al. 2001; Adrian J. 
Lambert et al. 2004) relative to AL controls. The precise reasons for this ambiguity 
appear complex but the tissue studied, the preparation used (isolated mitochondria 
vs. permeabilised tissue vs. tissue homogenate), the duration, age of onset and 
level of DR imposed, and the sex, age and the genetic background of the animal 
may all be important (Hempenstall et al. 2012; Gouspillou & Hepple 2013; Maynard 
S, Hejl AM, Dinh TS, Keijzers G, Hansen ÅM, Desler C, Moreno-Villanueva M, 
Bürkle A, Rasmussen LJ, Waldemar G 2015; Lauritzen et al. 2015). Strain TejJ48 
under DR, as predicted, displayed essentially no mitochondrial phenotype relative 
to its AL control. However, in strain TejJ114, mitochondrial respiratory capacity 
associated with State 3 and State 3u (maximal uncoupled oxygen consumption 
rates) were significantly reduced under DR. Both ageing and many pathologies 
associated with ageing reduce mitochondrial respiratory capacities in a range of 
tissues (Porter et al. 2015; Lee et al. 2016), and the apparent DR-induced hepatic 
mitochondrial dysfunction may offer new insights as to why DR truncates lifespan in 
this particular ILSXISS strain. To determine whether the hepatic mitochondrial 
dysfunction in TejJ114 was liver-specific, we determined mitochondrial respiratory 
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capacity in isolated skeletal muscle mitochondria in these same ILSXISS mice under 
AL and DR feeding. While DR is known to preserve mitochondrial function during 
ageing in certain mouse strains, such as C57BL/6 and male B6D2F1 (Hempenstall 
et al. 2012; Lanza et al. 2012), we saw no effect of DR on skeletal muscle 
mitochondrial respiratory capacity in any strain. In view of the well-defined role of 
PGC-1α in modulating mitochondrial function, and given that mitochondrial 
adaptations to DR may be driven through a PGC-1α -induced transcriptional 
program (Anderson et al. 2008; Finley et al. 2012; Gouspillou & Hepple 2013; Corton 
& Brown-Borg 2005), we investigated protein levels of PGC-1α  within liver in each 
strain under AL and DR. In line with the absence of any effect of DR on mitochondrial 
respiratory capacity, we observed no increase in hepatic PGC-1α (total, cytosolic, 
nuclear) or in mitochondrial transcription factor A (TFAM) protein levels of strain 
TejJ89 under DR. Similarly, PGC-1α and TFAM levels were unaffected by DR in 
strains TejJ48 or TejJ114. However, a tissue-specific response was observed with 
40% DR significantly increasing nuclear PGC-1α within skeletal muscle of strain 
TejJ89, in line with what has been reported in other studies (For review see 
Gouspillou & Hepple 2013). 
We then employed an immunoblot approach to examine respiratory chain 
complexes I, II, III, IV and V, and we again observed no treatment effect in any 
strains for liver, skeletal muscle or in heart. Indeed, it has been reported that DR-
induced attenuation of ageing-associated declines in mitochondrial function within 
skeletal muscle appears to be independent of any effect on mitochondrial respiratory 
chain protein levels (Lanza et al. 2012) However, this approach enabled us to 
examine mitonuclear protein imbalance; that is the ratio of nuclear encoded SDHB 
to mitochondrially encoded MTCO1. An increase in this ratio is associated with an 
induction in the cytoprotective mitochondrial unfolded protein response (UPRmt), a 
recently proposed conserved lifespan determinant (Houtkooper et al. 2013). We 
found no evidence that DR increased mitonuclear protein imbalance within the liver, 
skeletal muscle or heart of ILSXISS mice under DR feeding. The UPRmt invokes a 
transcriptional program in response to a number of processes, including 
mitochondrial dysfunction, resulting in the induction of various chaperones and 
proteases that help facilitate mitochondrial proteostasis (Schulz & Haynes 2015). 
We therefore, then examined the molecular chaperones HSP60 and HSP90, and 
similarly showed a lack of any treatment effect across our strains, except for a 
significant reduction in HSP90 levels within liver of TejJ114 mice under DR. HSP90 
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engages with a large number of ‘client’ proteins through co-chaperones, plays a 
major role in signal transduction, protects the 20S proteasome against oxidative 
inactivation and may actively regulate mitochondrial metabolism (Castro et al. 2014; 
Pearl 2016; Franco et al. 2015). Whilst it is difficult to disentangle cause and effect 
here, our data indicates that in strain TejJ114 40% DR leads to hepatic 
mitochondrial dysfunction and that this is correlated with reduced HSP90 levels. 
It is evident that both ageing and several disease states are associated with 
greater ROS-induced oxidative damage, but it is equivocal as to whether ROS-
induced oxidative damage is the mechanism underpinning ageing and disease 
(Walsh et al. 2014; Speakman & Selman 2011; Perez et al. 2009). A large number 
of studies have investigated whether DR can reduce ROS, induce various 
antioxidants and attenuate oxidative damage in model organisms. In an excellent 
recent meta-analysis, the Van Remmen laboratory (Walsh et al. 2014) examined 
several hundred studies that have investigated the effect of DR in rodents on ROS 
production, various antioxidants and on oxidative damage. Their approach found 
that DR had remarkably little impact on ROS production or antioxidant activity 
overall, but 53% of studies reported that DR reduced oxidative damage. Perhaps 
surprisingly we found that DR in strain TejJ89, which shows lifespan extension 
under 40% DR, had significantly higher hepatic mitochondrial H2O2 production, 
alongside greater hepatic total SOD activity and higher protein carbonyl levels 
relative to its appropriate AL control. In addition, TejJ89 had significantly higher 
hepatic mitochondrial H2O2 production relative to the other two strains under DR 
feeding. Strain TejJ114 had increased hepatic total SOD activity and protein 
carbonyl levels relative to its AL controls, but mitochondrial ROS levels were not 
significantly altered. Similarly, the hepatic protein carbonyl levels in line TejJ114 
under DR could not be explained by differences in hepatic NADPH oxidase levels 
(Figure S4). The mitochondrial ROS profile in skeletal muscle was similar in skeletal 
muscle but H2O2 production was significantly reduced by DR in TejJ114 compared 
to its appropriate control and when compared to the other two strains under DR. 
Consequently, our findings further question the precise role of ROS-induced 
oxidative damage being the mechanism underpinning ageing. We can speculate 
that the increased ROS under DR in strain TejJ89 elicited a beneficial mitohormesis-
like effect (Ristow & Schmeisser 2011) resulting in DR-induced longevity, although 
this remains to be determined and does not appear to involve the UPRmt. As a small 
aside, it is particularly sobering to note that in the comprehensive meta-analysis on 
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DR and oxidative stress in rodents undertaken by Walsh et al. (Walsh et al. 2014), 
96% of all observations were made in male rodents, with the remaining 4% 
undertaken using females alone or mixed sex populations. 
In conclusion, our findings do not completely support our initial predictions 
(Figure 4.1), in which we forecast a clear continuum from the stimulatory and 
beneficial effects of DR on the mitochondrial phenotype in positive responding strain 
TejJ89 through to predicted mitochondrial dysfunction in strain TejJ114 under DR. 
In the positive responding strain TejJ89 we saw no evidence of a DR-induced 
increase in mitochondrial respiratory capacity in liver and muscle mitochondria or in 
PGC-1α levels within liver, although nuclear PGC-1α levels were induced in muscle. 
Paradoxically, TejJ89 had increased hepatic mitochondrial ROS production, greater 
SOD activity and higher hepatic protein carbonyl levels under DR, further 
highlighting the complexity between mitochondrial respiratory capacity, 
mitochondrial ROS and oxidative damage (Salin et al. 2015). While strain TejJ114 
under DR did show evidence of mitochondrial dysfunction within liver relative to AL 
controls, this effect was tissue-specific as was not observed in skeletal muscle. 
What is clear is that it will now be important to investigate whether the liver-specific 
mitochondrial dysfunction observed in strain TejJ114 under 40% DR is evident 
under less restrictive feedings conditions, i.e. 10–30% DR, as for all these strains 
we do not currently know where exactly the optimal longevity ‘sweet-spot’ under DR 
sits. Our data raises the possibility that DR-induced longevity in ILSXISS mice does 
not appear to involve mitonuclear imbalance and UPRmt, which appears to be the 
case in worm DR (eat-2) mutants (Durieux et al. 2011). What is also clear is that 
almost all we know about the potential mechanisms underlying DR in rodents is 
based almost exclusively on C57BL/6 mice (Swindell 2012). Consequently, there is 
a need for more studies using mouse strains in addition to C57BL/6 mice, e.g. 
ILSXISS, DBA/2, UM-HET3, as these models may help provide new insights in to 
ageing mechanisms that are public, i.e. shared, across all mouse strains rather than 
mechanisms that are private, i.e. specific to C57BL/6 mice. 
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Chapter 5: Enhanced proteostasis as a mechanism underlying DR-induced 
lifespan– an investigation using ILSXISS recombinant inbred mice 
 
5. 1 Abstract 
Enhanced protein synthesis rate is proposed as underlying the pro-longevity 
effect of dietary restriction (DR). However, debate exists as to whether DR should 
increase protein synthesis, an energetically costly process, in a time of nutrient 
scarcity.  Alternatively maintenance of proteomic homeostasis (or proteostasis) has 
been implicated as a shared characteristic of slowed ageing. I hypothesised that 
proteostatic mechanisms would be increased in mice known to undergo lifespan 
extension with DR, as is seen in models of slowed ageing, and conversely reduced 
in mice known to experience lifespan truncation following restriction. In order to 
investigate the effect of DR on protein synthesis rates I examined the impact of 2 
months of 40% DR on protein synthesis rates in female ILSXISS mice that have 
been shown to exhibit strain-specific variation in lifespan under DR. Using an 
isotopically labelled marker, deuterium oxide (D2O), I simultaneously assessed 
protein synthesis in multiple subcellular fractions along with DNA synthesis in the 
myofibrillar, mitochondrial and cytoplasmic proteins in skeletal muscle, heart, and 
liver  tissue over 2 weeks in order to gain insight into proteostatic mechanisms. As 
assessed by the newprotein/newDNA ratio protein synthesis was found to be increased 
in cytoplasmic, mitochondrial and mixed proteins in the skeletal muscle of all strains 
following short-term DR. Increases in cytoplasmic proteins in strain TejJ89 were 
reported suggesting a correlation with DR-induced longevity. However, results were 
tissue specific, and no evidence of increased synthesis was found in any protein 
fraction in the heart. Collectively these results did not entirely support my initial 
predictions, as reduced protein synthesis was not found to be associated with 
lifespan shortening, and increases in the skeletal muscle in both mitochondrial and 
myofibrillar proteins were not strain-specific. With the exception of the increase in 
cytoplasmic proteins in strain TejJ89 skeletal muscle, these results suggest that 
increased synthesis is not associated the anti-ageing effects of DR, at least following 
short-term restriction.  
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5.2 Introduction 
Protein homeostasis, or proteostasis, is the ability of an organism to maintain 
the proteome through a number of intricate networks,  and the loss of which is 
associated with the ageing process (Lopez-Otin et al. 2013). Maintenance of a 
healthy proteome, involves a number of cellular pathways, collectively referred to as 
the proteostasis network. (See Figure 5.1) This network involves the coordination of 
protein synthesis, folding, modification, assembly, breakdown and clearance of 
damaged proteins (Wolff et al. 2014). These networks act to detect and repair 
upsets to the proteome, thus restoring a state of homeostasis (Vilchez et al. 2014). 
Changes to the proteome namely arise through changes in the rate of protein 
synthesis, the making of new proteins de novo, (Alvarez-Castelao et al. 2012), and 
the ability to alter rate of protein synthesis adaptively is crucial in regulating 
proteostasis (Alvarez-Castelao et al. 2012; Cajigas et al. 2010). It has been shown 
that a number of proteostatic mechanisms are enhanced in long-lived animals (Pride 
et al. 2015), with the these species having the most stable proteomes (Treaster et 
al. 2014). Furthermore, interventions which enhance components of these 
proteostatic networks extend lifespan in invertebrate and in mammals (Tonoki et al. 
2009; Olsen et al. 2006; Satoh et al. 2013; Labbadia & Morimoto 2015). It has been 
proposed that the beneficial effects of dietary restriction (DR) are at least partially 
mediated through improved proteostasis, particularly through increased rate of 
protein synthesis, and indeed increased protein synthesis has been extensively 
reported in rodents following DR (Lambert & Merry 2000; Goldspink & Kelly 1984; 
Jazwinski 2000; Ward & Richardson 1991; de Cabo et al. 2015). However reports 
of  reduced protein synthesis with DR  (Henderson et al. 2010), has led to debate 
over the relevance of increased protein synthesis as an important proteostatic 
mechanism in the anti-ageing effects of DR.  
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Figure 5.1:  The cellular pathways involved in maintaining the proteome. 
 
5.2.1 DR and Protein Synthesis 
Two apparently contradictory mechanisms relating to protein synthesis have 
been proposed as mediating the life-extending effects of DR. Researchers have 
postulated that increased protein synthesis following DR results in more efficient 
replacement of damaged proteins, thus leading to lower levels of oxidative damage, 
through efficient clearing and repairing of damaged proteins (Tavernarakis & Driscoll 
2002; Morimoto & Cuervo 2014). Indeed in rodents enhanced protein synthesis has 
been reported on numerous occasions (Holehan & Merry 1986; Jazwinski 2000; 
Lambert & Merry 2000; Lewis et al. 1985; Ward & Richardson 1991).  Long-term DR 
(28 months), including in 30 month old male C57BL/6 mice, increased hepatic 
protein turnover following DR (Hagopian et al. 2003). In monkeys  (Macaca mulatta) 
DR reportedly protected against the age-related decline in protein synthesis, but 
also increased protein synthesis relative to AL controls (Colman et al. 2009), and in 
human diploid fibroblasts serum from DR animals is known to delay senescence 
and increase protein synthesis in cultured cells (de Cabo et al. 2015). On the other 
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hand, DR has been proposed to decrease protein synthesis, with higher rate of 
protein breakdown, due to lower demand for protein replacement. In keeping with 
this theory, male C57BL/6 mice following long-term DR,  reportedly have reduced 
rates of protein synthesis in the hepatic tissue (John C Price et al. 2012), and also 
following long-term DR in the skeletal muscle and heart of male B6D2F1 mice (Miller 
et al. 2013). 
However upon reanalysis, using a new method of assessment, Miller and 
colleagues came to the opposite conclusion of how DR alters protein synthesis in 
the male B6D2F1 mouse. Initially  no alterations in rates of mitochondrial protein 
synthesis  (Miller et al. 2012), cytoplasmic or myofibrillar (mixed) proteins in heart or 
liver tissue were reported following  DR (Miller et al. 2013; Miller et al. 2012). Within 
any given tissue, protein content will reflect a dynamic turnover between protein 
degradation and synthesis (Poortmans et al. 2012), such that large increases in 
protein breakdown are likely to be matched by an increased rate of protein 
synthesis, in order to ensure the proteome remains in a state of homeostasis. 
Consequently measurement of synthesis rates in isolation could be perceived as 
unchanged, and increases in protein synthesis may go undetected (Miller et al. 
2014). To circumvent this Miller et al propose instead to compare quantity of protein 
synthesised in relation to the rate of cellular proliferation (measured as synthesis of 
DNA). Thus the ratio between new protein synthesis to new DNA synthesis 
(newprotein/newDNA) gives a reflective measure of the ongoing synthesis and 
breakdown of proteins and thus a more accurate representation of changes in 
proteostasis. When determined by the newprotein/newDNA ratio, short (1 week) and 
long-term (6 weeks) 40% DR is found to increase protein synthesis in all subcellular 
fractions assessed, including cytoplasmic, myofibrillar and mitochondrial proteins, 
in both the heart and skeletal muscle of male B6D2F1 mice (Miller et al. 2013; Drake 
et al. 2015). Moreover, following treatment with rapamycin, a DR mimetic associated 
with lifespan extension (Drake et al. 2013), and in the Snell long-lived mouse model 
(Drake et al. 2015) heart and skeletal muscle were also found to have increased 
rates of protein synthesis, suggesting enhanced proteostatic mechanisms to be a 
shared feature of slowed-ageing. 
Mitochondrial dysfunction is a hallmark of ageing (Lopez-Otin et al. 2013) and 
may be related to the decrease in synthesis rates of mitochondrial proteins observed 
by middle age in humans (Rooyackers et al. 1996). Synthesis of mitochondrial 
proteins however, termed mitochondrial biogenesis, is poorly defined and debate 
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has arisen as to how best to quantify mitochondrial biogenesis (Miller & Hamilton 
2012; Miller et al. 2016; Hancock et al. 2011) (See Table 5.1 for list of different 
methods of mitochondrial biogenesis quantification in DR studies)  For example, 
mitochondrial biogenesis is often determined through quantification of mRNA or 
mtDNA (Nisoli et al. 2005; Civitarese et al. 2007), however increases in mRNA 
content does not equate to increased protein abundance (Mootha et al. 2003), nor 
do changes in signalling proteins necessarily mean a change in biogenesis (see 
Miller & Hamilton 2012 for full discussion). Mitochondrial biogenesis is the 
generation  of new mitochondrial proteins (Ryan & Hoogenraad 2007), increases to 
which are proposed as underlying the beneficial lifespan effects of DR. However 
ambiguity exists regarding the effect of DR on mitochondrial biogenesis with DR 
reported to increase (López-Lluch et al. 2006; Nisoli et al. 2005; Civitarese et al. 
2007), or have no effect (Lanza et al. 2012; Hancock et al. 2011) in comparison to 
AL controls. The newprotein/newDNA ratio however may be one means to more 
accurately determine changes in synthesis.  
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Table5.1 Summary of DR on markers of mitochondrial biogenesis 
Author Genotype Sex DR Duration Tissue Method Result 
        
Lanza et al 
2012 
 
B6D2F1 
Mouse 
♂ 40% 
Onset 
24months 
of age 
 
10 days Sk. M mtDNA 
Protein content 
Stable isotope 
labelling 
↓ 
Hancock et 
al 2011 
 
Wistar 
Rat 
♂ 30% 14 
weeks 
Sk. M 
Heart 
Brain 
Liver  
Adipose 
tissue 
 
mRNA analysis 
of mito proteins 
 No 
change 
Nisoli et al 
2005 
 
 
C57BL/6 
eNOS(-/-) 
mouse 
♂ 40% 3 or 12 
months 
WAT mtDNA 
abundance 
mRNA 
expression of 
mito genes 
 
↑ 
Hempenstall 
et al 2012 
 
C57BL/6 
mouse 
♂ 30% 1, 9 or 
18 
months 
 
Sk.M Protein 
Content; PGC1a, 
mRNA 
expression mito 
genes 
 
No 
change 
Miller et al 
2012 
 
B6D2F1 
Mouse 
♂ 40% 4 Hours 
or 6 
weeks 
 
Sk.M 
Liver 
Heart 
D2O ↑*  
Miller et al 
2012 
 
B6D2F1 
Mouse 
♂ 40% @ 
6/12/24 
months 
of age 
 
6 weeks Sk.M 
Liver 
Heart 
D2O ↑* 
Mulvey et al 
2016 
 
 
 
 
ILSXISS 
TejJ89, 
TejJ48, 
TejJ114 
mice 
♀ 40% @ 12 
weeks of 
age 
10 
months 
Sk. M 
Liver 
Heart 
Protein content; 
PGC1-α 
↑ Sk. M 
–nuclear 
proteins 
only* 
Liver ns 
Heart ns 
Civitarese et 
al 2007 
 
Humans ♂ & 
♀ 
25% Mix 
of CR and 
increased 
exercise 
6 
Months 
Sk.M mRNA 
expression of 
mito genes 
↑ 
        
↓= Reduced mitochondrial biogenesis with DR                                                                                                                                                                         
No change= No effect of DR on mitochondrial biogenesis                                                                                                                                                      
↑= increased mitochondrial biogenesis with DR↑*=Increased mitochondrial biogenesis as assessed by the 
new protein to DNA synthesis ratio 
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5.2.2 Deuterium Oxide as a means of assessing proteostasis 
Increased protein synthesis following DR has often been reported following 
flooding doses of an essential amino acid such as phenylalanine, valine or leucine 
(Goldspink & Kelly 1984; Lewis et al. 1985; el Haj et al. 1986; Merry et al. 1987; 
Zangarelli et al. 2006; Dai et al. 2014). However, this method may stimulate a 
feeding response and thus may reflect an acute response to AA flooding, rather than 
long-term synthesis rates. An alternative method to measure synthesis involves 
using a labelled precursor, such as isotopically labelled water, deuterium oxide 
(D2O). D2O has free access to all body pools and equilibrates throughout all tissues 
rapidly (Busch et al. 2006; Neese et al. 2002; Hellerstein & Murphy 2004). Body 
water is enriched over an extended period of time, typically 2 weeks, and therefore 
offers a long-term labelling design, which is beneficial for study changes which occur 
with DR. D2O is an ideal precursor as hydrogen from water is associated with most 
biosynthetic processes, and the equilibrated water is therefore incorporated into a 
variety of tissues and proteins.   
5.2.3 ILSXISS mice  
Whilst DR was once considered a ubiquitous means of extending lifespan, 
recent evidence suggests that this may not always be the case. DR fails to extend 
longevity in some animals (Cooper et al. 2004; Kirk 2001) and mouse strains 
(Fernandes et al. 1976; Forster et al. 2003; Goodrick et al. 1990; Harper et al. 2006; 
Harrison & Archer 1987). Indeed,  genotype  has emerged as  a potentially important 
determinant of both the extent and direction of the DR longevity effect  (Rikke et al. 
2010; Liao et al. 2010; Mitchell et al. 2016). In two independent lifespan analysis of 
genetically heterogeneous recombinant inbred (RI) mouse strains, it was found that 
the strains exhibit extensive genetic variation in the lifespan response to DR (Liao 
et al. 2010; Rikke et al. 2010), ranging from lifespan lengthening to lifespan 
shortening. The strain-specific lifespan variation of the ILSXISS RI lines allows lines 
to be classified according to DR response (see Swindell 2012; Mulvey et al. 2014 
for discussion). To this end, we employed a comparative approach with three strains 
of female ILSXISS, shown to have a repeatable lifespan response in two 
independent DR studies (Rikke et al. 2010; Liao et al. 2010). One line of positive 
responders; TejJ89 (undergo lifespan extension with DR), non-responders; TejJ48 
(no lifespan effect with DR), and a line of negative responders; TejJ114 (truncation 
of lifespan with DR) were used comparatively assess proteostasis as a mechanism 
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involved in DR-induced lifespan extension. The examination of subcellular fractions; 
mitochondrial, cytoplasmic and myofibrillar, synthesis rates in skeletal muscle, heart 
and liver allows a comparison of tissues representative of post-mitotic, semi-mitotic 
and mitotic to more fully evaluate the effect of DR on proteostatic mechanisms 
(Miller et al. 2014; Miller et al. 2012). As the impact of DR on increased proteostasis 
is ambiguous we sought to investigate the association between DR and increased 
lifespan and to provide insight into the role of proteostasis as a candidate 
mechanism of lifespan extension with DR. 
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5.3 Methods 
5.3.1 Animals and Experimental Design  
Female mice from three strains of ILSXISS RI mice with established lifespan 
responses to 40% DR (Rikke et al. 2010; Liao et al. 2010) were used; TejJ89 
(lifespan extension with 40% DR), TejJ48 (no change to lifespan) and TejJ114 
(lifespan reduction) and were maintained as described in detail in Chapter 2 section 
2.1.2. Briefly, at 9 weeks of age eight animals from each strain were assigned to an 
AL or DR feeding regime within each strain. DR was introduced in a graded fashion, 
as described in Chapter 2, with full restriction of 40% implemented at 12 weeks of 
age, based on the AL counterparts intake from the previous week.  Mice were 
maintained on an AL or DR feeding regime for a period of 2 months, equivalent to 5 
months of age.  
At 5 months of age AL and DR mice (n=8 per group) were fasted overnight, 
in a fresh cage, with AL access to normal drinking water. DR mice were given an 
initial intraperitoneal injection (IP) of 99% 2H2O to rapidly enrich the pool of body 
water pool (assumed 60% of body weight) to 5% deuterium, and then enrichment 
was then maintained by ad libitum access to drinking water enriched with 8% 2H2O 
for a 2-week labelling period (Miller et al. 2012; Neese et al. 2002). Following the 2-
week enrichment period, the mice were fasted overnight and then culled under 
Home Office regulations following CO2 inhalation.  Plasma via blood from cardiac 
puncture blood was collected and spun down (as described in Chapter 2; 2.1.2) and 
the resultant plasma stored at −80°C. The heart, liver and the gastrocnemius 
muscles were collected snap frozen in liquid nitrogen and subsequently stored at 
−80°C. Bone marrow was collected, and used to calculate synthesis rates over the 
2 week labelling period by comparing bone marrow, essentially representing a fully 
turned over population of cells and therefore a precursor to the enrichment, with 
tissue from the same animal (Miller et al. 2012; Miller et al. 2013). Bone marrow 
from the femur was collected by removing both ends of the bone shaft with scissors, 
leaving the femur cavity exposed. The femur was held over fresh Eppendorf and the 
cavity was flushed with 1 ml of phosphate buffered saline using a 3cc syringe with 
a 25 gauge needle. The resultant material collected in the Eppendorf was 
immediately stored at -20°C. Samples were subsequently shipped on dry ice to the 
Translational Research on Aging and Chronic Disease Laboratory at Colorado State 
University for analysis (See Figure 5.1 for experimental design). 
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Figure 5.2: Schematic of experimental design used to determine the synthesis of 
DNA and protein at 5 months of age (following 2 months of ad libitum (AL) or 40% 
dietary restricted (DR) feeding). (A) (2H2O) was administered through AL access to 
drinking water for 2 weeks following IP injection. (B) Liver, heart, gastrocnemius and 
bone marrow were collected and (C) through a series of differential centrifugation 
steps and DNA extraction procedure, DNA was extracted and tissue separated into 
the mixed (myofibrillar; consisting of primarily of contractile proteins in the heart and 
skeletal muscle), cytoplasmic and mitochondrial protein fractions. (D) It was possible 
to measure the rates of newly synthesised proteins and DNA, assessed through the 
incorporation of deuterium from body water (Adapted from Miller and Hamilton 
2014). 
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5.3.2 Protein isolation 
Fractionation of heart, liver and skeletal muscle tissue was carried out 
according to a series of differential centrifugation steps, as described in previously 
published protocols (Robinson et al. 2010; Miller et al. 2012). All steps were taken 
under the supervision of, and with the assistance of collaborators at Colorado State 
University (CSU), CO, USA. Tissues were powdered using a pestle and mortar, 
under liquid nitrogen. Tissue was weighed out (50-70mg) and homogenised, using 
a bead homogenizer (Next Advance Inc., Averill Park NY), 1:10 in isolation buffer 
(100 mM KCl, 40 mM Tris HCl, 10 mM Tris Base, 5 mM MgCl2, 1mM EDTA, 1mM 
ATP, pH=7.5) with phosphatase and protease inhibitors (HALT, Thermo Scientific). 
Subcellular fractions of mixed (Mixed; consisting of nuclei, plasma and of essential 
contractile proteins (heart and skeletal muscle)), cytosolic (Cyto; other cytosolic 
organelles with the exception of mitochondria and nuclei) and mitochondrial (Mito) 
proteins were isolated following homogenisation as previously described (Miller et 
al. 2012; Drake et al. 2015; Busch et al. 2006).  
5.3.3 DNA isolation 
For DNA, ~8 µg of total DNA was extracted following the manufacturer’s 
protocol (MiniDNA kit, Qiagen) from approximately 30 mg tissue. This process 
involved leaving the tissue overnight in lysis buffer at 37°C to access DNA in the 
nucleus. The sample was prepared, loaded to a spin column, and centrifuged, 
through a series of purification steps. The DNA was eluted, to ensure the removal 
of nuclei from the spin column, into 200µl TE buffer (10 mM Tris, 1 mM EDTA, pH 
8.0) and stored at -20°C until preparation for analysis via GC/MS. Bone marrow 
suspension was centrifuged for 10 minutes at 2,000 x g. The pellet was treated using 
the same protocol employed for tissue DNA isolation. 
5.3.4 Sample preparation and analysis via Gas chromatography–mass 
spectrometry 
5.3.4 (A) Protein 
To hydrolyse the protein samples, 3ml (Cyto and Mix) or 750 µl (Mito) of 6N 
HCL was added to 13X100 glass tubes, followed by incubation for 24 h at 120°C.   
All subsequent steps described for this protocol were carried out by 
collaborators at CSU.  
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The hydrolysates were ion exchanged, dried under vacuum and 
resuspended in 1 ml molecular biology grade H2O. Derivation of 500 µl of 
suspended samples (500 µl acetonitrile, 50µl 1M K2HPO4 (pH 11), and 20 µl of 
pentafluorobenzyl bromide (Pierce Scientific, Rockford, IL)) was carried out, 
samples were sealed and left to incubate for 1h at 100°C. Ethyl acetate was used 
to extract derivatives. Through drying by N2 and subsequent vacuum centrifugation, 
the organic layer was removed, and samples were reconstituted in 1 ml of ethyl 
acetate prior to GC/MS analysis and then analysed as previously described.  
5.3.4 (B) Body Water 
To determine body water enrichment, 125 µl of plasma was placed into the 
inner well of o-ring screw on cap and placed inverted on heating block overnight. 
Next, 2 µl of 10 M NaOH and 20 µl of acetone were added to all samples and 20 µl 
0%–20% D2O standards and capped immediately. Samples were vortexed at low 
speed and kept overnight at room temperature. Samples were extracted with 
addition of 200 µl hexane, and the organic layer was transferred through anhydrous 
Na2SO4 into gas chromatography vials and analysed via EI mode using a DB-17MS 
column. 
5.3.4 (C) DNA synthesis measurement 
Determination of 2H incorporation into purine deoxyribose (dR) of DNA was 
performed, as previously described (Drake et al. 2015; Neese et al. 2002; Miller et 
al. 2013). Briefly, nuclease S1 and potato acid phosphatase was used to hydrolyse 
DNA isolated from whole tissue at 37°C overnight. Pentafluorobenzyl hydroxylamine 
and acetic acid were reacted with hydrolysates and then acetylated with acetic 
anhydride and 1-methylimidazole. Dichloromethane extracts were dried, 
resuspended in ethyl acetate, and analysed by GC/MS as previously described 
(Miller et al. 2014; Neese et al. 2002; Miller et al. 2013). The fractional synthesis 
rate (f) was calculated by using DNA from bone marrow since this pool is essentially 
fully turned over population and indicative of the true precursor enrichment (Miller & 
Hamilton 2012; Miller et al. 2013). 
5.3.5 New protein to new DNA synthesis ratio 
From the synthesis rates of protein and DNA, a protein synthesis to DNA 
synthesis ratio was calculated as this has been suggested to be indicative of 
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changes in proteostasis. This ratio illustrates how much new protein is made in 
relation to the rate of cellular proliferation (new DNA) during the labelling period 
(Miller et al. 2014; Drake et al. 2015). 
5.3.6 Statistical Analysis 
Statistical analysis was performed using PRISM. Differences between 
treatment (AL and DR) and Strain (TejJ89, TejJ48 and TejJ114) were compared 
using a two-way analysis of variance (ANOVA), but checked by linear model for 
consistency with analysis in previous chapters. When a significant difference was 
detected, post hoc analysis was performed with a Tukey multiple comparison test. 
Significance was set at p<0.05 and data are presented as means ±SEM. 
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5.4 Results 
Protein Synthesis 
5.4 (A) DR and protein synthesis in Skeletal Muscle 
A significant treatment effect on protein synthesis rates in skeletal muscle 
(whole gastrocnemius homogenate) was observed, with reductions detected, in all 
subcellular fractions following short-term DR (Figure 5.2 (A) Mito: F = 19.00, p < 
0.001, Figure 5.3 (A) Cyto= F = 8.426, p = 0.005 and Figure 5.4 (A) Myo: F = 21.22, 
p< 0.001). Strain TejJ89 was found to have reduced protein synthesis relative to AL 
controls in both the Mito (p<0.01) and Myo (p<0.01) protein fractions (Figure 5.2 A 
and 5.4 A). Strain was also found to have a significant effect on protein synthesis 
rate in both the Mito (F = 4.918, p= 0.011) and the Myo (F= 4.712, p= 0.013) 
subcellular fractions, with no detectable strain effect observed in the Cyto fraction. 
A one-way ANOVA was carried out, independent of treatment, both within the AL 
and DR mice in the Mito and Myo fractions, in order to determine direction of strain-
effect. No strain-effect was observed within the AL mice for either the Mito (Figure 
5.2 B) or Myo fraction (Figure 5.4 B). Strain was found to have a significant effect 
however, within the DR mice in both the Mito (F= 3.782, p= 0.036) and the Myo 
(F=5.890, p=0.007). In the Mito fraction (Figure 5.2 C) strain TejJ89 had significantly 
lower rates of protein synthesis compared to TejJ48 following short-term DR. In the 
Myo fraction (Figure 5.4 C) synthesis was significantly reduced in strain TejJ89 
compared with both TejJ48 (p<0.01) and TejJ114 (p<0.05). 
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Figure 5.3: Protein fractional synthesis rates (FSR) in the Mito subcellular fraction 
of skeletal muscle in three strains of female ILSXISS mice maintained on 40% DR 
or AL feeding for 2 months. (A) Significant effect of treatment and strain on FSR was 
observed on mitochondrial protein synthesis. (B) No strain effect was detected 
within the AL mice. Within the DR TejJ89 had reduced protein synthesis relative to 
TejJ48 (C). Values are means ± SEM, n = 8 per group (both AL and DR), *= AL vs 
DR p<0.05*, p<0.01**, t= treatment effect; p<0.001ttt, S= strain effect; p<0.05S 
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Figure 5.4: Protein fractional synthesis rates (FSR) in the Cyto subcellular fraction 
of skeletal muscle in three strains of female ILSXISS mice maintained on 40% DR 
or AL feeding for 2 months. (A)Treatment was found to have a significant effect on 
FSR in the Cyto fraction in skeletal muscle, with no strain effect detected in either 
AL (B) or DR (C) mice. Values are means ± SEM, n = 8 per group (both AL and DR), 
t= treatment effect; p<0.01tt. 
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Figure 5.5: Protein fractional synthesis rates (FSR) in the Myo subcellular fraction 
of the skeletal muscle in three strains of female ILSXISS mice maintained on 40% 
DR or AL feeding for 2 months (A) A significant treatment and strain effect was 
observed in the Myo FSR, with reduced rates of protein synthesis in TejJ89 with DR, 
relative to AL controls. (B) No strain effect was apparent within the AL mice of the 
Myo fraction, however a significant effect of strain was detected within the DR mice 
(C), with reduced synthesis in TejJ89. Values are means ± SEM, n = 8 per group 
(both AL and DR),* denotes p<0.05*, p<0.01**, t= treatment effect; p<0.001ttt, S= 
strain effect; p<0.05S. 
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5.4 (B) DR and protein synthesis in Heart  
In the heart there were no detectable treatment effects on any subcellular 
fraction (Mito; Figure 5.5 A, Cyto; Figure 5.6 A, Myo; Figure 5.7 A). No significant 
strain-effect was observed in either the Mito or Myo fractions.  However, significant 
strain- effect was observed in the cytoplasmic fraction (F = 5.448, p= 0.006). 
Independent of treatment, no strain effect was apparent within the AL mice in any 
of the subcellular fractions (Mito; Figure 5.5 B, Cyto; Figure 5.6 B, Myo; Figure 5.7 
B). Within the DR mice a strain effect was detected in the Cyto (F=5.448, p=0.006), 
with strain TejJ48 having increased synthesis rates relative to strain TejJ114 (Figure 
5.6 C). 
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Figure 5.6: Protein fractional synthesis rates (FSR) in the Mito subcellular fraction 
of the heart tissue in three strains of female ILSXISS mice maintained on 40% DR 
or AL feeding for 2 months (A) No treatment or strain effect was observed in the 
protein turnover. (B) No strain effect was apparent within the AL mice (B) or DR 
mice (C). Values are means ± SEM, n = 8 per group (both AL and DR). 
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Figure 5.7: Protein fractional synthesis rates (FSR) in the Cyto subcellular fraction 
of the heart tissue in three strains of female ILSXISS mice maintained on 40% DR 
or AL feeding for 2 months (A).  A significant strain effect was observed in the protein 
turnover. (B) No strain effect was apparent within the AL mice (B) or DR mice (C). 
Values are means ± SEM, n = 8 per group (both AL and DR). ),* denotes p<0.05, 
S= strain effect; p<0.01SS. 
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Figure 5.8: Protein fractional synthesis rates (FSR) in the Myo subcellular fraction 
of the heart tissue in three strains of female ILSXISS mice maintained on 40% DR 
or AL feeding for 2 months (A) No treatment or strain effect was observed in the 
protein turnover. (B) No strain effect was apparent within the AL mice (B) or DR 
mice (C).Values are means ± SEM, n = 8 per group (both AL and DR). 
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5.4 (C) DR and protein synthesis Liver 
No treatment effect was observed in Mito (Figure 5.8), Cyto (Figure 5.9) or 
Myo (Figure 5.10) protein synthesis rates in liver tissue in any strain. Similarly no 
strain effect was observed within AL or DR mice in any liver fraction. It is important 
to note that it is not possible to detect differences when the protein pool is fully turned 
over in each case, which was found to be the case for liver in this study.  
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Figure 5.9: Protein fractional synthesis rates (FSR) in the Mito subcellular fraction 
of the liver tissue in three strains of female ILSXISS mice maintained on 40% DR or 
AL feeding for 2 months (A) No treatment or strain effect was observed in the protein 
turnover. (B) No strain effect was apparent within the AL mice (B) or DR mice (C). 
Values are means ± SEM, n = 8 per group (both AL and DR). 
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Figure 5.10: Protein fractional synthesis rates (FSR) in the Cyto subcellular fraction 
of the liver tissue in three strains of female ILSXISS mice maintained on 40% DR or 
AL feeding for 2 months (A) No treatment or strain effect was observed in the protein 
turnover. (B) No strain effect was apparent within the AL mice (B) or DR mice (C). 
Values are means ± SEM, n = 8 per group (both AL and DR). 
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Figure 5.11: Protein fractional synthesis rates (FSR) in the Myo subcellular fraction 
of the liver tissue in three strains of female ILSXISS mice maintained on 40% DR or 
AL feeding for 2 months (A) No treatment or strain effect was observed in the protein 
turnover. (B) No strain effect was apparent within the AL mice (B) or DR mice (C). 
Values are means ± SEM, n = 8 per group (both AL and DR). 
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5.4  (D) DR and DNA Synthesis  
 
A significant treatment effect was apparent in skeletal muscle DNA synthesis 
rate (F= 14.84, p< 0.001), with strain TejJ89 having significantly lower synthesis rate 
relative to its AL control (Figure 5.11). No strain effects were apparent on DNA 
synthesis in the skeletal muscle. Within the heart tissue, no treatment or strain-effect 
was observed on DNA synthesis rate (Figure 5.12).  Rate of DNA synthesis was not 
altered by treatment in liver tissue (Figure 5.13), however strain was found to have 
an effect (F= 5.317, p= 0.008). When examined independent of treatment no strain 
differences were observed within the AL mice. Strain effects were however detected 
within the DR mice (F=5.634, p=0.010) with lower synthesis rates found in TejJ89 
when compared with both TejJ48 and TejJ114 (Figure 5.13 C). 
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Figure 5.12: DNA fractional synthesis rate (FSR) in the skeletal muscle in three 
strains of female ILSXISS mice maintained on 40% DR or AL feeding for 2 months. 
(A) A significant effect of treatment was detected in DNA FSR. No strain effects were 
detected in the AL (B) or DR (C) mice. Values are means ± SEM, n = 8 per group 
(both AL and DR). 
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Figure 5.13: DNA fractional synthesis rate (FSR) in the heart in three strains of 
female ILSXISS mice maintained on 40% DR or AL feeding for 2 months. (A) No 
effect of were apparent following short-term DR (A). Furthermore, no strain-effects 
were detected in the AL (B) or DR (C) mice. Values are means ± SEM, n = 8 per 
group (both AL and DR).  
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Figure 5.14: DNA fractional synthesis rate (FSR) in the liver in three strains of female 
ILSXISS mice maintained on 40% DR or AL feeding for 2 months. (A) No effect of 
treatment was apparent following short-term DR (A). No strain-effects were detected 
in the AL (B) mice, however in the DR mice, strain TejJ89 was found to have 
significantly reduced DNA synthesis compared to both other strains (C). Values are 
means ± SEM, n = 8 per group (both AL and DR), *denotes p<0.05*, p<0.01**, S= 
strain effect; p<0.01SS. . 
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5.4  (E) DR and Protein:DNA synthesis (newprotein/newDNA).  
 
In the skeletal muscle, treatment was found to have a significant 
effect on the new protein to DNA synthesis ratio in all subcellular fractions 
being elevated in DR mice (Figure 5.14 (A) Mito: F = 10.48, p= 0.002, 
Figure 5.15 (A) Cyto: F = 14.38, p< 0.001 and Figure5.16 (A) Myo: F= 
12.26, p=0.001). Cytoplasmic synthesis rates were increased by DR in 
strain TejJ89, compared to AL counterparts (Figure 5.15 A). No strain 
effect was apparent in the new protein to new DNA synthesis ratio of any 
protein fraction in either AL or DR mice No treatment or strain differences 
in this ratio was observed in either the heart (Figure 5.16) or liver (Figure 
5.17).  
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Figure 5.15: New Protein to DNA synthesis ratio in three strains of female ILSXISS 
mice maintained on 40% DR or AL feeding for 2 months in the Mito (A), Cyto (D) 
and Myo (G) fraction of skeletal muscle tissue. Synthesis ratios were found to be 
increased in all fractions following short-term DR. However no strain effects were 
apparent in the AL (B) or (C) DR mice of the Mito fraction. Similarly in the AL (E) or 
DR (F) rates of the Cyto, or the AL (H) or DR (I) of the Myo fraction, no strain specific 
differences were apparent. Values are means ± SEM, n = 8 per group (both AL and 
DR), ** denotes p<0.01, t= treatment effect; p<0.05t, p<0.01tt, p<0.001ttt. 
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Figure 5.16: Protein to DNA synthesis ratio in three strains of female ILSXISS mice 
maintained on 40% DR or AL feeding for 2 months in the Mito (A-C), Cyto (D-F) and 
Myo (G-I) fraction of  heart tissue. No treatment or strain effects were observed 
within any subcellular fraction. Values are means ± SEM, n = 8 per group (both AL 
and DR). 
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Figure 5.17: Protein to DNA synthesis ratio in three strains of female ILSXISS mice 
maintained on 40% DR or AL feeding for 2 months in the Mito (A-C), Cyto (D-F) and 
Myo (G-I)  fraction of  liver tissue. No treatment or strain effects were observed within 
any subcellular fraction. Values are means ± SEM, n = 8 per group (both AL and 
DR). 
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5.3 Discussion 
 
Loss of proteostasis is associated with ageing (Lopez-Otin et al. 2013) and a 
number of age-related pathologies (Labbadia & Morimoto 2015; Morimoto & Cuervo 
2014). As discussed earlier (section 5.2.1), enhanced proteostasis is proposed as 
a candidate mechanism underlying the anti-ageing effects of DR (Tavernarakis & 
Driscoll 2002). One component of proteostasis is protein synthesis, and it has been 
shown repeatedly that DR increases the rate of protein synthesis in rodents 
(Lambert & Merry 2000; Goldspink & Kelly 1984; Jazwinski 2000; Ward & 
Richardson 1991; de Cabo et al. 2015), although see also (Henderson et al. 2010), 
and DR slows age-related declines in hepatic protein synthesis and degradation 
rates (Lambert & Merry 2000). Similarly, there has been widespread support for the 
premise that mitochondrial biogenesis increases in rodents (Nisoli et al. 2005) and 
humans (Civitarese et al. 2007) under DR. However, more recently several studies 
have suggested that DR does not increase production of new mitochondria 
(biogenesis), but rather maintains energetically efficient mitochondria (Hempenstall 
et al. 2012; Lanza et al. 2012; Hancock et al. 2011). Indeed short-term 30% DR in 
C57BL/6 mice did not increase mitochondrial biogenesis in skeletal muscle, yet 
increased PGC1-α (Hempenstall et al. 2012), key regulator of mitochondrial 
biogenesis (Puigserver et al. 1998). These findings led the authors to suggest that 
rather than mitochondrial biogenesis being critical to DR-induced longevity it was 
more a case that a functionally efficient mitochondrial electron transport chain was 
critical, a finding that has now been reported in other model systems (Lanza et al. 
2012; Hempenstall et al. 2012; Mittal et al. 2009). That under DR, newly synthesised 
proteins are allocated to cellular somatic maintenance rather than growth (Hamilton 
& Miller 2017) perhaps makes energetic sense, in line with the disposable soma 
idea of Kirkwood (Kirkwood & Holliday 1979).  
While historically it has been impossible to disentangle how newly 
synthesised proteins are apportioned within the cell, I utilised a novel deuterated 
isotopic label. This enabled the ssimultaneous determination of  protein and DNA 
synthesis rates within cytoplasmic, mitochondrial and myofibrillar subcellular protein 
fractions within the liver, heart and skeletal muscle tissue of female ILSXISS mice 
following short-term (2 months) 40% DR  (Liao et al. 2010; Rikke et al. 2010). This 
approach helps provide mechanistic insight about how newly synthesised proteins 
are apportioned to newly proliferating cells versus those apportioned to somatic 
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maintenance through calculating the newprotein/newDNA ratio between. 
newprotein/newDNA ratio, whereby proliferating cells should show a ratio ~1 (↑ protein 
synthesis: ↑ DNA synthesis) and cellular maintenance should show a ratio >1 (↑ 
protein synthesis: ↔DNA synthesis) (Hamilton & Miller 2017). 
In skeletal muscle, short-term DR increased the newprotein/newDNA ratio in all 
subcellular protein fractions when compared to the ratio in AL mice. These findings 
are in agreement to previous reports in DR mice (Miller et al. 2012; Miller et al. 2013; 
Miller et al. 2014) and in a number of long-lived mouse models (Drake et al. 2013; 
Drake et al. 2014; Drake et al. 2015). In particular, DNA synthesis rates were 
reduced in strain 89 under DR, a phenotype reported in a number of long-lived 
mouse strains and perhaps suggests that this line has greater metabolic flexibility 
to reduce cell proliferation rates under DR. Similarly while there was a general DR-
wide increase in the newprotein/newDNA ratio in all strains, the effects were generally 
more apparent in line 89. Indeed, an increased newprotein/newDNA ratio in the 
cytoplasmic fraction was only significant between AL and DR mice from line 89 
within skeletal muscle. Interestingly, the synthesis of proteins from RNA in the 
cytoplasm is a known modulator of ageing and lifespan in yeast (Delaney et al. 2013; 
Borbolis & Syntichaki 2015). Consequently, the increase in the ratio in line 89 may 
be somehow relevant to DR-induced longevity, although this obviously requires 
further investigation. Importantly, my work showed that mitochondrial biogenesis in 
skeletal muscle, as determined by the newprotein/newDNA ratio, was increased under 
DR across all three strains, suggesting that DR does not increase production of new 
mitochondria, but rather maintains energetically efficient mitochondria in line with 
previous studies (Hempenstall et al. 2012; Lanza et al. 2012; Hancock et al. 2011), 
and that this may not be important to DR-induced longevity.   
In the heart, the newprotein/newDNA ratio in cytoplasmic, mitochondrial or 
myofibrillar was unaffected by DR in all ILXISS strains. The result is perhaps 
surprising given that newprotein/newDNA ratio has been reportedly increased in all 
subcellular protein fractions in heart following long-term DR (Miller et al. 2012; Miller 
et al. 2013). Moreover, this ratio in heart was also observed in long-lived Snell 
(Drake et al. 2013; Drake et al. 2015) and rapamycin treated mice (Drake et al. 
2014). What is clear from my data is that there was a trend for a DR-induced 
increase in the ratio in strain 89 but that this did not reach significance, potentially 
highlighting a lack of power in my study (n=8).  In a reanalysis of their data (Miller et 
al. 2012; Miller et al. 2013), using the newprotein/newDNA ratio, Miller et al (Miller et 
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al. 2014) reported that DR increased the ratio in skeletal muscle and heart although 
it is unclear which age-cohort of male B6D2F1 mice were presented. The mice in 
my study were 5 months of age, and thus still relatively young, and it may be 
possible that DR-induced changes in this ratio might only be detectable in the 
context of ageing, as multiple components of the proteostatic network are known to 
become impaired during ageing  (Taylor & Dillin 2011; Kaushik & Cuervo 2015). 
Following the 2 week labelling period utilised in this study, I found that all liver 
fractions were fully turned over, as reported previously in other D2O studies (Miller 
et al. 2012; Miller et al. 2013; Drake et al. 2013) leading to the introduction of a new, 
time-course approach that was introduced by Miller and Hamilton after the 
collections of our samples. Consequently, this meant that it was not possible to 
determine the newprotein/newDNA ratio in this tissue. However, the DNA fractional 
synthesis rate was significantly reduced in line 89 under DR when compared to the 
other 2 lines under DR, suggesting that cellular proliferation was significantly 
reduced in this tissue, again indicating a tissue maintenance phenotype in this line. 
Long-term DR has been shown to reduce both protein synthesis and breakdown in 
mice, suggesting that the beneficial effect of DR on cellular fitness may work instead 
through reduced protein synthesis (J. C. Price et al. 2012). Interestingly, cellular 
proliferations is associated with various cancers (Lopez-Saez et al. 1998), and while 
we do not know what the various ILXISS line die of under DR it would be interesting 
to determine whether this line retains reduced hepatic cellular proliferation in older 
ages and indeed whether this is associated with a reduced incidence of hepatic 
carcinomas. However, unfortunately I was not able to repeat this study in a longer-
term DR protocol due to time limitations and the tissue requirements of the 
mitochondrial studies (Chapter 4).  
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Chapter 6: General Discussion  
6.1 General Overview 
Identifying the mechanisms underlying the ageing process remains one of 
the greatest challenges, not only to biological research, but also to society in regards 
to the increased social and economic burden caused by the co-morbidities of 
ageing. As described in Chapters 1and 2 of this thesis, I utilised the inherent strain-
specific lifespan response to dietary restriction (DR) of ILSXISS recombinant inbred 
(RI) mice, categorised previously as “positive” (strain TejJ89), “non” (strain TejJ48) 
or  “negative” (strain TejJ114) responders, in terms of DR-induced longevity (Rikke 
et al. 2010; Liao et al. 2010). I employed this intrinsic variability in the DR response 
in order to probe putative mechanisms underlying slowed ageing and longevity. I 
sought to determine the impact of short- (2 months of 40% DR, equivalent to 5 
months of age) and long-term DR (10 months of 40%, equivalent to 13 months of 
age) on candidate hallmarks of ageing, including numerous physiological and 
metabolic parameters (Chapter 3), hepatic and skeletal muscle mitochondrial 
function (Chapter 4) and protein synthesis within liver, skeletal muscle and heart 
(Chapter 5).  
Overall, my findings from the experiments described in Chapters 3, 4 and 5 
highlight firstly that genotype appears important to the DR response in terms of the 
parameters I measured, with strain-specific differences widely observed. Secondly, 
metabolic flexibility, i.e. the ability for adaptive metabolism in a time of nutrient 
scarcity, appears to be an important process underlying DR-induced lifespan 
extension (Chapter 3 & 4). My findings indicate that the maintenance of gonadal 
white adipose tissue (WAT) and simultaneous hypertrophy of brown adipose tissue 
(BAT) may be important correlates of longevity under DR; both seen in strain TejJ89 
following long-term 40% DR, and neither observed in either the negative responding 
strain TejJ114 or non-respondingTejJ48. Long-term DR did not enhance hepatic or 
skeletal muscle mitochondrial function in contrast to a number of previous studies 
in mice (López-Lluch et al. 2006; Nisoli et al. 2005; Hempenstall et al. 2012; Lanza 
et al. 2012), but interestingly hepatic mitochondrial dysfunction was observed in the 
negative responding TejJ114 under long-term 40% DR. My research also showed 
that enhanced glucose homeostasis, including increased glucose tolerance and 
insulin sensitivity, proposed as being a conserved response to DR in mice, was not 
seen in ILSXISS strains following short- or long-term DR. In this chapter I will 
synthesise and review my main findings, suggest potential explanations for the 
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observed results, and highlight some limitations and propose some future research 
avenues that may help provide additional insights.   
 
 
 
 
Figure 6.1: Summary of original Aims; investigate the impact of 40% DR on three 
well characterised hallmarks of ageing in female ILSXISS mice.  
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6.2 40% DR differentially affects body mass and fat mass in ILSXISS mice 
dependent of duration 
 
 
 
 
 
 
 
Figure 6.2: Impact of short- (2 months) and long-term (10 months) 40% DR on body 
mass, gonadal white adipose tissue (WAT) mass and brown adipose tissue BAT) 
mass in female ILSXISS mice. 
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 Body mass (BM) was significantly reduced in all strains under short-term and 
DR, although neither the mass of gonadal WAT or BAT was decreased, suggesting 
that the losses in BM observed were due to decreases in other WAT depots or in 
lean mass. TejJ114 actually showed an increase in gonadal WAT (corrected for BM 
changes) under short-term DR, with similar results been reported following short-
term (3 weeks) of 5% DR female C57BL/6J mice (Li, Cope, Johnson, D. L. Smith, 
et al. 2010). The reason for the increase in gonadal WAT in TejJ114 is unclear, 
however physiological adaptations in behaviour, such as irregular eating patterns or 
binge eating under DR may impact on the accumulation in fat (Dietz 1995; Chaput 
et al. 2007) and perhaps TejJ114 was more prone to these behaviours, although 
this is purely conjecture as I did not look at this in my study. Female C57BL/6J mice 
under 5% DR showed “gorging behaviour” following implementation of restriction 
(Li, Cope, Johnson, D. L. Smith, et al. 2010), and the authors suggested that 
condensing food intake into a narrower time frame results in a more effective 
storage of triglycerides within the gonadal WAT depot, and also in  inguinal, 
retroperitoneal and mesenteric WAT. Reductions in lean mass  and organ mass  
have been shown following 3 months of DR in mice (Faulks et al. 2006; Mitchell et 
al. 2015a)  
Under long-term DR, strain TejJ114 was found to have lost a much greater 
amount of mass (52.3%), relative to its appropriate AL control, than either TejJ89 
(34.5 %) or Tej48 (24.6 %). Strain TejJ89 had proportionally similar gonadal WAT 
mass as AL controls, but BAT mass increased significantly within the DR group; 
UCP1 protein levels were unaffected. Conversely TejJ114 mice under long-term DR 
had significantly smaller mass-corrected gonadal WAT compared to AL mice, but 
BAT was unaffected. Maintenance of WAT has been described previously as a 
mediator of DR response in ILSXISS mice, with strains with the least reduction in 
fat more likely to show life extension, and those with the greatest reductions more 
likely to have shortened lifespan (Liao et al. 2011). Moreover, significant loss of fat 
under DR in long-lived adenylyl cyclase type 5 knockout mice has been linked to 
DR-induced metabolic deterioration and death (Yan et al. 2012). Increases in BAT 
are reported in mice and rats under DR (Fabbiano, Suarez-Zamorano, et al. 2016; 
Valle et al. 2005; Okita et al. 2012; Valle et al. 2008), and my findings indicate a link 
between WAT maintenance and BAT hypertrophy and DR-induced longevity in 
TejJ89. Mice under DR are known to be thermoregulatory stressed (Speakman & 
Keijer 2012), and so the significant loss in gonadal WAT mass, with no increases in 
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BAT mass, in strain TejJ114 following long-term DR may indicate that this strain is 
more reliant on shivering thermogenesis to maintain body temperature under DR, 
using gonadal WAT as an energy source. Mice lacking uncoupling protein 1 (UCP-
1 KO), which are unable to generate heat production through non-shivering 
thermogenesis within BAT, are found to switch to fatty acid metabolism and appear 
to be more reliant on shivering thermogenesis (Shabalina et al. 2010). Moreover, 
depletion of reactive oxygen species (ROS) results in hypothermia upon cold 
exposure in male C57BL/6J, and inhibits UCP1-dependent increases in whole body 
energy expenditure, and authors propose increased ROS in BAT as a mechanism 
that drives UCP1-dependent thermogenesis (Chouchani et al. 2016). Although ROS 
was not measured in BAT in this study, I observed reduced levels of ROS within 
skeletal muscle of strain TejJ114 under long-term DR (Chapter 4).  The idea of the 
rate of living theory was first proposed by Pearl in 1928 (Pearl 1928), and the 
reduction in body temperature (Tb) has been proposed as being critical to DR-
induced longevity (Duffy et al. 1989; Lane et al. 1995; Vaanholt et al. 2012; Turturro 
& Hart 1991). However, in ILSXISS mice, greater reductions in Tb following DR were 
associated with shortened lifespan under DR (Rikke et al. 2003; Rikke & Johnson 
2007), and my findings suggest that a lack of BAT hypertrophy, and in the case of 
TejJ114 the resulting loss of WAT, may be important.   
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6.3 Enhanced glucose homeostasis is not essential to longevity with DR 
 
 
 
 
 
 
 
 
 
Figure 6.3: Impact of short- (2 months) and long-term (10 months) 40% DR on 
glucose homeostasis in female ILSXISS mice. 
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Enhanced glucose homeostasis, including improved glucose tolerance, 
insulin sensitivity and decreased plasma levels of insulin and insulin-like growth 
factor-1 (IGF-1), has been reported following short and long-term DR in mice 
(Hempenstall et al. 2010; Argentino et al. 2005; Mitchell et al. 2016) and is also 
characteristic of longevity in some (Bartke et al. 2007; Blüher et al. 2003), but not 
all (Selman et al. 2008) long-lived mice. However, I found no evidence that 
differences in glucose tolerance, insulin resistance or IGF-1 were associated with 
DR-induced longevity in female ILSXISS mice, or indeed that impaired glucose 
homeostasis was associated with lifespan shortening under DR. While my findings 
do not support the premise of alterations in glucose and insulin to underlie the 
beneficial effects of DR, strain-specific difference in glucose homeostasis are well 
established under both AL and DR conditions. For instance, male C57BL/6 and 
DBA/2 mice following short-term DR are not found to have reduced fasting plasma 
insulin, and DBA/2 mice are hyperinsulinaemic relative to C57BL/6 mice under both 
AL and DR conditions (Hempenstall et al. 2010). I employed the Homeostatic Model 
of Assessment for insulin resistance (HOMA IR), a simple and time-efficient proxy 
for the determination of insulin resistance. However, while this has been shown to 
be a good proxy for insulin resistance in mice (Selman et al. 2009; Hempenstall et 
al. 2010) it has failed to adequately predict IR in a number of human studies (Ferrara 
& Goldberg 2001; Anderson et al. 1995; Yeni-Komshian et al. 2000). Surprisingly 
IGF-1, which has been shown to be decreased in DR mice (Hempenstall et al. 2010; 
Mitchell et al. 2016) was unaffected by DR in ILSXISS mice, irrespective of the DR 
duration.  Humans unlike rodents, are not found to have reduced IGF-1 following 
long-term DR (Fontana et al. 2008), and long-lived Klotho mice have increased 
insulin resistance and IGF-1 (Bartke 2006). Moreover, mice with reduced levels of 
IGF-1 have an increase in maximum but not median lifespan, indicating that a 
reduction in IGF-1 alone is insufficient to increase both mean and maximal life span 
in mice (Lorenzini et al. 2014). 
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6.4 Mitochondrial dysfunction was associated with lifespan shortening with 
DR  
 
 
 
 
 
 
 
 
Figure 6.4: Impact of long-term (10 months) 40% DR on mitochondrial function, ROS 
and oxidative damage in female ILSXISS mice. 
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Mitochondrial dysfunction is proposed as being a key hallmark of ageing and 
disease (Lopez-Otin et al. 2013), and reports in model systems suggest 
improvements in mitochondrial function correlate closely with DR-induced longevity  
(Ruetenik & Barrientos 2015; Feuers 1998; Zid et al. 2009). However, I observed in 
strain TejJ114 that long-term 40% DR induced hepatic mitochondrial dysfunction; 
mitochondrial function was unaffected by long-term DR in strains TejJ89 and TejJ48. 
While I originally predicted that mitochondrial dysfunction would be associated with 
a shortening of lifespan in TejJ114 under DR, the absence of any beneficial effect 
of DR on mitochondrial function in TeJJ89, unlike those reported in both skeletal 
muscle and liver under DR (Hempenstall et al. 2012; Lanza et al. 2012; Weindruch 
et al. 1980), suggest that, in ILXISS mice at least, enhanced mitochondrial 
respiration does not underlie DR-induced longevity. Although it should be noted that 
differences in mitochondrial protocols exist between my study and those of  Lanza 
(2012) and Hempenstall (2012). I also found that TejJ89 under long-term DR had 
greater production of hepatic reactive oxygen species (Hydrogen peroxide; H2O2) 
relative to AL controls, whilst lower ROS was seen in TejJ114. Recently debate has 
arisen over the precise role of oxidative damage in causing ageing (Speakman & 
Selman 2011; Gems & Doonan 2009), and my findings conflict with the widely held 
belief that DR acts through reductions in ROS-induced oxidative damage (Lambert 
& Merry 2004; López-Lluch et al. 2006). However, accumulating evidence suggests 
that ROS, including superoxide, hydrogen peroxide, and multiple others, are not the 
cause of oxidative damage, but instead act as important signalling molecules that 
protect against disease, thus consequently increases lifespan (Ristow & Zarse 
2010; Ristow & Schmeisser 2014), and may explain the DR-induced longevity and 
increased hepatic ROS in TejJ89. Increased hepatic oxidative damage was reported 
in strain TejJ114 under DR, but H2O2 levels were unaffected. Thus, it is feasible that 
an alternative ROS source, such as superoxide or the hydroxyl radical may be 
responsible for the increase in oxidative damage seen, perhaps related to the 
mitochondrial dysfunction observed in this same strain under DR. Indeed, while 
H2O2  is the most widely used measure of ROS production, it was recently reported 
in a meta-analysis that H2O2 is largely unchanged in rodents subject to DR (Walsh 
et al. 2014).  
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6.5 Increased cytoplasmic protein synthesis in the skeletal muscle is 
important to longevity with DR 
 
 
 
 
 
 
 
Figure 6.5: Impact of long-term (10 months) 40% DR on newprotein/newDNA ratio in 
three strains of female ILSXISS mice. 
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Loss of proteostasis is associated with ageing (Lopez-Otin et al. 2013), while 
the ability to maintain a healthy proteome through protein homeostasis, or 
proteostasis, is associated with enhanced longevity (Morimoto & Cuervo 2014; 
Treaster et al. 2014; Kaushik & Cuervo 2015). Here, through the use of  a novel 
technique; newprotein/newDNA ratio, which gives mechanistic insight about how newly 
synthesised proteins are apportioned to newly proliferating cells versus those 
apportioned to somatic maintenance (Miller et al. 2014), I investigated the role of 
proteostasis as a candidate mechanism underlying lifespan extension in ILSXISS 
mice. Protein synthesis rates in three subcellular protein fractions; cytoplasmic, 
myofibrillar and mitochondrial proteins, in skeletal muscle, heart and liver were 
determined under short-term 40% DR. In muscle increases in cytoplasmic, 
myofibrillar and mitochondrial were reported. I only observed an increase in the 
newprotein/newDNA ratio in the cytoplasmic protein fraction in strain TejJ89 under DR. 
The absence of any increase in this ratio in either the mitochondrial or myofibrillar 
proteins in skeletal muscle in any ILSXISS strain is perhaps surprising, given the 
increases in both fractions previously reported in male B6D2F1 skeletal muscle 
following DR reported by Miller et al (2012; 2013), who ultimately concluded that 
increased proteostasis is a shared feature of DR (Miller et al. 2014; Hamilton & Miller 
2017). Increased mitochondrial biogenesis has been proposed as a candidate 
mechanism underlying lifespan extension following DR (Lopez-Lluch et al. 2008; 
López-Lluch et al. 2006; Civitarese et al. 2007; Nisoli et al. 2005), although debate 
has existed on what is the best way to determine biogenesis (Miller et al. 2014; Miller 
et al. 2016). My results, which utilise the newprotein/newDNA ratio (Miller et al. 2014; 
Drake et al. 2015; Hamilton & Miller 2017) suggest that DR favours the maintenance 
of existing mitochondria, preserving mitochondrial efficiency, rather than inducing 
mitochondrial biogenesis, in line with other studies in skeletal muscle of mice under 
DR (Hempenstall et al. 2012; Lanza et al. 2012; Hancock et al. 2011). Moreover, I 
saw no changes in any protein fractions within the heart, unlike the increases 
reported in male B6D2F1 following short-term DR (Miller et al. 2012; Miller et al. 
2013). It is possible that due to only examining newprotein/newDNA ratio following 
short-term DR (5 months of age), it may be that no age-related impairments to the 
proteostatic systems existed and hence this may explain the absence of effects.  
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6.6 Limitations and future directions 
 
One limitation of this study is that our measurements were taken relatively 
early in the ad libitum lifespan (Liao et al. 2010; Rikke et al. 2010) of these mice, at 
5 and 13 months of age. The reason these particular time-points were chosen was 
that strain TejJ114 has a median lifespan of approximately 800 days under AL 
feeding, compared to median lifespan of 400 days under DR (Liao et al. 2010; Rikke 
et al. 2010). Although these strains were sampled at the same age, their biological 
age was likely to be different. The degree of inter-individual variation in biological 
age, rather than chronological (i.e. time since birth), is known to be substantial in 
humans (Shiels & Ritzau-Reid 2015; Belsky et al. 2015). Strain TejJ114 appear to 
have accelerated ageing with DR, and the identification of appropriate biomarkers 
of biological age will be key to understanding the mechanisms of DR induced slowed 
ageing (Shiels et al. 2017; Shiels & Ritzau-Reid 2015).   
Following DR, model organisms typically display a tent-shaped lifespan 
response (Clancy et al. 2002; discussed in Fontana & Partridge 2015). For example, 
in Drosophila, long-lived Chico mutants have optimal longevity on a different level 
of nutrient restriction compared to  wild-type controls (Clancy et al. 2002). Similarly 
both male and female DBA/2 and C57BL/6 mice  are known to have both strain and 
sex-specific differences in the level of DR known to maximise lifespan (Mitchell et 
al. 2016). Consequently, it is possible that 40% DR was too stringent a DR regime 
for strain TejJ114 and hence resulted in shortening of lifespan, but that it was optimal 
for longevity in stain TejJ89 (See Figure 6.7). Consequently, it would be interesting 
to undertake further lifespan studies in ILSXISS strains under different levels of DR. 
Indeed, a group in the US is currently exposing nine different ILSXISS female lines 
known to exhibit strain-specific lifespan responses to DR to 10%, 20% and 40% DR.  
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Figure 6.6: Proposed strain-specific differences in the levels of DR required to 
induce maximal longevity effects in ILSXISS strains TejJ89 (positive) and TejJ114 
(negative). 
 
 
As most research to date has been conducted on male C57BL/6 mice it is 
difficult to ascertain whether the proposed mechanisms, currently described as 
hallmarks of DR, are in fact universal modulators of slowed ageing, as there is little 
basis for comparison in other strains or indeed in female mice. Furthermore, while 
we found maintenance of WAT mass and increase in BAT to be associated with 
longevity under DR, we did not measure browning, the conversion of white 
adipocytes into brown adipocytes (Giralt & Villarroya 2013). Previous DR studies 
report browning of WAT in male mice, and suggest this being important to longevity 
under DR (Fabbiano, Suarez-Zamorano, et al. 2016). Moreover an investigation into 
the role of fibroblast growth factor 21 (FGF21) would be interesting, as it is 
associated with enhanced thermogenic activity in BAT by using UCP-1 to dissipate 
energy as heat, and FGF21 and UCP-1 appear to work synergistically under fasted 
conditions (Chapnik et al. 2017). Moreover, FGF21 is activated by non-shivering 
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thermogenesis and can induce browning of WAT (Hondares et al. 2011; Fisher et 
al. 2012).  
Another avenue which may be worth pursuing is the repetition of this study 
under the same experimental protocols used by Liao et al and Rikke et al (Liao et 
al. 2010; Rikke et al. 2010). While the authors state that mice were under 40% DR, 
they were actually fed every other day. This method of feeding is more similar to 
intermittent fasting, rather than typical DR, as mice are not in a fasted state on days 
of feeding, and as discussed earlier (section 6.2) gorging behaviour may have an 
impact on physiological response (Dietz 1995). Therefore it would be interesting to 
investigate the lifespan response of TejJ89, TejJ48 and TejJ114 following the daily 
40% DR protocol as used in this study, to determine if lifespan responses are the 
same under both restriction protocols.  
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6.7 Concluding remarks 
 
 
 
 
 
 
Figure 6.7: Summary figure of responses associated with lifespan extension in strain 
TejJ89 and lifespan shortening in TejJ114 following 10 months of 40% DR.  
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The results of this thesis have furthered our knowledge of the mechanisms 
underlying the DR response and helped to expand our understanding the 
importance of genotype in DR research. Collectively my data suggests a role for 
adaptive metabolism as being crucial to longevity with DR, with maintenance of 
mitochondrial efficiency, found to be more important to lifespan than enhanced 
function. Conversely, mitochondrial dysfunction, and metabolic inflexibility suggest 
that negative responders were metabolically constrained resulting in lifespan 
shortening. Strain TejJ48 as predicted was found unresponsive in most respects. 
Phenotypic plasticity of the mitochondria is essential to sustain both efficient 
mitochondria, but also to adapt to energetic demands (Hancock et al. 2011; Brand 
2005). Here I find that flexibility relating to adaptive metabolism, in terms of 
managing fat stores, and maintaining functionally efficient mitochondria, as crucial 
to longevity with DR, and it appears that the inability of strain TejJ114 to adapt to 
DR in times of nutritional deficit is detrimental to lifespan response. Perhaps 
surprisingly enhanced glucose homeostasis was not found to be a prerequisite to 
lifespan extension. Understanding the impact of genotype on metabolism is critical 
for transferability of DR research to implementing effective strategies for humans, 
and for the development of safe and efficacious DR pharmaceutical drug targets. It 
is clear that the dramatic rise in the proportion of elderly individuals making up our 
population is going to have significant ramifications. Consequently understanding 
the fundamental processes that drive ageing and increase the susceptibility to 
develop disease is undoubtedly one of the greatest current challenges in biomedical 
research. Future research efforts should take greater advantage of the inherent 
differences in longevity and pathology at death seen across different mouse strains 
(Storer 1966) to further understand how specific interventions, including DR, genetic 
inactivation of IIS/mTOR and rapamycin treatment, act to modulate lifespan and 
health in the background of increasing genetic heterogeneity. 
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Appendix I 
Supplementary data 
The following are the supplementary data related to Chapter 4: 
 
 
 
 
 
 
FigureS1: Respiratory control ratio, expressed as the ratio between state 3u (FCCP-
induced maximal uncoupled-stimulated respiration) and state 4o (respiration in the 
absence of ADP) in isolated liver (A) and skeletal muscle (B) mitochondria. No 
differences were observed by treatment within a strain or between strains. 
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Figure S2: Hepatic antioxidant defence and oxidative damage markers. Total SOD 
activity was unaltered between strains in either AL (A) or DR (B) mice. Total GSH 
levels were similarly unaffected by strain under AL (C) or DR feeding (D). 4-HNE 
levels were unaffected by treatment (E) or by strain (F). Protein carbonyl levels in 
AL mice (G) were unaffected by strain, but protein carbonyl levels were significantly 
reduced in strain TejJ48 compared to both strain TejJ89 and TejJ114 under DR (H). 
Values are expressed as mean ± SEM, where n= 6 per group. * p<0.05. 
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Figure S3: Protein levels of the OXPHOS proteins CI subunit (NDUFB8), CII-30kDa 
(SDH), CIII-Core protein 2 (UQCRC2), CIV subunit I (MTCO1) and CV alpha subunit 
(ATP5A) in AL and DR mice from each of the mouse strains. OXPHOS proteins 
were unaffected by treatment in liver (A-C), skeletal muscle (D-F) and heart (G-I). 
Values for A–E are arbitrary units (AU) expressed relative to total protein (Ponceau 
staining). Values are expressed as mean ± SEM, where n= 6 per group. 
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Figure S4: Hepatic NADPH oxidase levels. No differences were observed with 
treatment or between strains. Values are expressed as mean ± SEM, where n= 6 
per group. 
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Figure S5: Representative blots for total, cytoplasmic and nuclear PGC-1α (A), 
OXPHOS (B) and HSP60/90 (C) proteins in liver. 
 
Figure S6: Representative blots for UCP-1 (A) and Total Protein (B) in BAT of mice 
following 10 months DR.  
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